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Abstract: 
This work concerns the preparation of novel [2.2]paracyclophane derivatives intended for use 
as asymmetric ligands and investigations into surface coatings prepared from 
[2.2]paracylophanes. This begins with a general introduction to enantioselective synthesis, 
followed by a review of relevant reported ligands based on the [2.2]paracyclophane 
framework and their applications.  
Next is described the preparation of novel ligands based on the [2.2]paracyclophane structure. 
Starting with the preparation of a range of mono and disubstituted [2.2]paracyclophanes, 
including several novel analogues, this moves on to investigating resolution procedures 
where a novel method for the preparation of enantiopure 4-bromo[2.2]paracyclophane is 
described. The coupling of prepared phenyl oxazoline analogues with the 
[2.2]paracyclophane moiety via the Buchwald-Hartwig amination is used to prepare several 
novel ligands and characterisation, along with a detailed investigation in the optimisation of 
their synthesis is presented.  The focus of the work then moves to the analogous 
octafluoro[2.2]paracyclophane and several routes towards its preparation are investigated. 
The structure was functionalised and attempts at preparing analogous fluorinated ligands to 
those already detailed are discussed. 
Protective surface coatings prepared from [2.2]paracyclophanes are known as parylenes and 
herein is presented methods for improved surface adhesion of these coatings. This was 
accomplished through the use of sol-gel coating pre-treatments. The pre-treatment 
formulations presented were characterised and ultimately proved superior to the current 
industrial benchmark. A number of fluorinated sol-gel additives were also prepared and 
characterised, two of which are novel, along with a brief study on the incorporation of 
organic dyes into sol-gel coatings.  
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The work concludes with a discussion of the outcomes and suggestions for future work. The 
most significant issue is the improvement of the synthesis of the new ligands which it is 
suggested may be enhanced by either the application of microwave synthesis or altering the 
coupling partners. Once this has been achieved the next steps would be examining the crystal 
structure of an isolated ligand-metal complex and then the application of this complex in 
model asymmetric transformations. 
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Abbreviations: 
AcOH   Acetic acid 
AF4   Octafluoro[2.2]paracyclophane 
AIBN   Azobisisobutyronitrile 
BCl3   Boron trichloride 
BF3   Boron trifluoride 
BINAP  2,2’bis(diphenylphosphino)-1,1’-binaphthyl 
BTF   Trifluorotoluene 
CCl4   Carbon tetrachloride 
CF3   Trifluoromethyl 
CIP   Cahn-Ingold-Prelog 
Cl2   Chlorine gas 
COSY   Correlation spectroscopy 
CsF   Caesium fluoride 
CTAB   Cetyl trimethylammonium bromide 
CVD   Chemical vapour deposition 
DAST   Diethylaminosulfur trifluoride 
DCM   Dichloromethane 
DiPAMP  (R,R)-1,2-Bis[(2-methoxyphenyl)(phenylphosphino)]ethane 
DMA   Dimethylacetamide 
DMF   Dimethylformamide 
DMSO   Dimethylsulfoxide 
DPPF   1,1’-bis(diphenylphosphino)ferrocene 
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EDX   Energy dispersive X-ray spectroscopy 
EtOH   Ethanol 
FeBr3   Iron (III) bromide 
HBr   Hydrogen bromide 
HCl   Hydrogen chloride 
HF   Hydrogen fluoride 
HNO3   Nitric acid 
HOOH   Hydrogen peroxide 
H2SO4   Sulfuric acid 
i-PrNEt  Ethyldiisopropylamine 
IR   Infrared 
KI   Potassium iodide 
KOtBu   Potassium tert-butoxide 
MAAH  Methacrylic acid 
MAPTMS  3-Methacryloxypropyltrimethoxysilane 
mCPBA  m-Chloroperoxybenzoic acid 
MeCN   Acetonitrile 
MeOH   Methanol 
MPS   Mesoporous silicates 
N2   Nitrogen gas 
NaBH4   Sodium borohydride 
n-BuLi   n-Butyllithium 
NMR   Nuclear magnetic resonance 
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NOESY  Nuclear Overhauser effect spectroscopy 
NO2BF4  Nitronium tetrafluoroborate 
OPc   Octafluoro[2.2]paracyclophane 
Pc   [2.2]Paracyclophane 
PCl5   Phosphorus pentachloride 
Pd(dba)2  Bis(dibenzylideneacetone)palladium(0) 
PFOTS  1H,1H,2H,2H-Perfluorooctyltriethoxysilane 
Phanephos  (RP)-4,12-bis-diphenylphosphino[2.2]paracyclophane 
pOPc   Perfluoro[2.2]paracyclophane 
PPh3   Triphenylphosphine 
rpm   Rotations per minute 
SEM   Scanning electron microscopy 
SF4   Sulfur tetrafluoride gas 
SNAr   Type of nucleophilic aromatic substitution 
SRN1   Radical nucleophilic aromatic substitution 
SO2   Sulfur dioxide gas 
SOCl2   Thionyl chloride 
SO2Cl2   Sulfuryl chloride 
TB   Trypan blue 
TBAB   Tetrabutylammonium bromide 
t-Bu   tert-Butyl 
t-BuLi   tert-Butyllithium 
TES   Transmission electron microscopy 
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TEOS   Tetraethyl orthosilicate 
THF   Tetrahydrofuran 
TiCl4   Titanium (IV) tetrachloride 
TLC   Thin layer chromatography 
TMS   Tetramethylsilane 
Tol   Toluene 
TsOH   p-Toluenesulfonic acid 
UV-Vis  Ultraviolet-Visible 
ZnCl2   Zinc chloride 
ZPO   Zirconium (IV) propoxide 
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1.0  Introduction to Enantioselective Synthesis   
1.1  Introduction 
The first documented observation of stereochemistry was made by Louis Pasteur in 1849 
when he observed that the salts of tartaric acid could rotate plane polarised light. Then in 
1874, Jacobus Henricus van't Hoff and Joseph Le Bel attributed this optical activity to the 
tetrahedral arrangement of atoms about a carbon centre
1
 (Figure 1.1). 
 
Figure 1.1: Both enantiomers of a simple chiral molecule. 
Molecules of this nature are referred to as chiral, as it is not possible to superimpose the 
molecule onto its mirror image. These mirror images are called enantiomers. A simple natural 
analogy for this is the comparison between the right and left hand. In fact, nature 
demonstrates a consistent asymmetry with the vast majority of naturally occurring amino 
acids having an L configuration.
2
 Enantiomers demonstrate identical physical and chemical 
properties in an achiral environment except in the direction that they rotate plane polarised 
light. The properties of enantiomers differ when they interact with other chiral molecules, 
receptors or enzymes within the body for example, which may result in different biological 
responses. This can be seen with simple compounds such as (S)-limonene which smells like 
lemons and (R)-limonene which smells like oranges. Another example is (S, S)-aspartame 
which is used as an artificial sweetener while (R, R)-aspartame has a bitter taste (Figure 1.2). 
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Figure 1.2: The structure of simple enantiomer pairs which affect the body differently. 
Perhaps the most famous example and the one which highlighted the importance of chirality 
and enantiopure substances is thalidomide, a compound prescribed to treat morning sickness 
in the 1960’s. (R)-Thalidomide does indeed treat morning sickness however the (S)-
enantiomer was found to be teratogenic leading to foetal abnormalities (Figure 1.3). It was 
later found that thalidomide racemises in vivo meaning that even an enantiopure form would 
not have averted this tragedy.
3
 
 
Figure 1.3: The enantiomers of thalidomide. 
Currently, European and U.S. law dictates that all pharmaceutical products must be fully 
evaluated and for chiral compounds this includes testing both enantiomers.
4
 This means there 
is a need for effective enantioselective synthesis, which involves the preparation of chiral 
products with a specific preference for a single enantiomer. The compounds shown in Figure 
1.4 are used to treat a variety of illnesses and have accounted for billions of dollars in sales. 
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This illustrates the possible commercial applications of improved enantioselective synthetic 
methods. 
 
Figure 1.4: The structure of three successful chiral drug compounds. 
1.2  Synthesis of enantiopure compounds 
The methods for producing enantiopure compounds may be categorised under three broad 
headings which are the chiral pool strategy, resolution of racemic mixtures and asymmetric 
synthesis (Figure 1.5). 
 
Figure 1.5: The methods for preparing enantiopure compounds. 
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1.2.1  Chiral pool strategy 
The term chiral pool refers to readily available, naturally occurring enantiopure compounds 
such as amino acids, sugars, alkaloids and terpenoids. These may be used as starting 
materials to synthesise the desired enantiopure product by providing basic chiral centres 
which can be built upon. This may be an attractive approach if the desired product is 
structurally similar to the starting material so as to have a short synthetic sequence. However 
care must be taken to preserve the chirality of the starting material. This method has been 
used in the synthesis of prostaglandin F2α
5
and chiraphos (Scheme 1.1).
6
 
 
Scheme 1.1: Chiral pool synthesis of prostaglandin F2α and chiraphos. 
1.2.2  Resolution 
Resolution is the process by which a racemic mixture is separated into its two enantiomers. It 
is the most widely used industrial method for obtaining enantiopure compounds. The 
disadvantage of this method is that the highest obtainable yield by definition is 50%. 
Resolution may be categorised under four headings which are classical resolution, kinetic 
resolution, enzymatic resolution and chromatographic resolution. 
1.2.2.1  Classical resolution 
Classical resolution involves derivatising a racemic mixture with an enantiopure reagent to 
yield a diastereomer. Diastereomers, unlike enantiomers, have different physical and 
Introduction to Enantioselective Synthesis  Chapter 1 
5 
   
chemical properties which allow them to be separated by conventional techniques. The 
resolving agent is then removed to yield the desired material in an enantiopure form. This 
approach is applied extensively in industry such as the resolution of Naproxen (Scheme 1.2). 
This particular example is noteworthy as the unwanted (R)-enantiomer 1 can be efficiently 
racemised and recycled to give yields for (S)-Naproxen 2 above 95% along with over 98% 
recovery of the resolving agent N-propylglucosamine 3.
7
 
 
Scheme 1.2: The resolution of (S)-Naproxen. 
1.2.2.2  Kinetic resolution 
Kinetic resolution relies on the different rates of reaction of a pair of enantiomers with a 
chiral reagent or catalyst. Ideally, one enantiomer reacts while the other does not, making 
them readily separable. As with classical resolution, the unwanted enantiomer must be 
racemised and resolved to increase the yield. If these processes can occur concurrently the 
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process is referred to as dynamic kinetic resolution. Noyori et al. reported the preparation of 
(R)-1-phenylethanol using kinetic resolution facilitated by a ruthenium catalyst (Scheme 
1.3).
8
 
 
Scheme 1.3: The kinetic resolution of (R)-1-phenylethanol. 
1.2.2.3  Chromatographic resolution 
Chromatographic resolution relies on the different affinities of enantiomers between a chiral 
stationary phase and a mobile phase. This is an attractive method as it does not involve 
additional steps to derivatise enantiomers, separate them and then regenerate the desired 
compound. As an example, Li et al. reported the efficient resolution of a range of α,α’-
dihydroxybiaryls using a modified silica prepared from readily available amino acid 
derivatives (Figure 1.6).
9
 
 
Figure 1.6: The structure of three successfully resolved biaryl compounds. 
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1.2.2.4  Enzymatic resolution 
Enzymes may also be used for the resolution of enantiomers. In the example shown in 
Scheme 1.4, resolution is achieved using the enzyme Pseudomonas Stutzeri lipase TL. A 
racmate of cis-5’-hydroxythalidomide 4 is selectively acylated to give enantiopure 5 while 
leaving the other enantiomer unchanged. These compounds can then be separated by 
conventional means and the initial compound regenerated using TsOH in MeOH.
10
  
 
Scheme 1.4: Enzymatic resolution of a thalidomide derivative. 
1.2.3  Asymmetric synthesis 
Asymmetric synthesis may be defined as a synthesis in which an achiral unit in a substrate 
molecule is converted to a chiral unit such that the possible stereoisomers are formed in 
unequal amounts.
7
 There are various ways this may be achieved and the approaches make use 
of chiral reagents, chiral auxiliaries or chiral catalysts to introduce the chirality into the 
substrate molecule. 
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1.2.3.1  Chiral reagents 
This approach involves the conversion of an achiral substrate to a chiral substrate with the 
use of an appropriate chiral reagent which controls the asymmetry introduced. Chiral 
allylboranes are common reagents for this methodology (Scheme 1.5). For example, 
Hoffmann et al. developed allylboronate 6 for the preparation of a range of homoallylic 
alcohols 7.
11
 Brown et al. prepared a range of chiral lactones 8 using allylboronate 9.
12,13
 The 
obvious limitation of this methodology is the requirement for stoichiometric quantities of 
potentially expensive or difficult to prepare chiral reagent.  
 
Scheme 1.5: The stereoselective allylation of carbonyl compounds using chiral 
allylboronates. 
1.2.3.2  Chiral auxiliaries  
A chiral auxiliary is a reagent incorporated into the substrate molecule to influence the 
stereoselectivity of one or more subsequent reactions. The diastereomers produced are 
separated and the auxiliary is then removed from the products and, in ideal cases, recycled. 
Examples are shown in Figure 1.7 and include pseudoephedrine 10 used to produce 
enantiomerically pure carboxylic acids, alcohols, aldehydes and ketones.
14
 Other frequently 
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used chiral auxiliaries are the valine 11 and norephedrine 12 derived oxazolidinones 
developed by Evans.
15,16
 
 
Figure 1.7: Common chiral auxiliaries. 
1.2.3.3  Chiral catalysts 
The third approach to asymmetric synthesis is the use of a chiral catalyst to facilitate an 
asymmetric transformation. This method is attractive because it does not require 
stoichiometric quantities of the chiral material which is one of the biggest disadvantages of 
using chiral reagents or chiral auxiliaries. Chiral catalysts may be categorised under four 
headings which are enzymes, catalytic antibodies, organocatalysts and metal catalysts. 
1.2.3.3.1 Enzymes 
Enzymes as catalysts are efficient, fast acting and usually give high levels of 
enantioselectivity. A successful use of an enzyme as a stereoselective catalyst is shown in 
Scheme 1.6 which is the synthesis of (S)-norcoclaurine 13. Tyrosine 14 is first 
decarboxylated and the subsequent aldehyde 15 coupled with dopamine 16 in the presence of 
the enzyme (S)-norcoclaurine synthase (NCS) to furnish the product.
17
 The limitations of 
enzymes are their pH sensitivity and limited solubility in organic solvents. They may also be 
less stable in these solvents than in aqueous solutions. Enzymes are natural materials 
designed to facilitate specific transformations so they tend to be substrate specific and not 
applicable as a general method. 
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Scheme 1.6: The synthesis of (S)-norcoclaurine. 
1.2.3.3.2 Catalytic antibodies 
Antibodies are used by the immune system to neutralise foreign objects such as bacteria and 
viruses. Like enzymes, they are proteins and operate in a similar fashion to enzymes in that 
they have an active site that will respond to a specific substrate. In recent years it has been 
shown that antibodies can be utilised as asymmetric catalysts. The example in Scheme 1.7 
shows the conversion of the ketone 17 to the (S)-enantiomer of the Wieland-Miescher ketone 
18 via the Robinson annulation using the antibody Ab38C2.
18
 
 
Scheme 1.7: The synthesis of enantiopure Wieland-Miescher ketone. 
1.2.3.3.3 Organocatalysts 
An organocatalyst as the name suggests, is an organic molecule which does not contain a 
metal but which catalyses a chemical transformation. This is currently a major area of 
research and the advantages these materials offer are that they are easily accessible and 
robust, usually being stable towards moisture and oxygen. They also avoid the use of metals 
which makes them more environmentally friendly and cheaper to produce. Examples include 
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L-Proline 19
19
, thioureas such as 20
20
 and alkaloids such as 21
21
,which have all been used as 
organocatalysts for a variety of asymmetric transformations (Figure 1.8). 
 
Figure 1.8: Three compounds used as organocatalysts. 
1.2.3.3.4 Metal catalysts 
Metal catalysts are the largest and most active area in asymmetric synthesis. These systems 
operate with a reactive metal centre coordinated to a chiral ligand. As such these ligands 
typically have donor atoms such as nitrogen, oxygen, phosphorus or sulfur. The metal 
activates the reagents allowing the reaction to proceed and the chirality of the products is 
translated from the chiral ligands around the metal centre. Figure 1.9 shows ligands which 
have been used in this methodology and these may possess axial chirality (BINAP 22)
22
, 
central chirality (DiPAMP 23)
23
 or planar chirality (Phanephos 24).
24
 
 
Figure 1.9: Three different chiral ligands used in asymmetric metal catalysis. 
Phanephos is an example of a [2.2]paracyclophane and since it was shown to be an effective 
compound for use in asymmetric catalysis, there has been a dramatic increase in research 
concerning [2.2]paracylophanes. 
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1.3  Conclusion 
This chapter has provided an introduction to enantioselective synthesis and will be followed 
by a review of relevant reported ligands based on the [2.2]paracyclophane framework and 
their applications in Chapter 2. Chapter 3 will describe the preparation of a novel class of 
asymmetric [2.2]paracyclophane ligands from commercially available starting materials. 
Chapter 4 contains a comprehensive review of the closely related 
octafluoro[2.2]paracyclophane. This is followed by Chapter 5 which is a description of 
progress towards the preparation of an analogous class of fluorinated [2.2]paracylophane 
ligands to complement those prepared in Chapter 3. Chapter 6 details protective surface 
coatings prepared from [2.2]paracyclophanes which are known as parylenes and here are 
presented methods for improved surface adhesion of these coatings. This was accomplished 
through the use of sol-gel pre-treatments on aluminium substrates, sol-gels themselves being 
another frequently used class of surface coatings. Chapter 7 discusses the preparation of a 
number of fluorinated sol-gel additives, along with a brief study on the incorporation of 
organic dyes into sol-gel coatings. Finally, Chapter 8 contains a brief conclusion along with 
suggestions for future work. 
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2.0  Review of [2.2]Paracyclophane Ligands: Preparation and Application 
2.1  Introduction 
The first report of [2.2]paracyclophane 1 was in 1949 with its isolation from a mixture of 
hydrocarbon polymers.
1
 The beginning of [2.2]paracyclophane (Pc) chemistry as a field of 
research however, is likely best credited to Cram and co-workers for their work commencing 
in 1951.
2
 Widespread industrial use of this compound and its derivatives are owed to Gorham 
for the development of a chemical vapour deposition (CVD) process to produce polymeric 
surface coatings
3
, commonly known as parylenes. The use of 1 and derivatives in this regard 
will be discussed in more detail in Chapter 7. The Pc framework has also been utilised in 
ligands for asymmetric catalysis. The advent of this area can be attributed to the preparation 
of enantiopure (RP)-4,12-bis-diphenylphosphino[2.2]paracyclophane 2 by Pye and Rossen in 
1997 (Scheme 2.1), used for rhodium catalysed asymmetric hydrogenations.
4
 
 
Scheme 2.1: The synthesis of (RP)-4,12-bis-diphenylphosphino[2.2]paracyclophane. 
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2.2  Preparation of [2.2]paracyclophane 
1 and certain derivatives may be prepared via the Winberg dimerisation.
5,6
 This reaction 
proceeds through the formation of the 1,4-quinodimethane intermediate 3. An optimised 
Winberg dimerisation is shown in Scheme 2.2 and can be used to prepare some useful halide 
derivatives.
7
 
 
Scheme 2.2: The preparation of [2.2]paracyclophane and simple derivatives. 
2.3  Assignment and stereochemical notation of [2.2]paracyclophane 
derivatives 
Substituted Pc derivatives may possess no asymmetric carbon centres yet they may still be 
chiral molecules and this is because they exhibit planar chirality. This occurs due to two non-
coplanar rings which are not symmetrical and rotation being restricted by the bonds 
connecting them, ethyl bridges in the case of Pc derivatives. Therefore, substituted Pc may 
exist as two enantiomers RP and SP, where subscript P denotes planar chirality. A numbering 
scheme must be introduced which can be used to assign the various positions of the molecule 
and this is shown in Figure 2.1.
8
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Figure 2.1: Numbering and assigning [2.2]paracyclophane derivatives. 
The plane with the highest level of substitution is considered the chiral plane. Position 1 is 
labelled as the closest out of plane atom to the chiral plane. This will be one of the ethyl 
bridge carbons in the case of Pc derivatives and the one chosen should lead to the lowest 
numbering for the highest priority substituent as per the Cahn-Ingold-Prelog (CIP) system.
9,10
 
The adjacent atoms a, b and c will then show either a clockwise (RP) or counter clockwise 
(SP) orientation which provides a stereochemical assignment. When substituents are on the 
same ring this is readily assigned, when the substituents are on opposing rings the chiral 
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plane is determined based on the highest priority substituent. To assign the tri-substituted 
enantiomers of 4-hydroxy-5-methyl-16-bromo[2.2]paracyclophane 4, the bromo substituent 
has the highest priority according to the CIP system however it does not reside on the chiral 
plane, as this has been defined as the most heavily substituted plane. Therefore the hydroxy 
substituent takes priority and is used as the basis to assign the stereochemistry. The 
development of more complex Pc structures has led to some ambiguity with nomenclature
11
 
but the rules that have been presented here will be sufficient to assign all compounds 
described in this work. 
The most commonly reported Pc regioisomers are shown in Figure 2.2. Bridge substituted 
analogues are quite rare but have been reported. 
 
Figure 2.2: Common regioisomers of disubstituted [2.2]paracyclophane. 
2.4  Resolution of [2.2]paracyclophane derivatives 
Effective resolution protocols are a necessity if asymmetric ligands based on the Pc 
framework are to gain more attention. Various methods have been developed in classical 
resolution, kinetic resolution and enzymatic resolution, and examples are presented for key 
monosubstituted derivatives in Table 2.1. The chromatographic resolution approach is less 
common.
12
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Table 2.1: Resolution protocols for key [2.2]paracyclophane derivatives. 
 
R Resolution procedure 
NH2 Crystallisation of diastereomeric salts of (1S)-(+)-10-camphorsulfonic acid.
13
 
OH Enzymatic kinetic resolution of OAc derivatives and subsequent 
hydrolysis,
14,15,16,17
 crystallisation of diastereomeric esters of (1S)-(-)-
camphanic acid and subsequent hydrolysis,
18
 crystallisation of 
diastereomeric imines of methylbenzylamine and subsequent Dakin 
oxidation.
19
 
CHO Crystallisation of diastereomeric imines of methylbenzylamine and 
subsequent hydrolysis
19,20
 and enzymatic kinetic resolution.
21
 
COCH3 Crystallisation of diastereomeric SAMP-hydrazones followed by reduction 
with NaBH4.
22
 
CO2H Crystallisation of diastereomeric Brucine salts
23
 and crystallisation of 
diastereomeric salts of α-methyl-4-nitrobenzylamine.24 
 
Other notable resolutions of monosusbtituted Pc include that of phosphine derivatives via 
diastereomeric phosphine-palladacycle complexes
25
 and 4-bromo[2.2]paracyclophane via 
kinetic resolution using a Buchwald-Hartwig amination.
26
 Some success in the resolution of 
more heavily substituted derivatives has been reported with pertinent examples being the bis-
phosphine oxide 5,
4
 the bis-phenol 6,
27
 the bis-bromide 7
28
 and a tetra-substituted derivative 
8
29
 (Figure 2.3). 
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Figure 2.3: The structures of resolved substituted [2.2]paracyclophanes. 
Any endeavour in preparing enantiomerically pure Pc derivatives will likely require the use 
of one of these key intermediates presented in Table 2.1 or the development of an entirely 
new resolution protocol. Recent developments in the area have been focused on a single 
resolution protocol that could be used to prepare a range of Pc derivatives in enantiomerically 
pure form. The sulfoxide methodology is at present the most promising approach. 
Sulfoxide derivatives of Pc were first prepared using Anderson reagent 9 and it was found 
that the resulting diastereomers could be separated via column chromatography (Scheme 
2.3).
30
 Sulfoxides garnered from the thiosulfinate 10
31
 were also found to be separable. The 
reaction proceeds with inversion of the sulfur centre but is stereospecific, the resulting 
diastereomers differ only in planar chirality. Both the toluene (Tol) and tert-butyl (t-Bu) 
moieties allow resolution however the different groups significantly alter the subsequent 
chemistry that can be carried out on the Pc framework. 
 
Scheme 2.3: The resolution of diastereomeric sulfoxide derivatives. 
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Sulfoxide-metal exchange on the Tol derivative 11 using n-butyl lithium (n-BuLi) generates 
the 4-lithio[2.2]paracyclophane intermediate 12 and subsequent treatment with the 
appropriate electrophile yields a range of enantiopure monosubstituted Pc derivatives 
(Scheme 2.4).
32,33
  
 
Scheme 2.4: The preparation of enantiopure [2.2]paracyclophane derivatives. 
Bromination of 11 may allow access to enantiopure pseudo-geminal derivatives 13, but thus 
far selective substitution of the bromo group has proven problematic. Sulfide 14 and sulfone 
15 analogues were also examined with mixed results (Scheme 2.5).
33
 
 
Scheme 2.5: The preparation of sulfide and sulfone analogues. 
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The sulfoxide methodology has been applied to pseudo-ortho derivatives allowing an 
alternative resolution approach to the phosphine oxide precursor of Phanephos 5 (Scheme 
2.6).
34
 
 
Scheme 2.6: The resolution of disubstituted sulfoxide derivatives. 
The use of the t-Bu derivative 16 allows selective ortho-lithiation of the Pc framework rather 
than substitution of the sulfoxide moiety. This is permissible only if the diastereomer has the 
t-Bu group orientated away from the ring as in Scheme 2.7.
35
 
 
Scheme 2.7: Ortho-lithiation and derivatisation of sulfoxide derivatives. 
If the t-Bu group is orientated in towards the ring then lateral substitution of the C2 
methylene carbon may occur as is the case in Scheme 2.8.
36
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Scheme 2.8: Bridge functionalisation of sulfoxide derivatives. 
The t-Bu derivative 16 is not amenable to psuedo-geminal substitution and its resistance to 
sulfoxide-metal exchange makes selective removal of the sulfoxide substituent problematic.  
The t-Bu sulfoxide may be converted to the thiol 17 if desirable via the pathway shown in 
Scheme 2.9.
37,38
 
 
Scheme 2.9: The synthesis of thiol derivatives. 
The examples presented in this section provide an overview of the established resolution 
methodologies concerning Pc derivatives and the recent advances. This account is not 
exhaustive and there are other examples of resolutions of Pc derivatives presented in the 
literature. For further discussion of this area see reviews by Hopf
39
, Gibson
8
 and Rowlands.
36
 
2.5  Oxazoline containing [2.2]paracyclophane derivatives 
Oxazoline containing Pc derivatives have allowed the preparation of a versatile group of 
bidentate ligands. Examples to date encompass P,N, N,O, N,N, S,N and Se,N ligands and 
these have been applied to various asymmetric transformations.  
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2.5.1  As ligands in transition metal catalysis 
The most common approach to preparing these derivatives is to begin with the carboxylic 
acid 18 and generate the corresponding amide 19 from an amino alcohol (Scheme 2.10). The 
oxazoline 20 is then formed via the Appel reaction. The stereochemistry and substitution of 
the oxazoline moiety is tuned by selecting the appropriate amino alcohol, so this method is 
widely applicable. In the example presented here by Hou et al., direct ortho-lithiation of 20 
and treatment with diphenyl disulfide or diphenyl diselenide yielded three 
chromatographically separable stereoisomers 21a-c and 22a-c. The bridge substituted 
analogues 21c and 22c were not expected. The fact that only one bridge substituted 
diastereomer was detected indicates a steric effect from the oxazoline isopropyl group.
40
 
 
Scheme 2.10: The preparation of N,S and N,Se ligands. 
These ligands were applied in a palladium catalysed allylic alkylation (Table 2.2). It was 
found that the selenium derivatives 22a-c were slightly more selective than sulfur derivatives 
Review of [2.2]Paracyclophane Ligands: Preparation and Application Chapter 2 
25 
   
21a-c and the bridge substituted derivatives 21c and 22c were more efficacious than their aryl 
substituted counterparts. The stereochemistry of the products appears to be controlled by the 
planar chirality of the ligand in the case of the aryl analogues 21a-b and 22a-b. Both 
diastereomers of the bridge substituted derivatives were not prepared so it is not clear if this 
is the case with that substitution pattern. 
Table 2.2: Asymmetric allylic alkylations of 1,3-diphenylallyl acetate.
40
 
 
Ligand Solvent Salt Time (h) Yield (%) ee (%) Configuration 
(SPS)-21a Tol LiOAc 40 98 54 R 
(SPS)-21a DCM LiOAc 24 98 50 R 
(SPS)-21a DCM KOAc 36 98 53 R 
(SPS)-21a MeCN KOAc 32 98 54 R 
(RPS)-21b MeCN KOAc 21.5 98 63 S 
(SPRS)-21c MeCN KOAc 1.5 98 94 S 
(SPS)-22a MeCN KOAc 20 98 57 R 
(RPS)-22b MeCN KOAc 30 98 73 S 
(SPRS)-22c MeCN KOAc 2 98 93 S 
 
Another report published at the same time detailed the preparation of a number of oxazoline 
containing pseudo-geminal derivatives. Standard bromination of amide 23 yielded 24 
exclusively. The oxazoline 25 was furnished from 24 using the Appel reaction and this 
derivative gave access to useful analogues 26 and 27 (Scheme 2.11). None of these 
derivatives were prepared in optically pure form in this case.
41
 
Review of [2.2]Paracyclophane Ligands: Preparation and Application Chapter 2 
26 
   
 
Scheme 2.11: The preparation of oxazoline containing disubstituted derivatives. 
Hou et al. then used an analogous method to that presented in Scheme 2.14, to prepare a 
series of pseudo-geminal precursors 28a-d and 29a-d which could be separated via column 
chromatography (Scheme 2.12). From these precursors was derived a series of ligands with 
varied groups on both the oxazoline moiety 30a-d, 31a-d and the phosphorus centre 32a-d.
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Scheme 2.12: The preparation of P,N ligands. 
These ligands were also applied in a palladium catalysed allylic alkylation (Table 2.3). 
Contrary to the results presented in Table 2.2, in this case the central chirality of the 
oxazoline determined the configuration of the product. Altering the aryl substituents on the 
phosphorus centre had mixed results. The 4-methoxy derivative 32c showed a marked 
increase in selectivity and was the best reported ligand overall, while the 2-methyl derivative 
32a showed very little selectivity and was the worst in the series. 
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Table 2.3: Asymmetric allylic alkylations of 1,3-diphenylallyl acetate.
42
 
 
Ligand Time (min) Yield (%) ee (%) Configuration 
(RPS)-30a 20 98 37 S 
(SPS)-31a 15 98 6 S 
(RPS)-30a 10 98 49 S 
(RPS)-30a 90 98 62 S 
(RPS)-30b 210 98 11 S 
(SPS)-31b 90 98 41 S 
(RPS)-30c 60 98 42 S 
(SPS)-31c 60 98 29 S 
(RPR)-30d 60 98 73 R 
(SPR)-31d 90 98 54 R 
(RPR)-32a 180 98 6 R 
(RPR)-32b 60 98 69 R 
(RPR)-32c 20 98 90 R 
(RPR)-32d 240 98 49 R 
 
Hou et al. subsequently prepared a series of N,O ligands again utilising the precursors 28a-d 
and 29a-d. Bromo-lithium exchange and treatment with benzophenone furnished ligands 
33a-d and 34a-d (Scheme 2.13).
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Scheme 2.13: The preparation of N,O ligands. 
These ligands were applied in the addition of diethyl zinc to a variety of aldehydes (Table 
2.4). It was found that matched planar and central chirality was optimal for appreciable 
selectivity. The benzyl ligand 33c proved to be particularly efficacious over a range of 
substrates. 
Table 2.4: Asymmetric addition of diethyl zinc to benzaldehyde.
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Ar Ligand Time (h) Yield (%) ee (%) Configuration 
Ph (SPS)-33a 9 96 93 R 
Ph (RPS)-34a 24 35 5 S 
Ph (SPS)-33b 24 37 32 R 
Ph (RPS)-34b 24 13 7 S 
Ph (SPS)-33c 7 93 93 R 
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Ph (RPS)-34c 24 12 7 S 
Ph (SPR)-33d 24 12 5 S 
Ph (RPR)-34d 18 85 87 S 
p-ClC6H4 (SPS)-33c 8 96 94 R 
p-BrC6H4 (SPS)-33c 9 95 93 R 
p-MeOC6H4 (SPS)-33c 24 86 82 R 
o-MeOC6H4 (SPS)-33c 4 94 81 R 
α-naphtyl (SPS)-33c 20 87 86 R 
β-naphtyl (SPS)-33c 9 95 95 R 
 
The final report from Hou et al. also examined N,O ligands with a series which varied in 
steric bulk about the hydroxyl substituent. 33a-c and 34a-c were examined previously and 
were now compared to ligands with less steric bulk. 35a-c and 36a-c represent the least 
hindered hydroxyl group and then an intermediate series in 37a-b and 38 (Figure 2.4).
44
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Figure 2.4: The preparation of N,O ligands. 
These ligands were also applied in the addition of diethyl zinc to aromatic aldehydes (Table 
2.5). The less hindered ligands 35a-c and 36a-c gave improved or comparable yields and 
selectivity in all cases compared to 33a-c and 34a-c. Again the results showed that matched 
planar and central chirality was optimal. The methylated derivative 37b was shown to be 
slightly more selective than its phenyl counterpart 33c over a range of substrates. 
Table 2.5: Asymmetric addition of diethyl zinc to benzaldehyde.
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Ar Ligand Time (h) Yield (%) ee (%) Config. 
Ph (SPS)-35a[(SPS)-33a] 5 (9) 94 (96) 91 (93) R (R) 
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Ph (RPS)-36a[(RPS)-34a] 24 (24) 49 (35) 25 (5) S (S) 
Ph (SPS)-35b[(SPS)-33b] 7 (24) 93 (37) 94 (32) R (R) 
Ph (RPS)-36b[(RPS)-34b] 24 (24) 46 (13) 36 (7) S (S) 
Ph (SPS)-35c[(SPS)-33c] 5 (7) 94 (93) 91 (93) R(R) 
Ph (RPS)-36c[(RPS)-34c] 24 (24) 51 (12) 45 (7) S (S) 
Ph (SPS)-37a 3.5 93 97.9 R 
Ph (SPS)-37b 1.5 95 98.4 R 
Ph (RPS)-38 48 <5 - - 
p-ClC6H4 (SPS)-37b[(SPS)-33c] 2 (8) 96 (96) 97.6 (94) R (R) 
p-BrC6H4 (SPS)-37b [(SPS)-33c] 2 (9) 95 (95) 96.8 (93) R (R) 
p-MeOC6H4 (SPS)-37b [(SPS)-33c] 3.5 (24) 94 (86) 96 (82) R (R) 
o-MeOC6H4 (SPS)-37b [(SPS)-33c] 1 (4) 96 (94) 96 (81) R (R) 
 
Using a ligand with an achiral oxazoline moiety 39a-b afforded excellent yields and 
selectivity, comparable to 37a and 37b which also possessed central chirality (Scheme 2.14). 
This clearly demonstrates that the planar chirality is crucial in the selectivity of the ligand. It 
is of note that 38, which possessed opposing planar and central chirality was an ineffective 
ligand. 
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Scheme 2.14: The synthesis and application of N,O ligands in the addition of diethyl zinc.
44
 
These ligands were also utilised in the nickel catalysed asymmetric addition of diethyl zinc to 
a range of chalcones (Table 2.6). The reaction yields were uniformly excellent and the 
selectivity was moderate to high. The configurations were not assigned for the majority of 
cases but for those that were the product matched the configuration of the planar chirality of 
the catalysts. Again mismatched planar and central chirality was observed to reduce 
selectivity. 
Table 2.6: Asymmetric addition of diethyl zinc to chalcones.
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Ar1 Ar2 Ligand Ligand 
(mol%) 
ee (%) Config. 
Ph Ph 33-34 10 0 - 
Ph Ph (SPS)-37a 10 8 S (-) 
Ph Ph (SPS)-35a [(RPS)-36a] 10 52 (0) S (-) 
Ph Ph (SPS)-35b [(RPS)-36b] 10 63 (0) S (R) 
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Ph Ph (SPS)-35c [(RPS)-36c] 10 53 (4) S 
Ph Ph (SPS)-35b 20 75 - 
p-MeC6H4 Ph (SPS)-35b 20 63 - 
p-BrC6H4 Ph (SPS)-35b 20 71 - 
p-ClC6H4 Ph (SPS)-35b 20 72 - 
Ph p-BrC6H4 (SPS)-35b 20 61 - 
Ph p-MeOC6H4 (SPS)-35b 20 83 - 
 
The majority of the ligands presented thus far have been pseudo-geminal structures however 
Bolm et al. have reported pseudo-ortho ligands. The precursor series 40 was functionalised 
with varying imidazole groups. The subsequent ligands 41a-d and 42b,d were used to 
prepare catalytic iridium carbene complexes 43a-c and 44b (Scheme 2.15).
45
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Scheme 2.15: The preparation of iridium carbene complexes. 
These iridium complexes were then applied to the asymmetric hydrogenation of a variety of 
alkenes 45a-e. Substrates 45a and 45b were tested at both 25 °C and 50 °C (Table 2.7). The 
higher temperature afforded higher yields but generally reduced selectivity. 43c which 
possessed only planar chirality was found to be the best performing ligand and was extended 
to substrates 45c-e. Yields were uniformly excellent except when using only 1 bar of H2. The 
configuration of the products when using catalyst 43b and 44b were the same indicating that 
in this case central chirality may be more dominant than planar chirality. 
 
Review of [2.2]Paracyclophane Ligands: Preparation and Application Chapter 2 
36 
   
Table 2.7: Asymmetric hydrogenation of alkenes.
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Substrate Catalyst Time 
(h) 
Temp 
(°C) 
H2(bar) Yield 
(%) 
ee (%) Config. 
45a (SP)-43a 6-24 25/50 50 -/40 -/0 - 
45a (SPS)-43b 6-24 25/50 50 17/61 12/4 R 
45a (RPS)-44b 6-24 25/50 50 15/59 11/10 R 
45a (SP)-43c 6-24 25/50 50 35/76 28/15 R 
45b (SP)-43c 6-24 25/50 50 25/100 11/4 - 
45c (SP)-43c 2 25 50 100 9 R 
45c (SP)-43c 6-24 25 10 100 13 R 
45c (SP)-43c 48 25 1 46 46 R 
45d (SP)-43c 6-24 25 50 99 38 R 
45e (SP)-43c 6-24 25 50 100 21 R 
 
Bolm et al. produced a later report detailing a series of N,O ligands. A variety of 
regioisomers were prepared including pseudo-geminal 46-47, pseudo-ortho 48-49 and ortho 
50-51 derivatives (Figure 2.5).
46
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Figure 2.5: The preparation of N,O ligands. 
These ligands were applied in the addition of diethyl zinc to benzaldehyde (Table 2.8).  
Pseudo-geminal ligands 46a-b demonstrated the highest selectivity while 47 showed the 
lowest. Opposing planar and central chirality was optimal and an increase in steric bulk on 
the oxazoline as with 46b increased yield and selectivity. The planar chirality seems to 
determine the configuration of products with pseudo-geminal ligands 46-47 and ortho ligands 
50-51. In the case of pseudo-ortho ligands 48-49 however the central chirality appears to be 
the deciding factor. 
Table 2.8: Asymmetric addition of diethyl zinc to benzaldehyde.
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Ligand Time Yield (%) ee(%) Configuration 
(RPS)-46a 2 78 78 R 
(SPS)-47 24 93 11 S 
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(SPS)-48 4 96 51 S 
(RPS)-49 24 74 35 S 
(RPS)-50 48 72 44 R 
(SPS)-51 24 79 62 S 
(RPS)-46b 4 93 87 R 
 
The final report from Bolm et al. details the preparation of a series of P,N ligands. Again 
pseudo-geminal 52-53, pseudo-ortho 54-55 and ortho derivatives 56-57 were prepared. There 
was also variation around the phosphorus centre and the oxazoline moiety 54a-c and 55a-c 
(Figure 2.6).
47
 
 
Figure 2.6: The preparation of N,P ligands. 
These ligands were applied in a palladium catalysed allylic alkylation (Table 2.9). The 
pseudo-geminal ligands 52-53 with matched planar and central chirality provided the 
Review of [2.2]Paracyclophane Ligands: Preparation and Application Chapter 2 
39 
   
optimum selectivity and the central chirality appears to determine the configuration of the 
product. This is also the case for the ortho ligands 56-57. The pseudo-ortho ligands 54a and 
55a in contrast perform best with mismatched planar and central chirality and the product 
configuration appears to be determined by the planar chirality. Replacing the phenyl groups 
on the phosphorus centre with Tol groups increased selectivity, markedly so in the (SPS) 
derivative 54b. Interestingly, changing the oxazoline substituent from an isopropyl to a 
phenyl group reversed the situation and the mismatched analogue 54c outperforms the 
matched analogue 55c. 
Table 2.9: Asymmetric allylic alkylation of 1,3-diphenylallyl acetate.
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Ligand Time (h) Yield (%) ee (%) Configuration 
(RPS)-52 8 96 30 S 
(SPS)-53 6 >98 56 S 
(SPS)-54a 10 >98 28 R 
(RPS)-55a 10 >98 82 S 
(RPS)-56 8 >98 23 S 
(SPS)-57 7 >98 47 S 
(SPS)-54b 20 >98 63 R 
(RPS)-55b 5 >98 89 S 
(SPR)-54c 5 >98 89 R 
(RPR)-55c 20 >98 62 S 
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2.5.2  As organocatalysts 
The last report discussing oxazoline containing Pc ligands is more unusual as a rather 
different approach has been taken in the preparation of the target compound. Firstly the 
unusual aza derivative 58 has been utilised as a precursor.
48
 The oxazolines 59a-d were 
prepared from the cyano moiety of 58 via the Witte Seeliger reaction. This is in contrast to 
previous examples which all relied on some variation of amide formation followed by 
cyclisation via the Appel reaction. The final step to yield organocatalysts 60a-d is treatment 
with the oxidant mCPBA (Scheme 2.16).
49
 
 
Scheme 2.16: The preparation of N-oxide organocatalysts. 
The catalysts were applied in the allylation of 4-methoxybenzaldehyde (Table 2.10). The 
choice of solvent and base had a significant impact on the yield and selectivity of the 
reaction. MeCN and i-Pr2NEt were found to be the optimal solvent and base respectively. The 
configuration of the product appears to be controlled by the planar rather than central 
chirality. The t-Bu derivative 60a provided the highest ee of 90%. 
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Table 2.10: Asymmetric allylation of 4-methoxybenzaldehyde.
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Catalyst Base Solvent Yield (%) ee (%) Configuration 
(RPS)-60a i-Pr2NEt THF 83 47 S 
(RPS)-60a i-Pr2NEt Toluene 61 48 S 
(RPS)-60a i-Pr2NEt DCM 82 86 S 
(RPS)-60a i-Pr2NEt MeCN 91 90 S 
(RPS)-60a Et3N MeCN 67 38 S 
(RPS)-60b i-Pr2NEt MeCN 83 75 S 
(RPR)-60c i-Pr2NEt MeCN 92 37 S 
(RPR)-60d i-Pr2NEt MeCN 85 43 S 
 
The catalysts were then applied to a variety of aromatic aldehydes using the optimised 
conditions (Table 2.11). This series further confirmed that the planar chirality was the 
determining factor in the configuration of the products. 60a was again found to be the most 
selective catalyst across all substrates with the exception of 4-nitrobenzaldehyde where it was 
slightly outperformed by 60b. 
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Table 2.11: Asymmetric allylation of aromatic aldehydes.
49
 
 
Ar Catalyst Yield (%) ee (%) Configuration 
Ph (RPS)-60a 95 93 S 
Ph (RPS)-60b 90 87 S 
Ph (RPR)-60c 93 47 S 
Ph (RPR)-60d 89 53 S 
4-CH3C6H4 (RPS)-60a 87 88 S 
4-CH3C6H4 (RPS)-60b 91 67 S 
4-CH3C6H4 (RPR)-60c 84 36 S 
2-CH3C6H4 (RPR)-60d 85 41 S 
2-CH3C6H4 (RPS)-60a 88 85 S 
2-CH3C6H4 (RPR)-60c 86 31 S 
3,4-(OCH3)2C6H3 (RPS)-60a 93 96 S 
3,4-(OCH3)2C6H3 (RPR)-60c 90 12 S 
4-ClC6H4 (RPS)-60a 91 91 S 
4-ClC6H4 (RPS)-60b 90 82 S 
4-ClC6H4 (RPR)-60c 88 27 S 
4-ClC6H4 (RPR)-60d - - - 
2-ClC6H4 (RPS)-60a 89 93 S 
2-ClC6H4 (RPS)-60b 92 83 S 
4-N2OC6H4 (RPS)-60a 96 87 S 
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4-N2OC6H4 (RPS)-60b 89 91 S 
4-CF3C6H4 (RPS)-60a 91 96 S 
4-CF3C6H4 (RPS)-60b 88 74 S 
2-naphtyl (RPS)-60a 92 87 S 
2-naphtyl (RPS)-60b 84 71 S 
2-furan (RPS)-60a 73 72 S 
2-furan (RPS)-60b 73 51 S 
 
2.6  Conclusion 
This review introduces [2.2]paracyclophane beginning with its discovery and details the 
advent of its application in asymmetric catalysis. The methods of assigning stereochemical 
configuration to planar chiral Pc structures have been detailed along with the established 
protocols and current research trends in the resolution of this class of compounds.  Oxazoline 
containing Pc derivatives have been discussed in detail, both their preparation and application 
in asymmetric catalysis. Although these ligands have proved versatile in their own right, they 
represent only a subset of Pc ligands which have been investigated. For a broader discussion 
of the area see reviews by Hopf
39
, Gibson
8
, Paradies
50,51
, David
52
 and Rowlands.
53
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3.0  Preparation of Asymmetric Ligands Based on [2.2]Paracyclophane 
3.1  Introduction 
This chapter describes the synthetic work carried out towards the preparation of novel Pc 
ligands. This begins with the preparation of a variety of mono and disubstituted derivatives of 
[2.2]paracyclophane 1. A selection of these derivatives were then utilised in preparing novel 
oxazoline containing derivatives of 1 via the Buchwald-Hartwig amination. Various 
conditions and substrates were examined for these amination reactions and these are 
discussed in detail. 
The general design and structure of these Pc ligands is shown in Scheme 3.1. This specific 
design was chosen for a number of reasons. Firstly, no ligands have been reported with this 
type of arrangement. The structurally closest examples are discussed in Chapter 2. Secondly, 
it was envisaged that the ligand would act as a bidentate N,N ligand forming a six membered 
system with a metal centre. Finally, it was proposed that a high level of stereo control could 
be obtained due to having two separate chiral moieties on the ligand, planar chirality from the 
Pc group and central chirality from the oxazoline substituent. 
 
Scheme 3.1: A general outline for the preparation of novel oxazoline containing 
[2.2]paracyclophane ligands and the proposed binding of a metal atom. 
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3.2  Synthesis of monosubstituted [2.2]paracyclophane derivatives  
A range of monosubstituted Pc derivatives were prepared from the precursor 1 using various 
methodologies (Scheme 3.2). 
 
Scheme 3.2: The preparation of monosubstituted [2.2]paracyclophanes. 
3.2.1  Synthesis of 4-bromo[2.2]paracyclophane 
4-bromo[2.2]paracyclophane 2 is synthesised directly from 1 using a combination of bromine 
and iron in DCM.
1
 The reaction was heated at reflux for 20 hours and 2 may be isolated by a 
standard aqueous workup in 96% yield (Scheme 3.3). No further purification is required. 
 
Scheme 3.3: The synthesis of 4-bromo[2.2]paracyclophane. 
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The proposed mechanism shown in Scheme 3.4, is an electrophilic aromatic substitution with 
the iron (III) bromide (FeBr3) catalyst formed in situ from elemental bromine and iron. This 
catalyst facilitates the electrophilic addition of bromine which forms a resonance stabilised 
carbocation. Aromaticity is restored by the abstraction of a proton to give the product, 
hydrogen bromide (HBr) and regenerate the catalyst. 
 
 Scheme 3.4: The proposed mechanism for the formation of 4-bromo[2.2]paracyclophane.  
3.2.2  Synthesis of 4-formyl[2.2]paracyclophane 
4-Formyl[2.2]paracyclophane 3 may be synthesised directly from 1 by Rieche formylation
2
 in 
reported quantitative yield.
3,4
 It may also be produced from the corresponding sulfoxides.
5
 
Here 3 was prepared by the Rieche formylation but it was found the reported conditions were 
not optimal. Using the reported conditions which involved a reaction time of 6 hours and 
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isolation by standard aqueous workup
4
, it was found that the resulting product was not pure 
and contained significant amounts of 1. Using an extended reaction time of 20 hours and 
purifying the product using flash column chromatography pure product was isolated in a 63% 
yield (Scheme 3.5). 
 
Scheme 3.5: The synthesis of 4-formyl[2.2]paracyclophane. 
The proposed mechanism shown in Scheme 3.6 begins with the generation of the electrophile 
from dichloromethoxymethane and titanium tetrachloride (TiCl4). This electrophile attacks 
the aromatic ring and forms a resonance stabilised carbocation. The proton is abstracted to 
form HCl and regenerates the catalyst. Finally, treatment with water results in the loss of the 
chloro and methyl groups as HCl and MeOH respectively, yielding the product. 
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Scheme 3.6: The proposed mechanism for the formation of 4-formyl[2.2]paracyclophane. 
3.2.3  Synthesis of 4-hydroxy[2.2]paracyclophane 
4-Hydroxy[2.2]paracyclophane 4 is most readily prepared from 3 via an acid catalysed Dakin 
oxidation.
4
 Alternatively it may be synthesised from the bromo derivative 2 using a three step 
protocol beginning with lithiation, transmetallation onto boron and subsequent hydrolysis of 
the borate ester to yield the title compound.
6
 Here the Dakin oxidation was utilised to give 4 
in 55% yield (Scheme 3.7). 
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Scheme 3.7: The synthesis of 4-hydroxy[2.2]paracyclophane. 
The proposed mechanism shown in Scheme 3.8 begins with the formation of a resonance 
stabilised oxonium ion by protonation with H2SO4. Hydrogen peroxide (HOOH) then attacks 
the carbocation resulting in another oxonium species. There is a hydrogen transfer and a loss 
of water, forming a carbonyl oxonium ion. The carbonyl carbon is attacked by MeOH 
followed by another hydrogen transfer. This yields the desired product, regenerates the 
catalyst and produces methyl formate as a by-product. 
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Scheme 3.8: The proposed mechanism for the formation of 4-hydroxy[2.2]paracyclophane. 
3.2.4  Synthesis of 4-nitro[2.2]paracyclophane 
4-Nitro[2.2]paracylophane 5 was originally synthesised from 1 by nitration using a mixture 
of AcOH and HNO3 yielding 5 in yields of 33%.
7
 A more recent report detailed a modified 
procedure which gave an improved yield of 5 at 48%.
8
 The low yields are attributed to the 
oxidation sensitivity of 1 which, under these conditions, leads to the formation of tars. Yields 
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above 95% have been achieved using an acidic ion exchange resin called Nafion.
9
 Using a 
modified version of the procedure reported by Paradies et al.
8
, 5 was prepared in quantities 
above 5 g in 27% yield (Scheme 3.9). The time this reaction is allowed to proceed for is 
crucial and it was found that 30-60 seconds was optimal. If the reaction was allowed to 
proceed any longer yields were significantly reduced. 
 
Scheme 3.9: The synthesis of 4-nitro[2.2]paracyclophane. 
The proposed mechanism shown in Scheme 3.10, begins with the electrophilic addition of the 
nitronium ion to the aromatic ring. The resulting carbocation is resonance stabilised and 
aromaticity is restored by loss of an aromatic proton. 
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Scheme 3.10: The proposed mechanism for the formation of 4-nitro[2.2]paracyclophane. 
3.2.5  Synthesis of 4-amino[2.2]paracyclophane 
4-Amino[2.2]paracyclophane 6 was initially synthesised via the reduction of 5 using MeOH 
and Platinum oxide in 89% yield.
7
 A later report utilises a similar procedure with hydrogen 
gas as the hydrogen source instead of methanol.
10
 6 was also prepared using a phase transfer 
catalysis procedure which furnished the compound in 95% yield.
9
 A two-step procedure 
beginning with metalation and subsequent amination of bromo derivative 2 has also been 
reported.
11
 Here, 6 was prepared from 5 using HCl with iron as a catalyst in yields of up to 
83% (Scheme 3.11). Although a standard procedure for the reduction of nitro compounds, this 
method does not appear to have been applied to 5. This compares well to the other reported 
procedures and has the benefit of avoiding expensive materials such as platinum and crown 
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ethers. Furthermore, the product may be isolated by standard aqueous workup and requires no 
further purification. 
 
Scheme 3.11: The synthesis of 4-amino[2.2]paracyclophane. 
The proposed mechanism shown in Scheme 3.12 is facilitated by acid and electrons from the 
iron catalyst. First the nitro group is reduced to a hydroxylamine which is reduced again to 
yield the amine. 
 
 Scheme 3.12: The proposed mechanism for the reduction of 4-nitro[2.2]paracyclophane.  
3.3  Synthesis of disubstituted [2.2]paracyclophane derivatives 
A range of disubstituted [2.2]paracyclophane analogues were also prepared (Scheme 3.13). 
Analysis of these analogues required a close examination of the 
1
H NMR spectra to elucidate 
at which position substitution had occurred and this will be discussed in detail. 
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Scheme 3.13: The preparation of disubstituted [2.2]paracyclophanes. 
3.3.1  Synthesis of 4-bromo-13-nitro[2.2]paracyclophane 
4-Bromo-13-nitro[2.2]paracyclophane 7 is prepared from 5 using bromine and iron in 
reported yields of up to 70%.
8,12,13
 Here, 7 was isolated in yields up to 28% (Scheme 3.14).  
 
Scheme 3.14: The synthesis of 4-bromo-13-nitro[2.2]paracyclophane. 
The mechanism for this reaction is proposed to be similar to that shown in Scheme 3.4, 
however the regioselectivity is explained by the formation of a complex between the nitro 
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group and the hydrogen atom at the 4’ position as shown in Scheme 3.15. This effect has also 
been documented to occur with methyl ester, methyl ketone and carboxy Pc derivatives and is 
termed the pseudo-geminal effect.
14
 
 
Scheme 3.15: The proposed mechanism for the bromination of 4-nitro[2.2]paracyclophane. 
The low yield for the desired product is attributed to the formation of two distinct 
trisubstituted by-products which were isolated here. Surprisingly no mention of this issue 
appears in the literature. The by-products can be readily identified as trisubstituted by having 
only five aromatic protons in their 
1
H NMR spectra (Figure 3.1). They therefore must differ 
in the addition of two bromine atoms from the starting material 5. They also share the same 
splitting pattern of 2 singlets, 2 doublets and a doublet of doublets (dd). The two doublets and 
the dd indicate a monosubstituted ring with the doublet displaying the small coupling 
constant being ortho to the substituent, in this case a nitro group. The dd is then in the para 
position and the other doublet, with the larger coupling constant, being in the meta position. 
The opposing ring is responsible for the two singlets and these indicate disubstitution in a 
para orientation. 
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Figure 3.1: A segment of the 
1
H NMR spectra of trisubstituted by-products. 
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 It would be likely for the two bromo substituents to be on the opposing ring to the nitro 
substituent. The initial investigation into directing effects by Cram et al
13
 would support this 
inference as they have not identified any homo-annular bromination of 5. Although it is 
reported that the vast majority of product (70%) is the pseudo-geminal configuration, pseudo-
meta is the next most abundant isomer (8%). On this basis and in consideration of the 
splitting pattern only two structures are possible which are 4,7-dibromo-13-
nitro[2.2]paracyclophane 8 and 4,7-dibromo-12-nitro[2.2]paracyclophane 9. These are 
presented in Figure 3.2 and it is suggested both have been isolated here. However with the 
available information it is not possible to definitively assign which one is which. 
 
Figure 3.2: The structures of the by-products in the Bromination of 4-
nitro[2.2]paracyclophane. 
3.3.2  Synthesis of 4-bromo-13-amino[2.2]paracyclophane 
4-Bromo-13-amino[2.2]paracyclophane 10 has been prepared by reduction using hydrogen 
and platinum
15,16
 and with HCl and Iron
8
 in yields up to 91%. The latter approach was carried 
out here to give 10 in 68% yield (Scheme 3.16). The mechanism for this reaction is proposed 
to be analogous with that shown in Scheme 3.12. The 
1
H NMR data for this compound is in 
agreement with the published values for this regioisomer. 
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Scheme 3.16: The synthesis of 4-bromo-13-amino[2.2]paracyclophane. 
3.3.3  Synthesis of 4-nitro-13-formyl[2.2]paracyclophane 
This compound has not been previously reported. The Reich formylation was extended to 5 
to garner 4-nitro-13-formyl[2.2]paracyclophane 11 in 18% yield (Scheme 3.17). The 
mechanism for this reaction is analogous with that proposed in Scheme 3.6 but again with the 
pseudo-geminal effect responsible for the regioselectivity. 
 
Scheme 3.17: The synthesis of 4-nitro-13-formyl[2.2]paracyclophane. 
The 
1
H NMR spectrum shows the characteristic formyl proton at 9.94 ppm along with the 
presence of six aromatic protons. This confirms that 5 has been substituted with the formyl 
moiety. Furthermore it can be readily elucidated that the substitution pattern is hetero-annular 
due to the splitting pattern of the aromatic protons shown in Figure 3.3. The two doublets 
with small coupling constants are the ortho protons, the 2 dds are the para protons and the 
remaining two doublets are the meta protons, relative to each functional group.  
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Figure 3.3: A segment of the 
1
H NMR spectrum of 4-nitro-13-formyl[2.2]paracyclophane. 
At this point the structure could be assigned as a pseudo-geminal, pseudo-ortho, pseudo-meta 
or pseudo-para regioisomer. The nitro and formyl functional groups cause the closest alkyl 
proton to be shifted downfield so it would be expected to observe two alkyl protons clearly 
separated from the remaining six. This is what is observed and the COSY spectrum shows 
coupling between these two indicating they are on positon 1’ and 2’ or the same side of the 
system (Figure 3.4). 
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Figure 3.4: A segment of the COSY spectrum of 4-nitro-13-formyl[2.2]paracyclophane. 
This then eliminates the pseudo-ortho and pseudo-para configurations. The remaining 
possibilities are then the pseudo-geminal and pseudo-meta isomers and as stated previously 
the pseudo-geminal effect of the nitro group should lead to specificity. However the COSY 
spectrum does not allow assignment of these two alkyl protons as cis or trans to one another. 
This required examination of through-space coupling by nuclear Overhauser effect 
spectroscopy (NOESY) analysis. Coupling between these protons would confirm the product 
as the pseudo-geminal isomer while no interaction would indicate the pseudo-meta isomer. 
This was attempted but a clear spectrum could not be obtained. It is on the basis of the 
pseudo-geminal effect that the product is tentatively assigned as the pseudo-geminal isomer 
however the spectroscopic evidence presented here is not sufficient for unambiguous 
assignment. 
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3.3.4  Synthesis of 4-amino-7-formyl[2.2]paracyclophane 
This compound has not been previously reported. Initially reduction of 11 was attempted 
using HCl and iron to prepare 12 however it was found that the starting material degraded 
and no product was detected (Scheme 3.18). Reaction times as short as 15 minutes and lower 
temperatures still resulted in degradation.  
 
Scheme 3.18: The unsuccessful synthesis of 4-amino-13-formyl[2.2]paracyclophane. 
In light of this it was then attempted to extend the Reiche formylation to 6. It was expected 
that in this case homo-annular substitution would be observed due to the activating effect of 
the amino substituent. This was found to be the case and the para isomer 4-amino-7-
formyl[2.2]paracyclophane 13 was isolated in 26% yield (Scheme 3.19). It was expected that 
the ortho isomer may be produced but likely in lower quantities as this position is not as 
sterically favourable however no such material was isolated. 
 
Scheme 3.19: The synthesis of 4-amino-7-formyl[2.2]paracyclophane. 
Homo-annular analogues prove much simpler to assign than hetero-annular analogues. Firstly 
the presence of the formyl moiety is confirmed by a singlet at 9.76 ppm in the 
1
H NMR 
spectrum. The aromatic splitting shows 4 dd’s which correspond to an unsubstituted ring 
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(Figure 3.5). The two singlets indicate a para orientation. The ortho isomer would present 
two doublets as would the meta isomer however these would be readily distinguishable by the 
coupling constant. 
 
Figure 3.5: A segment of the 
1
H NMR spectrum of 4-amino-7-formyl[2.2]paracyclophane. 
3.4  Resolution of [2.2]paracyclophane derivatives 
3.4.1  Resolution of 4-amino[2.2]paracyclophane 
(RP)-4-amino[2.2]paracyclophane 6 was resolved using a previously reported procedure.
11
 
Resolution was achieved by recrystallisation of diastereomeric salts formed from (1S)-(+)-10-
camphorsulfonic acid. Yields of 24% were reported however only yields up to 6% were 
achieved here (Scheme 3.20). 
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Scheme 3.20: The resolution of 4-amino[2.2]paracyclophane. 
3.4.2  Resolution of 4-bromo[2.2]paracyclophane  
Resolution of [2.2]paracyclophane derivatives via the use of diastereomeric sulfoxides has 
been discussed in detail in Section 2.4. The method was utilised here and proceeded as 
reported garnering both the 14-(RPS) and 14-(SPS) derivatives in 25% and 26% yield 
respectively (Scheme 3.21).
5,17
 
 
Scheme 3.21: The resolution of 4-(4-Tolylsulfinyl)-[2.2]paracyclophanes. 
From these resolved sulfoxides Rowlands et al. prepared an impressive variety of useful 
enantiopure derivatives. However they were not successful in preparing any halide 
derivatives. Attempts to do so using electrophiles such as bromine and iodine resulted in 
protonation of the intermediate lithio species yielding only the parent compound 1. In this 
work, bromobenzene was added to the lithio species generated in-situ with the aim of a 
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bromo-lithio exchange occurring. This proved to be the case and 2-(SP) was isolated in 35% 
yield (Scheme 3.22). This represents a novel method for the preparation of both enantiomers 
of 2. 
 
Scheme 3.22: The resolution of 4-bromo[2.2]paracyclophane. 
3.5  Synthesis of phenyl-oxazoline derivatives 
As mentioned in Section 2.5, oxazolines are usually prepared from the cyclisation of the 
appropriate amino alcohol and carboxylic acid. The carboxylic acid is normally activated by 
generating the corresponding acid chloride via thionyl chloride (SOCl2) or a modification of 
the Appel reaction which uses triphenylphosphine (PPh3). Oxazolines are also readily 
prepared using the Witte Seeliger reaction.
18
 This is the cyclisation of nitriles and amino 
alcohols using zinc chloride (ZnCl2) as a catalyst.
19,20
 This procedure was utilised here to 
prepare a range of compounds, two of which have not been previously reported (Table 3.1). 
A mechanism for this reaction has not been reported. 
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Table 3.1: The preparation of phenyl-oxazoline derivatives via the Witte Seeliger reaction. 
 
R1 R2 R3 R4 R5 Yield Reported 
yield 
NH2 H H H H 24% 72%
21
 
NH2 H H iPr H 82% 72%
21
 
NH2 H H Bn H 58% 65%
21
 
NH2 H H tBu H 40% 77%
21
 
NH2 OMe OMe iPr H 45% ---- 
Br H H iPr H 42% 78%
21
 
I H H iPr H 48% ---- 
 
3.6  Synthesis of phenyl-oxazoline [2.2]paracyclophane ligands 
It was envisaged that the prepared phenyl-oxazolines could be linked to the Pc moiety using 
the Buchwald-Hartwig amination. This reaction forms a carbon-nitrogen bond via the 
palladium catalysed cross-coupling of an amine and a halide. To begin, 2 and the oxazoline 
15 were selected. Along with these components Buchwald-Hartwig reactions also require an 
appropriate ligand and base to proceed. Hence a series of conditions were examined to 
determine the optimum reagents for the synthesis. This included different palladium sources 
and bases and three ligands which were triphenylphosphine (PPh3), 
2,2’bis(diphenylphosphino)-1,1’-binaphthyl (BINAP) and 1,1’-
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bis(diphenylphosphino)ferrocene (DPPF). The results of these experiments are given in Table 
3.2. 
Table 3.2: Buchwald-Hartwig reaction of 4-bromo[2.2]paracyclophane with (S)-2-(4-
isopropyl-4,5-dihydrooxazol-2-yl)aniline.
[a,b] 
 
Entry Pd source Base Ligand Time (days) Yield 
1 Pd(OAc)2 CsCO3 PPh3 5 ---- 
2 Pd(OAc)2 CsCO3 BINAP 5 12%
 
3 Pd(OAc)2 CsCO3 DPPF 5 ---- 
4 Pd(OAc)2 tBuOK PPh3 5 ---- 
5 Pd(OAc)2 tBuOK BINAP 5 13%
 
6 Pd(OAc)2 tBuOK DPPF 5 ---- 
7 Pd(dba)2 CsCO3 PPh3 5 ---- 
8 Pd(dba)2 CsCO3 BINAP 5 13%
 
9 Pd(dba)2 CsCO3 DPPF 5 --- 
10 Pd(dba)2 tBuOK PPh3 5 ---- 
11 Pd(dba)2 tBuOK BINAP 5 14%
 
12 Pd(dba)2 tBuOK DPPF 5 ---- 
13 Pd(dba)2 tBuOK BINAP 5 19%
[c] 
14 Pd(dba)2 tBuOK BINAP 7 20%
[c] 
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[a] 0.5 mmol 15, 1.2 eq. 2, 5% Pd, 10% ligand, 2 eq. base, 10 ml toluene at 120 °C. [b] 
Yields based on isolated mixture of diastereomers 16 [c] 10% Pd, 20% ligand. 
Based on the results of this series of reactions several conclusions can be drawn. The 
selection of palladium source and base do not appear to significantly impact the reaction. The 
choice of ligand is essential and no product was observed when DPPF or PPh3 was used. 
Higher loadings of palladium and BINAP increased the yield by approximately 5% (Entry 
13) while longer reaction times had little effect (Entry 14). Even after 7 days significant 
amounts of starting material remain in the mixture and it was found that 45-50% of the 
starting material could be retrieved. 
The 
1
H NMR spectra of the isolated mixture shows two peaks at approximately 10.21 and 
10.33 ppm. These have been identified as the NH peaks for the diastereomers 16-(RPS) and 
16-(SPS) respectively, based on a crystal structure obtained of 16-(SPS). This region of the 
spectra is generally clean so it provides a convenient way of assessing the diastereomeric 
ratio (d.r.) of the products. In all cases here there was no excess and an equal distribution of 
diastereomers was observed. However on lowering the reaction temperature to 70 °C a 
change in the product distribution is observed, with 16-(RPS) produced in 62:38 d.r. (Figure 
3.6).  
Preparation of Asymmetric Ligands Based on [2.2]Paracyclophane Chapter 3 
72 
   
 
Figure 3.6: A segment of the
1
H NMR spectrum of the diastereomeric mixture. 
Using the established conditions but changing the solvent to benzene gave 16-(RPS) in 90:10 
d.r. which is a very significant increase in selectivity and surprising given the only change is 
the solvent. Unfortunately this diastereomer could not be recrystallised to purify the material 
further. 
It was found that using the appropriate solvent system 16-(SPS) and 16-(RPS) had small 
differences in their Rf values and could be separated by careful flash column 
chromatography. The products were not completely pure after separation and required 
recrystallisation. This was successful with the 16-(SPS) diastereomer which was isolated as 
white crystals. Again the 16-(RPS) diastereomer could not be recrystallised. Further, 
attempting to recrystallize from a 1:1 mixture of diastereomers could not be achieved and 
enriching the 16-(SPS) isomer by column chromatography first was necessary. Crystals of the 
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16-(SPS) isomer suitable for X-ray crystallography were obtained and the structure is 
presented in Figure 3.7. 
 
Figure 3.7: The crystal structure of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine. 
Full details of the crystallographic data including bond lengths and bond angles are presented 
in Appendix 106. This compound is expected to act as a bidentate N,N ligand that will bond 
to a metal centre. A hypothetical model of 16-(RPS) bonded to a zinc atom has been prepared 
and this is shown in Figure 3.8. 
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Figure 3.8: Molecular model of a proposed ligand-zinc complex with minimised energy from 
different perspectives. 
Using this purification protocol the preparation of other derivatives was attempted (Table 
3.3). The isopropyl derivative was ultimately prepared in only 6% yield while the benzyl 
derivative was prepared in 7% yield. The t-Bu derivative was detected in the reaction mixture 
however ultimately none could be isolated. While the yields are poor it is important to note 
that this method represents a one pot synthesis and resolution procedure. This is significant as 
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resolving [2.2]paracyclophane precursors is arguably the most laborious aspect of dealing 
with this class of ligands. 
Table 3.3: The synthesis of phenyl-oxazoline-[2.2]paracyclophane ligands using the 
Buchwald-Hartwig amination.
[a] 
 
Entry R Yield 
1 iPr 6% 
2 Bn 7% 
3 tBu ---- 
[a] 1 mmol oxazoline, 1.2 eq. 2, 10% Pd, 20% ligand, 2 eq. base, 20 ml toluene at 120 °C, 5 
days.  
3.7  Attempted optimisation of ligand synthesis 
Although a procedure for the preparation and resolution of novel ligands had been 
demonstrated the yields were extremely poor. The limits of catalyst and ligand loadings as 
well as reaction time and temperature were at the practical limits so it was decided to 
investigate changes to the synthetic routes (Table 3.4). Switching to an amino Pc and a bromo 
oxazoline (Entry 1) showed no increase in the yield at 18% as 19% was achieved under these 
conditions with the initial reagents. Using an iodo oxazoline (Entry 2) there was a marked 
increase in yield to 29%. 
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Furthermore, an oxazoline derivative containing aryl methoxy groups was examined (Entry 
3). It was hoped this electron rich system would couple more readily however it was found to 
perform less effectively than the original system garnering only 10% product. Furthermore 
the resulting diastereomers could not be separated chromatographically as was the case with 
the original ligands. 
Table 3.4: Attempted optimisation of phenyl-oxazoline-[2.2]paracyclophane synthesis.
[a] 
 
Entry X
1 
X
2 
X
3 
X
4 
Yield 
1 NH2 Br H H 18% 
2 NH2 I H H 29% 
3 Br NH2 OCH3 OCH3 10% 
[a] 1 mmol oxazoline, 1.2 eq. cyclophane, 10% Pd, 20% ligand, 2 eq. base, 20 ml toluene at 
120 °C, 5 days.  
A linear synthetic sequence was also considered where the aryl nitrile is coupled to the Pc 
moiety and the subsequent product utilised in the Witte Seeliger reaction to give the final 
ligands (Table 3.5). Using the bromo Pc and an amino nitrile no product was detected (Entry 
1). Switching the functionalities, using amino Pc and halo nitriles yielded no detectable 
product either (Entry 2 and 3). It is suggested that the deactivating nitrile in the ortho position 
is the cause for this lack of reactivity. Using the more electron rich dimethoxy derivative, the 
resulting product 2-(4-amino-[2.2]paracyclophane)-4,5-dimethoxybenzonitrile 17 was 
isolated in 32% yield (Entry 4).  
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Table 3.5: Buchwald-Hartwig reaction of substituted [2.2]paracyclophanes with aryl 
nitriles.
[a] 
 
Entry R
1 
R
2 
R
3 
R
4 
Yield 
1 Br NH2 H H ---- 
2 NH2 Br H H ---- 
3 NH2 I H H ---- 
4 Br NH2 OCH3 OCH3 32%
[b] 
[a] 1 mmol nitrile, 1.2 eq. Pc, 10% Pd, 20% ligand, 2 eq. base, 20 ml toluene at 120 °C, 5 
days [b] 2 days. 
17 was then used in the Witte Seeliger reaction where it proceeded in only 16% yield 
(Scheme 3.23). This result indicates that the linear synthetic approach is not superior to the 
initial convergent synthesis. 
 
Scheme 3.23: The synthesis of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)4,5-
dimethoxy-phenyl)-[2.2]paracyclophane-4-amine. 
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3.8  Conclusion 
A series of monosubstituted Pc were prepared including bromo, formyl, hydroxy, nitro and 
amino derivatives. Using a number of these compounds, additional functionality was added to 
prepare a range of disubstituted derivatives including two novel materials. The resolution of 
two Pc derivatives was investigated and a novel procedure for preparing enantiopure 4-
bromo[2.2]paracyclophane was reported. Following this, a series of phenyl-oxazolines were 
prepared via the Witte Seeliger reaction, including two novel derivatives, for use in 
Buchwald-Hartwig aminations intended to prepare novel asymmetric ligands. Initial studies 
were aimed at optimising conditions and two novel asymmetric ligands were isolated in 
enantiopure form and characterised. The yields however were under 10% so further work was 
aimed at an alternative synthetic route that would be more efficacious. Attempts at different 
combinations of amines and halides provided a mild improvement in the case of iodides. A 
more electron rich phenyl-oxazoline system prepared by introducing aryl methoxides failed 
to improve the coupling efficiency.  Finally a linear synthetic sequence was investigated but 
again this did not provide a more effective route over the initial preparation. Further work is 
needed to optimise this synthesis and the most likely avenues will be the use of microwave 
synthesis or some redesign of the oxazoline component to make it more amenable to 
Buchwald-Hartwig coupling. 
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4.0  Review of the Synthesis and Modification of 
Octafluoro[2.2]paracyclophane 
4.1  Introduction 
Octafluoro[2.2]paracyclophane (OPc) 1, commonly referred to industrially as AF4, is a 
fluorinated analogue of [2.2]paracyclophane with the alkyl hydrogen atoms replaced by 
fluorine (Figure 4.1). This compound finds widespread application in industry for preparing 
surface coatings. These coatings offer superior thermal and UV stability, a low dielectric 
constant and excellent barrier properties in comparison to their hydrocarbon counterparts.
1,2
 
However a facile and high yielding synthesis of 1 has proven difficult and the following 
details the advances to date in its preparation and modification. 
 
Figure 4.1: The structure of octafluoro[2.2]paracyclophane. 
4.2  Preparation of octafluoro[2.2]paracyclophane 
The initial procedures for the preparation of 1 were developed in the early 1960’s when a 
number of 1,4-bis-alkylsulfonyls 2 were pyrolysed at high temperatures (600-800 
°
C) to yield 
1.
3
 Around the same time, a similar high temperature procedure in the presence of copper was 
developed using 1,4-bis-alkylhalo analogues 3 and 4  from derivative 5 (Scheme 4.1).
4
 These 
methods did not exclusively yield 1 and a variety of cyclic and linear oligomers were also 
formed contributing to a yield of approximately 30% by either method. Subsequent research 
focused on pathways which would lead exclusively to 1.
5
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Scheme 4.1: The synthesis of 1,4-bis-alkylsulfonyl and 1,4-bis-alkylhalo precursors for the 
high temperature synthesis of octafluoro[2.2]paracyclophane. 
The high temperature synthesis optimised by Wheelright et al.
5
 remained the only route to 
produce 1 for almost 30 years. It was not until the early 1990’s that a new method was 
presented. Dolbier et al. attempted to extend the Hoffman elimination of an amino 
tetrafluorborate salt 6 to yield 1, based on a previous synthesis of the parent hydrocarbon 
paracyclophane (Scheme 4.2).
6
 This proved unsuccessful as did an attempt to use a carboxylic 
acid salt 7. It was found that treatment of compound 4 with a combination of titanium 
tetrachloride and lithium aluminium hydride afforded 1 in a 32% yield.
7
  
 
Scheme 4.2: Development of a low temperature preparation of 
octafluoro[2.2]paracyclophane. 
Although this work removed the necessity for high temperatures, it presented a new issue. An 
appreciable yield was only obtained when the reaction was carried out under highly dilute 
conditions, 1.5L of solvent yielded 1.7g of 1 (32%) and extremely slow addition of reactants 
Review of the Synthesis and Modification of Octafluoro[2.2]paracyclophane Chapter 4 
83 
   
was necessary. This limitation is explained by consideration of the reaction mechanism which 
proceeds via formation of the reactive tetrafluoro-p-xylylene 8, as evidenced by a small 
amount of the trimer 9 in the reaction mixture (Scheme 4.3). There is an increase in the 
concentration of 8 as the dilution factor is decreased so it must be maintained to limit the 
collisions with the di-radical intermediate 10. This dilution also provides the optimal kinetic 
environment to minimise the bimolecular oligomerisation of the extended conformer 11. 
 
Scheme 4.3: The possible reaction pathways of the intermediate tetrafluoro-p-xylylene. 
Dolbier et al. reported an improved method several years later which obviated the need for 
high dilution. Based on a study into Diels-Alder reactions by Mori et al.,
8,9
 it was found that a 
combination of trimethylsilyl tributyltin and caesium fluoride (CsF) could affect the required 
debromination of 4 to yield 1 in 40% yield (Scheme 4.4). It was found that a solvent system 
of 4:1 THF:DMSO was crucial for this to proceed. A mechanistic reasoning explains the need 
for this and the formation of 8. CsF has limited solubility in this solvent system so it impedes 
the rate of formation of the necessary intermediate such that at any one time its concentration 
is low. This essentially presents the same favourable kinetic environment that high dilution 
facilitates, but without the increased solvent volume.
10
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Scheme 4.4: A tin catalysed debromination to prepare octafluoro[2.2]paracyclophane. 
This synthesis allowed production of 1, did not require high dilution technology and was 
industrially feasible to produce the material on a kilogram scale, but some issues remained. 
The reaction was still low yielding at 40%, there is significant cost associated with the 
reagents, and the use of stochiometric quantities of an organostannane is undesirable.  
In a subsequent report by Dolbier et al., it was shown that 1 could be produced in a 60% yield 
without the use of stannanes. Treating the chloro analogue 3 with zinc dust in 
dimethylacetamide (DMA) yielded the product without needing high dilution conditions 
(Scheme 4.5). The mechanism is not fully understood but it is believed that the coupling 
occurs on the metal surface. Not requiring high dilution would imply that the pathway does 
not involve generation of free intermediate 8.
11
 
 
Scheme 4.5: The zinc catalysed coupling of 1,4-bis-chlorodifluoromethylbenzene to prepare 
octafluoro[2.2]paracyclophane.. 
A year following this report, Uneyama et al. presented a new carbon-fluorine bond cleavage 
route to 1 from the inexpensive starting material 1,4-bis-trifluoromethyl benzene 12 (Scheme 
4.6). A magnesium-promoted defluorinative silylation of one of the trifluoromethyl (CF3) 
groups was used to yield the corresponding trimethylsilyl compound 13. This was then heated 
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at reflux in anisole in the presence of catalytic amounts of CsF and Pd2(dba)3 providing 1 in 
yields of 53%.
12
 
 
Scheme 4.6: The preparation of octafluoro[2.2]paracyclophane via the formation of an 
organosilane and a subsequent Pd/CsF catalysed coupling. 
This procedure, along with the previously mentioned zinc catalysed method, represent the 
current leading technology for the synthesis of 1. The yields of both procedures are 
comparable so when deciding which route is best it would be prudent to consider the 
precursor compounds required. While 12 is inexpensive and readily available in bulk 
commercially, 3 is not commercially available and its preparation from an inexpensive 
precursor could prove laborious.  
There are two pathways presented in the literature to this end and these will now be 
considered. The first is described in a patent from the mid 1990s
13
 and is summarised in 
Scheme 4.7. Terephthalaldehyde 14 is fluorinated using sulfur tetrafluoride (SF4) to yield 1,4-
bis-difluoromethyl benzene 5
14
 and this is subsequently chlorinated (or brominated if desired) 
by a photo halogenation process to yield the desired precursor 3. SF4 is a highly corrosive gas 
which liberates HF on contact with moisture. Such a material is undesirable industrially. 
However, the use of this material can be circumvented in two steps, by chlorinating 14 with 
boron trichloride (BCl3) to yield 1,4-bis-dichloromethyl benzene 15
15
, and a subsequent solid 
state halogen exchange process with CsF to give 5
16
 or the use of phase transfer agents.
17
 
Thionyl chloride (SOCl2) may be utilised in place of BCl3 to yield 15.
18
 The second approach 
to this precursor was published in 2007 by Dolbier et al. and describes its production from 
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1,4-bis-trichloromethyl benzene 16 (readily produced itself via photochlorination of p-
xylene) using anhydrous HF with reported yields of 79% for 3.
16
 
 
Scheme 4.7: Two chemical pathways to the precursor 1,4-bis-chlorodifluoromethylbenzene. 
4.3  Preparation of substituted octafluoro[2.2]paracyclophane derivatives 
There have been numerous reports to date examining analogues of 1 and they range from the 
preparation of commercially useful substituted analogues to studies of chiral di-
paracyclophanes which are of academic interest. Pc systems have elicited much academic 
interest due to their unique chemical behaviours such as unusual reactivities, trans-annular 
communication and spectroscopic abnormalities
1
. It is worth noting that the reports discussed 
in the following were all carried out by Dolbier’s group. Work published in 1999 details 
procedures for the electrophilic aromatic substitution of 1. Methods were developed to 
introduce an impressive variety of functionalities, beginning with nitration using nitronium 
tetrafluoroborate (NO2BF4) in sulfolane (Scheme 4.8).
19
 This work is particularly relevant 
because these additional groups can act as linkers for the attachment of other chemical 
entities to the precursors or the subsequent coating they generate.  
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Scheme 4.8: The preparation of a variety of monosubstituted octafluoro[2.2]paracyclophane 
derivatives.
19
 
It was subsequently shown that utilising harsher nitrating conditions could yield a di-nitro 
analogue of 1 in 81% yield, again using NO2BF4 in sulfolane but at a higher temperature. The 
product was found to be an equivalent mixture of three hetero-annularly substituted isomers 
which were pseudo-ortho 17, pseudo-meta 18 and pseudo-para 19 (Scheme 4.9). No pseudo-
geminal or homo-annular substitution was detected. Interestingly the pseudo-ortho isomer 
could be readily separated by column chromatography (along with any mono-nitrated or 
starting material). These isomers could all be reduced to the corresponding amines and 
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converted to bromo or chloro derivatives by substitution. Attempts at the reduction of a single 
nitro group were achieved but were found to be low yielding at 11%.
20
 
 
Scheme 4.9: The preparation of di-nitro derivatives of octfluoro[2.2]paracyclophane and 
their subsequent reduction and halogention. 
Direct bromination was also carried out on 1 using N-bromosuccinimide and H2SO4 and gave 
an unexpected result. The reaction proceeded in 55% yield and the product was exclusively a 
homo-annular p-dibromide which is unusual given the deactivating nature of halo 
substituents.
20
 This provides a method for the synthesis of novel homo-annularly and hetero-
annularly disubstituted analogues of 1. Such compounds may prove superior to their 
hydrocarbon counterparts as ligands for asymmetric synthesis because they show a 
significantly higher resistance to thermal isomerisation.
20,21
 
As shown previously, the CF3 derivative of 1 could be produced in 5 steps (Scheme 4.8). 
Attempts were made to extend Sawada’s free radical trifluoromethylation procedure to 1 
which utilises decomposition of trifluoroacetyl peroxide in DCM.
22
 Although the CF3 radical 
Review of the Synthesis and Modification of Octafluoro[2.2]paracyclophane Chapter 4 
89 
   
added to one of the rings, no rearomatisation was observed. Instead the resulting 
cyclohexadienyl radical 20 proved stable enough to dimerise to one of the isomers 21 or 22 
(Scheme 4.10). The value of these isomers is in the generation of CF3 radicals.
23
 Usually 
these are generated using trifluoroacetyl peroxide which is thermally unstable even at room 
temperature or by the use of Scherer’s radical which is considered an excellent clean 
source.
24
 The isomers shown here are stable crystalline compounds which produce CF3 
radicals at temperatures above 150 
°
C with the only by product being the essentially 
chemically inert 1. 
 
Scheme 4.10: The preparation of trifluoromethyl substituted bis-
octafluoro[2.2]paracyclophane analogues. 
Following this was the first report of a di-octafluoro[2.2]paracyclophane produced via the 
palladium catalysed reductive homo-coupling of the iodo analogue 23 (Scheme 4.11). The 
result was again an isomeric mixture of 24 and 25. Low temperature 
19
F NMR studies 
showed that the meso compound 25 is a rotamer. The introduction of a CF3 group as in 26 
yielded only the meso compound 27 by a similar procedure.
25
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Scheme 4.11: The preparation of di-octafluoro[2.2] paracyclophanes and trifluoromethyl 
derivatives. 
Facile access to the iodo analogue 23 also allowed an investigation into the use of Suzuki 
cross couplings (Scheme 4.12). The reactions proved very effective when using non-hindered 
boronic acids and pinacol esters. A method was also developed for the production of boronic 
acid derivative 28. This novel material showed comparable yields under the same conditions 
when coupled with non-hindered aryl iodides.
26
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Scheme 4.12: Suzuki cross couplings of octafluoro[2.2]paracyclophane derivatives. 
It was found that phenyl spacer groups could be introduced between the OPc units under 
appropriate conditions to yield novel compounds 29 and 30 (Scheme 4.13). 
 
Scheme 4.13: The preparation of di-cyclophane derivatives using Suzuki cross couplings. 
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An examination of the SRN1 reactivity of 23 showed that it reacts with certain aryl thiolates 
and stabilised enolates (Scheme 4.14). This result was promising because it indicated that 
many novel OPc derivatives may be produced from SRN1 nucleophiles. These reactions did 
however require photochemical initiation and did not proceed via thermal methods alone.
27
 
 
Scheme 4.14: The preparation of substituted octafluoro[2.2]paracyclophane derivatives by 
an SRN1 pathway. 
An unusual product of nucleophilic attack of the nitro analogue 31 led to the discovery of a 
novel ring cleaving reaction of OPc (Scheme 4.15).
28
 Although there were reports of opening 
the [2.2]paracyclophane system with the parent hydrocarbon,
29,30
 this occurred via the alkyl 
bridge carbons whereas in this case the cleavage occurs at the alkyl-aryl bond. It is suggested 
that this occurs via an SNAr pathway. 
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Scheme 4.15: The ring cleaving reaction of nitro OPc with a nucleophile. 
4.4  Preparation of substituted octafluoro[2.2]paracyclophane analogues by 
Diels-Alder reactions 
Arynes (or benzynes) are a highly reactive intermediary species that are known to readily 
take part in Diels-Alder reactions. It was shown in a report from 2002 that benzynes 32 and 
33 can be produced from mono and di-iodo substituted analogues of 1 (Figure 4.2).
31,32
  
 
Figure 4.2: The structure of 4,5-dehydrooctafluoro[2.2]paracyclophane and 4,5,15,16-bis-
dehydrooctafluoro[2.2]paracyclophane. 
Prior to this report in 1969, Longone et al. had used [2.2]paracyclophane in the presence of 
anthracene to produce the Diels-Alder adduct, however the yield was only 15%.
33
 In the same 
year Cram et al. also reported a bis Diels-Alder product via the dehalogenation of 4,5,15,16 
tetrabromo[2.2]paracyclophane.
34
  Longone generated the necessary aryne using KOtBu a 
method normally avoided since its original reporting.
35
 This is because arynes typically react 
with the nucleophilic t-Bu ion leading to significant amounts of by-product. In the case of 
arynes generated from 1 however this method is ideal giving excellent yields with virtually 
none of this by-product detected. As an example, Scheme 4.16 shows the Diels-Alder 
products produced from iodo analogues of 1 (which occur via the formation of the 
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corresponding arynes 32 and 33) with anthracene as a substrate which gave excellent yields. 
Other substrates employed were benzene, naphthalene, t-butylbenzene, furan and 
[2.2]paracyclophane, each of which demonstrated comparable yields with anthracene. 
 
Scheme 4.16: Diels-Alder cycloaddition reactions yielding substituted 
octafluoro[2.2]paracyclophane derivatives. 
As a continuation of this synthesis it was found that the Diels-Alder adduct 34, amongst 
others, could be used to prepare novel OPc derivatives such as the anthraceno analogue 35 
(Scheme 4.17). This compound is of note because it was found to form a dimer when exposed 
to UV light. The structure is unusual in that the anthracene ring directly involved in the OPc 
system breaks aromaticity to form a cyclobutane ring.
36
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Scheme 4.17: The preparation of 1,4-anthraceno-octafluoro[2.2]paracyclophane and its 
dimerisation. 
The approach used thus far in this area was the Cram methodology but Diels-Alder adducts 
may also be produced using the Cadogan method.
37
 This method generates the aryne by 
reaction of an N-nitroacetanilide, produced in-situ by the reaction of acetanilide 36 and 4-
chlorobenzoyl nitrite 37, which proceeds to react with the desired arynophile. This method is 
typically low yielding with the reaction of acetanilide and anthracene for example, yielding 
only 16% of the Diels-Alder adduct. When extended to the acetanilide derivative 38 the yield 
was 90% (Scheme 4.18). The increased efficiency of the reaction is ascribed to the bridge 
fluorine atoms because they increase the ring hydrogen acidity and produce a more electron 
deficient aryne. 
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Scheme 4.18: The preparation of the anthracene Diels-Alder adduct of 
octafluoro[2.2]paracyclophane. 
The Cadogan methodology was also found to be very effective for reactions with alkenes. For 
example, the reaction with oct-1-ene yielded 91% of the ene product 39 (Scheme 4.19). 
Interestingly, the same reaction under Cram conditions yielded no product, only reduction of 
the aryl iodide. No alkene utilised was shown to produce any ene product under Cram 
conditions. 
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Scheme 4.19: Ene reactivity of octafluoro[2.2]paracyclophane derivatives under Cadogan 
and Cram conditions. 
The final report relating to this area details a sequential ene reaction followed by a Diels-
Alder reaction with cyclohepta-1,3,5-triene. The ene adduct 40 produced via the Cadogan 
method reacts further with an additional aryne to yield a Diels-Alder adduct (Scheme 4.20). 
The product was synthesised as a diastereomeric 2:1 mixture 41 and 42 in a yield of 25%. It 
was possible to fully characterise the mixture solely by NMR.
38
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Scheme 4.20: Sequential ene and Diels-Alder reaction of OPc-acetamide and cyclohepta-
1,3,5-triene. 
4.5  Preparation and modification of perfluoro[2.2]paracyclophane 
A logical progression from the preparation of 1 was the synthesis of 
perfluoro[2.2]paracyclophane (pOPc) 43 (Scheme 4.21). The initial preparation of this 
compound detailed two synthetic routes; a five step procedure beginning with 2,3,5,6-
tetrachloroterphthalonitrile 44, and a second refined pathway beginning with 1,2,4,5-
tetrachlorobenzene 45. Although a zinc-catalysed homo-coupling is again utilised to produce 
pOPc, the presence of aromatic fluorine instead of hydrogen meant a different approach was 
required to make the necessary precursor 46. It was determined that ultimately 43 may be 
produced in a 39% yield when the coupling is carried out in MeCN at 100 
°
C for 38 hours.
39
 
Review of the Synthesis and Modification of Octafluoro[2.2]paracyclophane Chapter 4 
99 
   
 
Scheme 4.21: Two synthetic pathways for the synthesis of perfluoro[2.2]paracyclophanes. 
Following the preparation of 43, an investigation was carried out to examine the reactivity of 
this compound to nucleophilic aromatic substitution.
40
 It was found that 43 could indeed be 
modified in this manner and several examples were reported using both mono and bi-dentate 
nucleophiles. The presence of such significant amounts of fluorine produces an extremely 
electron deficient aromatic system which is then quite reactive to nucleophiles (Scheme 4.22). 
No disubstitution is observed in the phenol derivative 47 and this is likely due to the strongly 
electron donating ability of the phenoxide. It is noteworthy that this effect is transmitted to 
the other ring of the system. This then explains why the more weakly donating methoxy 
derivative 48 shows some disubstitution exclusively in the form of the pseudo-para isomer 
49. The reaction of 43 with sodium thiophenoxide yielded no monosubstituted product but 
gave a para isomer 50, indicating that this group had an activating effect. This is in 
agreement with a previous study of the reaction of sodium thiophenoxide and 2,3,5,6-
tetrafluorobenzene.
41
 The most successful bi-dentate ligand class were found to be catechols 
followed closely by bis-amines. In a reaction with ethylene glycol no cyclisation product was 
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observed. Competition experiments showed that 43 was in fact much more reactive than 
hexafluorobenzene under these conditions. It was determined that the most likely mechanistic 
pathway for these reactions is an SNAr mechanism. 
 
Scheme 4.22: Nucleophilic substitution reactions of perfluoro[2.2]paracyclophane. 
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Mono-substituted analogues of 43 constitute a break in the symmetry and this allowed a 
detailed study of the spectral and conformational properties of these new analogues. 
Examination of the 
19
F coupling constants, particularly long range four and five bond 
couplings, allowed a detailed characterisation of the system and any disubstituted products 
could be differentiated. It was found that substitution skews the geometry of the system such 
that the unsubstituted ring may be drawn toward or away from the new substituent (Figure 
4.3). The results showed that this was not just due to the size of the substituent but is likely to 
be heavily dependent on the electronic environment of the aromatic rings. The experimental 
data was found to be in good agreement with computational models.
42
 
 
Figure 4.3: Possible conformations of the perfluoro[2.2]paracyclophane system with respect 
to the new substituent. 
The most recent report concerning 43 is the atropoisomerism of the acetoacetic ester 
produced by the reaction of 43 and ethyl acetoacetate.
43
 Atropisomers are stereoisomers 
resulting from restricted rotation about a single bond where the barrier of rotation is 
sufficiently high that both isomers can be isolated. In this case the isomers were produced as 
a mixture 51 and 52 (Scheme 4.23) in the form of a crystalline solid and it was determined 
that the compound exists purely in the enol form with no keto tautomer detected by 
1
H NMR. 
In solution the energy barrier to rotation was found to be 23.5 Kcal mol
-1
 and it is suggested 
this is due to interference from the close fluorinated methylene bridge. The ester was then 
cyclised under basic conditions to a furan product 53. 
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Scheme 4.23: The preparation of the acetoacetic ester derivative of 
perfluoro[2.2]paracyclophane and its subsequent cyclisation under basic conditions. 
4.6  Conclusion 
This review has discussed the history and development of OPc and subsequent investigations 
into its chemistry. The development of facile synthetic pathways to the compound and the 
subsequent functionalisation of its structure have demonstrated that it is amenable to a broad 
variety of chemistry. Its unusual electronic properties, ascribed to the highly fluorinated 
structure, have led to it being surprisingly efficacious under a range of conditions. At present 
it is a highly desirable material in industry for protective coatings. Research to date has 
demonstrated that it would be an ideal precursor to a new generation of multifunctional 
coatings as it can be readily modified. The chirality of the substituted Pc framework, along 
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with its unique electronic properties, means that it could have applications as a scaffold in 
asymmetric synthesis and catalyst design, areas which have not yet been fully explored. 
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5.0  Preparation of Asymmetric Ligands Based on 
Octafluoro[2.2]paracyclophane 
5.1  Introduction 
This chapter details the investigation into the synthetic routes to 
octafluoro[2.2]paracyclophane (OPc) 1. Mono-substituted derivatives of 1 were also prepared 
and interpretation of their NMR spectra is discussed in detail. Finally, the Buchwald-Hartwig 
amination was used in attempts to couple the OPc framework with a phenyl-oxazoline to 
prepare analogous ligands to those reported in Chapter 3. 
5.2  Preparation of octafluoro[2.2]paracyclophane 
Two synthetic routes to 1 were investigated and these are presented in Scheme 5.1. 
 
Scheme 5.1: Synthetic routes for the preparation of octafluoro[2.2]paracyclophane. 
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5.2.1  Synthesis of 1,4-bis-dichloromethylbenzene 
Terephthaldehyde 2 was selected as an inexpensive and readily available starting material for 
the synthesis of 1. It was intended that the initial step would involve the conversion of 2 to 
the geminal dichloride 1,4-bis-dichloromethylbenzene 3. To this end four options were 
available, chlorination via chlorine gas (Cl2),
1
 phosphorus pentachloride (PCl5),
2
 boron 
trichloride (BCl3)
3
 or thionyl chloride (SOCl2).
4
 Due to availability and ease of handling, it 
was decided to utilise the BCl3 and SOCl2 routes (Scheme 5.2). 
 
Scheme 5.2: The synthesis of 1,4-bis-dichloromethylbenzene. 
BCl3 was purchased as a 1M solution in pentane.  This was added to a solution of dry hexane 
and 2 which was heated at reflux for 4 hours. The product was isolated in 45% yield (98% 
reported
3
) by a standard work-up followed by flash column chromatography. In addition, the 
intermediate 4-dichloromethylbenzaldehyde 4 was isolated in a yield of 11%. 
In the alternative procedure, SOCl2 was used neat with a catalytic amount of dimethyl 
formamide (DMF). After a 3 hour reflux, the reaction mixture was poured onto cold water 
and the product was immediately precipitated and collected by filtration. The yield was 70% 
(94% reported
4
) and no further purification was required. Using SOCl2 provided a simpler, 
higher yielding procedure and has the additional advantage of being significantly cheaper 
than BCl3. 
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The reaction involving BCl3 is proposed to proceed via the formation of an alkoxyboron 
dichloride and presumably the migration of a second chlorine atom to the carbon centre to 
yield the product (Scheme 5.3). The SOCl2 reaction then follows the same pathway differing 
only in producing sulphur dioxide (SO2) as a by-product. 
 
Scheme 5.3: The proposed mechanisms for the formation of 1,4-bis-dichloromethyl benzene. 
5.2.2  Synthesis of 1,4-bis-difluoromethylbenzene 
Two general routes were considered to prepare 1,4-bis-difluoromethylbenzene 5 (Scheme 
5.4), a halogen exchange process beginning with 3, or direct fluorination of 2. 5 has been 
synthesised by both routes with examples shown of solid phase exchange processes,
5,6
 
exchange processes via phase transfer catalysis
5,7
 and direct fluorination using various 
fluorinating reagents.
8–10
 
 
Scheme 5.4: The synthesis of 1,4-bis-difluoromethylbenzene. 
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5.2.2.1  Fluoride exchange processes 
The halogen exchange process relies on the nucleophilic displacement of chlorine by fluorine 
via an SN2 mechanism (Figure 5.1). However, to achieve this, there must be an interaction 
between 3 and the fluoride generated from CsF. Solubility is the main issue as 3 is insoluble 
in water and the ionic salt CsF is insoluble in most organic solvents. Phase transfer catalysis 
offers a solution to this problem by allowing the reaction to be carried out with a mixture of 
two immiscible solvents, in this case benzene and water. The reaction is mediated by the use 
of a phase transfer catalyst. Such catalysts are usually ammonium salts or phosphonium salts 
if strongly basic conditions or very high temperatures are required.
11,12
 Tetrabutyl ammonium 
bromide (TBAB) is a widely used catalyst and was used in this work. The tetrabutyl 
ammonium cation forms a complex with the fluoride anion resulting in a neutral species 
capable of passing from the aqueous phase into the organic phase, thus delivering the 
fluoride. The nucleophilicity of the fluoride anion should also be increased without the 
stabilising effect of the hydration shell provided by the aqueous solvent. It was also 
envisaged that the carbon centre would be more susceptible to nucleophilic attack due to the 
electron withdrawing chlorine atoms. This process is similar to the Finkelstein reaction which 
involves the substitution of alkyl chlorides and bromides for iodides and has been further 
extended to encompass α-carbonyl, allyl and benzyl halides.13,14 
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Figure 5.1: The proposed mechanism for the synthesis of 1,4-bis-difluoromethylbenzene via 
phase transfer catalysis. 
On performing this procedure in a mixture of benzene and water with temperatures up to 100 
°
C, no product was detected by 
19
F NMR. The reaction was then attempted in dry DMF in 
which CsF has limited solubility. TBAB was again added to aid the delivery of the fluoride 
ion and the reaction was carried out for 24 hours at reflux. Again no product was detected. 
Finally, the starting material and CsF were mixed together and heated as a solid melt. There 
were practical issues with mixing a sealed melt so the reaction could not be stirred which 
likely hindered the progress significantly. 
19
F NMR showed traces of product but no material 
was isolated from the mixture. 
5.2.2.2  Direct fluorination of terephthaldehyde 
The failure of the halogen exchange processes meant considering alternative routes. Direct 
fluorination of 2 was the obvious choice because if successful it would remove one step in the 
synthetic sequence. Due to the success of BCl3 in yielding 3, boron trifluoride (BF3) seemed a 
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logical choice. However when the reaction was carried out no product was formed. This is 
likely due to BF3 being a weaker Lewis acid. 
The boron trihalides shown in Figure 5.2 are trigonal planar molecules with sp
2
 hybridisation 
where the boron atom has an empty p-orbital, allowing it to act as a Lewis acid. It would be 
expected that because of the relative electronegativity of the different halides that BF3 would 
yield the most electron deficient boron atom of the boron trihalides and hence be the 
strongest Lewis acid. However, the trend in Lewis acidity goes in the opposite direction with 
BBr3 being the most acidic. This is because there is an orbital overlap between the empty p-
orbital of boron and the full p-orbitals of the halides. This overlap is most efficient with 
fluorine and decreases going down the group. Therefore the boron p-orbital in BF3 actually 
has the most electron density of the boron trihalides making it the weakest Lewis acid. On 
forming the appropriate adduct this π contribution would be lost as the molecular geometry 
switches from trigonal planar to tetrahedral, thus forming the alkoxyboron intermediate 
would not be favoured.
15
 
 
Figure 5.2: The relative Lewis acidity of the boron trihalides. 
Diethylaminosulfur trifluoride (DAST) was selected as an alternative fluorinating agent. It is 
quite similar in reactivity to SF4 from which it is synthesised but much more easily handled. 
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DAST was added to a dry solution of 2 in DCM along with a catalytic amount of ethanol 
(EtOH). The reaction was heated at reflux for 16 hours and quenched with water. An aqueous 
workup and subsequent flash column chromatography allowed isolation of 5 in a 67% yield 
(94% reported
9
). 
The proposed mechanism for this reaction, shown in Scheme 5.5, begins with the generation 
of hydrofluoric acid (HF) in the presence of EtOH. This reduces the carbonyl to an alcohol 
nucleophile which subsequently attacks the sulfur atom of the DAST reagent. This leads to 
regeneration of the initial HF and the formation of an S-O bond which then rearranges with 
loss of another fluorine atom to the carbon centre to yield the product and an amino sulfoxide 
by product. 
 
Scheme 5.5: The proposed mechanism for the preparation of 1,4-bis-difluoromethyl benzene. 
5.2.3  Synthesis of 1,4-bis-chlorodifluoromethylbenzene 
Only two methods are presented for the preparation of 1,4-bis-chlorodifluoromethylbenzene 
6. The first is chlorination of 5 which can be achieved using either chlorine gas (Cl2) in 
tetrachloromethane
16
 (CCl4) or sulfuryl chloride (SO2Cl2) and a radical initiator (Scheme 5.6). 
The latter process is more suitable to carry out on laboratory scale due to the toxicity of 
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chlorine gas and the difficulty in handling harmful gases. The second method is fluorination 
of 1,4-bis-trichloromethylbenzene using anhydrous  HF in DCM.
6
  
 
Scheme 5.6: The synthesis of 1,4-bis-chlorodifluoromethyl benzene. 
Initially CCl4 and benzene were selected as possible solvents for the reaction on the basis that 
they have no alkyl hydrogen atoms which would compete with the desired transformation. 
The radical initiator utililised was azobisisobutyronitrile (AIBN). Benzene was chosen as the 
solvent on the basis of availability however the reaction was found to proceed poorly. Even at 
extended periods heating at reflux (up to 9 days) and at higher catalyst loadings, no product 
was formed by TLC. It was noted that AIBN was soluble in SO2Cl2 so the reaction was run 
neat and it was found to proceed much more efficiently. After 5 days heating at reflux the 
mixture was diluted with DCM and quenched with slow additions of ice water. The organic 
layer was extracted and the solvent removed in vacuo. The resulting oil was purified by flash 
column chromatography affording 5 in 20% yield along with the intermediate 1-
(chlorodifluoromethyl)-4-(difluoromethyl)benzene 7 in 34% yield. 
AIBN is thermally decomposed to form two radicals with the elimination of nitrogen gas 
(N2). This radical abstracts a chlorine atom from SO2Cl2 which in turn rearranges to form 
sulfur dioxide (SO2) and a chlorine radical. This initiates the radical chain reaction. The 
chlorine radical abstracts an alkyl hydrogen atom from the starting material generating 
hydrogen chloride and a new radical species. This radical then follows the same pathway as 
the initiation step which yields the product and regenerates the chlorine radical in the process. 
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This process repeats until one of three termination steps occurs. The reaction ends in the 
formation of Cl2, the desired product or a diarylfluoroethane type product (Scheme 5.7). 
 
Scheme 5.7: The proposed mechanism for the formation of 1,4-bis-
chlorodifluoromethylbenzene. 
5.2.4  Synthesis of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene 
1-(Trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene 9 can be prepared from 1,4-bis-
trifluoromethylbenzene 8, and is known to be another precursor to 1 which may be 
synthesised via two routes, both of which are defluorinative silylations. The first method is 
photo promoted
17
 while the second utilises magnesium
18
 (Scheme 5.8). The second method 
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was chosen due to a higher reported yield. In addition, the photochemical method is 
hampered by formation of polymeric by-products. 
 
Scheme 5.8: The synthesis of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene. 
The reaction was carried out under anhydrous conditions with the precursor 8 being added to 
the mixture dropwise. The reaction is highly exothermic so the precursor was added over 30 
minutes. Standard workup and flash column chromatography afforded the product in 32% 
yield (48% reported
18
). The literature indicated that the product was contaminated with a 
small amount of side product where an additional fluorine atom has been substituted with 
hydrogen (protodesilylation). However none of this by-product was detected by 
1
H or
19
F 
NMR. 
The reaction is proposed to begin with a magnesium promoted defluorination shown in 
Scheme 5.9. Normally this would be unlikely due to the strength of the C-F bond 
(approximately 550KJ mol
-1
) but in this case the resulting benzylic anion is stabilised by its 
resonance contributors. Nucleophilic attack of this anion on the silicon centre with the loss of 
chloride then yields the product. 
Preparation of Asymmetric Ligands Based on Octafluoro[2.2]paracyclophane Chapter 5 
117 
   
 
Scheme 5.9: The proposed mechanism for the formation of 1-(Trimethylsilyl)difluoromethyl-
4-trifluoromethylbenzene. 
5.2.5  Synthesis of octafluoro[2.2]paracyclophane 
For details of the available synthetic routes to octafluoro[2,2]paracyclophane 1 see Section 
4.2. The methods selected here were the fluoride catalysed 1,6 elimination reaction beginning 
with 9
18
 and the zinc catalysed coupling of 6
19
 (Scheme 5.10). 
 
Scheme 5.10: The synthesis of octafluoro[2,2]paracyclophane. 
5.2.5.1  Zinc catalysed homo-coupling 
In this procedure 6 was added to a dispersion of zinc in dry DMA. The reported conditions 
detail maintaining the reaction at 100°C for 4 hours however in this case no product was 
detected. Further modifications were attempted (Table 5.1) but even at reflux and reaction 
times of 2 days no product was detected (Entry 1). On the advice of the authors of the 
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procedure, it was indicated that the zinc or the zinc washing procedure may have been the 
issue. Two different batches of zinc were used with various washing procedure and in each 
case no product was isolated. 
Table 5.1: Reaction conditions for the zinc catalysed coupling of 1,4-bis-
chlorodifluoromethylbenzene. 
 
Entry Time (h) Temperature (°C) Zinc purity Zinc washing Yield 
1 4, 24, 48 100, reflux >99 N/A ---- 
2 4, 24, 48 100, reflux >99 2% HCl, H2O, EtOH, Et2O ---- 
3 4, 24, 48 100, reflux >99 H2O, EtOH, Me2CO, Et2O ---- 
4 4, 24, 48 100, reflux 98 N/A ---- 
5 4, 24, 48 100, reflux 98 2% HCl, H2O, EtOH, Et2O ---- 
6 4, 24, 48 100, reflux 98 H2O, EtOH, Me2CO, Et2O ---- 
 
5.2.5.2  Fluoride catalysed 1,6 elimination 
The fluoride catalysed method involved heating 9 at reflux in dry anisole in the presence of 
catalytic amounts of fluoride from CsF and Pd2(dba)3. The product was isolated by flash 
column chromatography in 18% yield (53% reported). It is proposed that the method suffers 
from an unwanted protodesilylation reaction which attributes to the low yield (Scheme 5.11) 
and this species 10 was observed by 
19
F NMR but was not isolated. 
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Scheme 5.11: The protodesilylation of 1-(Trimethylsilyl)difluoromethyl-4-
trifluoromethylbenzene. 
The mechanism proposed for this reaction begins with loss of the silicon moiety via the 
addition of fluoride (Scheme 5.12). This process is thought to proceed due to the stable F-Si 
bond. The resulting benzylic anion loses fluoride from the trifluoromethyl group at the 4 
position. This generates the reactive p-xylylene, and homo-coupling yields the product. The 
palladium is thought to facilitate this coupling but the exact role it plays in the mechanism is 
not clear. 
 
Scheme 5.12: The proposed mechanism for the synthesis of octafluoro[2,2]paracyclophane 
via fluoride catalysed 1,6 elimination. 
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5.3  Preparation of octafluoro[2.2]paracyclophane derivatives 
5.3.1  Synthesis of 4-nitro-octafluoro[2.2]paracyclophane 
1 was nitrated using a mixture of nitric acid (HNO3) and sulfuric acid (H2SO4) and the 
product 11 was isolated in 26% yield (56% reported)
20
. Along with 11, the di-nitro product 
12 was isolated in 19% yield as a mixture of 3 isomers, pseudo-ortho, pseudo-meta and 
pseudo-para. 1 was also retrieved in 22% (Scheme 5.13). The mechanism of this reaction is 
discussed in Section 3.2.4. 
 
Scheme 5.13: The synthesis of 4-nitro-octafluoro[2.2]paracyclophane. 
5.3.2  Synthesis of 4-amino-octafluoro[2.2]paracyclophane 
4-Amino-octafluoro[2,2]paracyclophane 13 was produced by reduction of 11 using a mixture 
of HCl and iron (Scheme 5.14)
20
. The product was isolated by filtration in a yield of 80% 
(82% reported) and did not require any further purification. The mechanism of this reaction is 
discussed in Section 3.2.5. 
 
Scheme 5.14: The synthesis of 4-amino-octafluoro[2,2]paracyclophane. 
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The amino analogue has been selected for discussion because of the clear resolution in the 
1
H 
NMR spectrum (Figure 5.3). The amino protons H4 were assigned at 5.6 ppm based on the 
broad peak, chemical shift and integration. The adjacent peak was assigned as H5 based on it 
being a doublet with a small coupling constant attributed to long range coupling with H7. 
Once H5 was assigned the COSY allowed ready identification of H7 and H8 (Figure 5.4). 
The COSY allows assignment of the adjacent ring if one of the four protons is assigned first. 
A single proton is shifted significantly downfield with respect to the others at 8.0 ppm and 
this was assigned H13 due to its pseudo-geminal position which brings it closest spatially to 
the electron withdrawing nitrogen atom. Knowing this the pseudo-ortho, pseudo-meta and 
pseudo-para positions can be readily assigned from the COSY. 
 
Figure 5.3: The assigned 
1
H NMR spectrum of 4-amino-octafluoro[2,2]paracyclophane. 
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Figure 5.4: The assigned COSY spectrum of 4-amino-octafluoro[2,2]paracyclophane. 
5.3.3  Preparation of oxazoline-octafluoro[2.2]paracyclophane derivatives 
The amino derivative 13 was utilised along with the iodo phenyl-oxazoline 14 in the 
Buchwald-Hartwig amination. The successful conditions outlined in Chapter 3 were used 
(10% Pd and 20% ligand) however no product was detected. A second attempt was made 
increasing the reaction time to 7 days and delivering two portions of ligand and catalyst, a 
second quantity at 4 days reaction time. Even at these extended reaction times and loadings 
still no product was detected. 
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Scheme 5.15: The attempted synthesis of the diastereomers of N-(2-(4-isopropyl-4,5-
dihydrooxazol-2-yl)phenyl)-octafluoro[2.2]paracyclophane-4-amine. 
5.4  Conclusions 
The synthetic routes to 1 were investigated and it was prepared using a fluoride catalyst 1,6 
elimination in 18% yield. The reported zinc catalysed method could not be reproduced even 
after extensive attempts using various conditions. 1 was successfully derivativised to prepare 
the monosubstituted nitro OPc 11 which was then reduced to give the amino OPc 13. 
Attempts to couple 13 to an iodo phenyl-oxazoline 14 using the Buchwald-Hartwig amination 
were not successful. 
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6.0  Parylene Coating Pre-Treatment and Adhesion Promotion 
6.1  Introduction 
A series of sol-gel formulations were applied as pre-treatments to aluminium panels in an 
attempt to improve the adhesion of parylene N surface coatings. These pre-treatments were 
characterised by IR and 
29
Si NMR spectroscopy. The aluminium panels were subsequently 
coated in parylene N and their adhesion promotion was evaluated using the cross hatch 
measurement. 
6.1.1  Parylene coatings 
Parylene is a commonly used industrial term to describe a number of vapour deposited 
poly(p-xylylene) polymers. Since their development in the late 1940’s1 these materials have 
garnered attention as protective coatings due to their attractive physical and chemical 
properties and are widely used by the electronic and medical device industries.
2,3
 The 
conformal coating can be applied at ambient temperatures with tailored thickness, and 
specific properties of the coating can be altered by adjusting the chemistry of the precursors 
by the addition of various chemical substituents. The precursors used to produce these 
coatings are [2.2]paracyclophanes and a variety have been reported (Scheme 6.1).  
 
Scheme 6.1: Examples of different parylene coatings. 
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The development by Gorham
4
 of a deposition process in 1966 ultimately led to the 
widespread industrial use of these coatings. The precursors are pyrolysed at temperatures of 
approximately 650 
°
C in a vacuum chamber resulting in the formation of the reactive p-
xylylene monomers which are deposited and begin chain growth polymerisation on the 
substrate (Scheme 6.2). Typical chain lengths are of the order of 2000-4000 units. This is 
considered to be a green process as no initiators or terminators are used and the process 
produces no by-products. As a result, the coatings are free of contaminants and chemically 
pure.  
 
Scheme 6.2: The vapour deposition process for parylene coatings. 
However, some substrates can prove more difficult than others to properly coat in parylene 
due to the difference in surface adhesion of the coating. A practical example is shown in 
Figure 6.1. This is a medical device wire composed of a nickel-chromium alloy. Thermal 
treatment has caused the parylene coating to fail and very extensive delamination has 
occurred. Only small amounts of the coating remain. 
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Figure 6.1: SEM image of a wire coated in parylene C which has heavily delaminated. 
A typical metal surface will have a number of free hydroxyl groups present. The 
concentration of hydroxyl groups depends on how the metal has been treated, for example 
plasma or acid treatment can increase this concentration. The mechanism by which parylene 
polymerises is a radical reaction so there will be no chemical bonding occurring between the 
metal surface (hydroxyl groups) and the growing polymer, resulting in poor adhesion. To 
improve adhesion, adhesion promoters are used and the adhesion promoter of choice for 
parylene coatings is 3-methacryloxypropyltrimethoxysilane (MAPTMS). This organosilane 
contains two reactive sites, a methoxysilane group that can react with the metal surface and a 
methacryloxy group that can be used in radical organic polymerisation. This dual 
functionality makes MAPTMS an excellent candidate as an adhesion promoter for parylene 
on metal surfaces, the principle of which is shown in Scheme 6.3.
5
 The standard industrial 
approach for the pre-treatment of aluminium 2024 panels to be coated in parylene N is to add 
MAPTMS directly into the chamber. This is done by placing an absorbent which has soaked 
up MAPTMS in with the panels and when the chamber is placed under vacuum the 
MAPTMS is dispersed. 
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Scheme 6.3: Parylene adhesion promotion on metal substrates using MAPTMS. 
6.1.2  Sol-gels and their use as pre-treatments 
The sol-gel method is a frequently used way of applying surface coatings to a material. In this 
process the sol (or solution) gradually moves towards the formation of a gel network which 
contains both a liquid and solid phase. This process can be used for several applications such 
as making coatings, ceramics, fibres, gels and powders as shown in Figure 6.2. 
 
Figure 6.2: Different applications of the sol-gel process.
6
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The process begins with the growth of discrete particles from a monomeric material by a 
series of hydrolysis and condensation reactions as shown in Figure 6.3. This results in a 
colloidal suspension which is an evenly dispersed phase (the particles) within a continuous 
phase or dispersion medium (the solvent). These particles continue to grow and link together 
to form a polymeric network and the sol may then be applied in conjunction with a curing 
treatment to remove the solvent leaving a solid surface coating. The polymer will have a 
complex randomly branched structure meaning the final solid coating will be a non-
crystalline material. 
 
Figure 6.3: General hydrolysis and condensation reactions of a silicon alkoxide that lead to 
the formation of polymer networks from sol-gel precursors.
7
 
The next aspect of the sol-gel process to consider is selecting the appropriate materials. 
Invariably these materials are metal or metalloid atoms surrounded by ligands, some of which 
must be labile to facilitate polymerisation. The most common compounds used in sol-gel 
chemistry are metal alkoxides and metal chlorides particularly of silicon, aluminium, titanium 
and zirconium.
8
 These are readily hydrolysed in water with the reaction being catalysed by 
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the addition of acid or base. Specific compounds used depend on the desired application and 
properties such as hardness, resistance to chemical erosion or hydrophobicity. To achieve 
this, additives may be added to the sol-gel preparation or the monomers themselves can be 
chemically modified. 
6.2  Sol-gel pre-treatment formulation and coating preparation 
To investigate the optimisation of surface adhesion using sol-gel coatings, a series of 
formulations were prepared (Table 6.1). These formulations vary two parameters, the 
concentration of MAPTMS and the acidity of the solution via the addition of nitric acid 
(HNO3) solution. 
Table 6.1: Sol-gel pre-treatment formulations. 
Sample MAPTMS (ml) IPA (ml) H2O (ml) HNO3 (ml) HNO3 (M) 
S1 1.25 45 5.0 - - 
S2 2.50 45 5.0 - - 
S3 5.00 45 5.0 - - 
S4 10.00 45 5.0 - - 
S5 1.25 45 4.5 0.5 0.01 
S6 2.50 45 4.5 0.5 0.01 
S7 5.00 45 4.5 0.5 0.01 
S8 10.00 45 4.5 0.5 0.01 
S9 1.25 45 4.5 0.5 0.1 
S10 2.50 45 4.5 0.5  0.1 
S11 5.00 45 4.5 0.5 0.1 
S12 10.00 45 4.5 0.5 0.1 
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After stirring for 24 hours, the sol-gel formulations were applied to aluminium alloy 2024 
panels by a spin coating deposition process. The spin coating process relies on centrifugal 
force to coat the substrate and provides high quality uniform coatings. Using higher spin rates 
thinner coatings are produced so this method allows control over the coating thickness. The 
sol-gels were applied at a speed of 500 rpm for 40 seconds and cured for 1 hour at 100 °C. 
Another set of samples were prepared using the same condition but a higher spin rate of 1000 
rpm. 
Aluminium 2024 has a composition which roughly includes 4.3-4.5% copper, 0.5-0.6% 
manganese, 1.3-1.5% magnesium and less than 0.5% of silicon, zinc, nickel, chromium, lead 
and bismuth. Immediately prior to spin coating, the panels were treated with the cleaning 
process shown in Figure 6.4 to prepare the surface. This process removes any dirt or grease 
and activates the surface by formation of reactive hydroxyl groups that will enable the 
immobilisation of the hydrolysed and oligomeric MAPTMS species. 
 
Figure 6.4: Cleaning process for coating aluminium alloy 2024-T3 panels. 
The sol-gel coated panels were subsequently coated with a layer of parylene N via the vapour 
deposition process outlined in Scheme 6.2. 
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6.3  Analysis 
6.3.1  
29
Si NMR spectroscopy 
The 
29
Si NMR method allows the level of hydrolysis and condensation of silicon containing 
species such as MAPTMS to be determined semi-quantitatively. Similar to the 
13
C nuclei, 
29
Si has a low isotopic abundance, approximately 4.7%. It also has a lower susceptibility to 
the technique because of its gyromagnetic ratio which is approximately five times lower than 
the hydrogen nuclei. The chemical shift of the silicon nuclei is dependent on the substituents 
around it so the various different stages in the sol-gel polymerisation can be identified. The 
chemical shifts of the 
29
Si nuclei, as they relate to hydrolysis and condensation are presented 
in Table 6.2.
9
 
Table 6.2: The relevant chemical shifts of the 
29
Si species in sol-gel formulations.
9
 
Species Notation Chemical shift (ppm) ±0.1 
RSi(OMe)3 T0
0 
-42.3 
RSi(OMe)2OH T0
1 
-41.4 
RSiOMe(OH)2 T0
2 
-40.6 
RSi(OH)3 T0
3 
-40.1 
RSi(OMe)2-O-Si T1
0 
-49.9 
RSi(OMe)OH-O-Si T1
1
 -50.5 
RSi(OH)2-O-Si T1
2
 -49.3 
RSi(OMe) – (O-Si)2 T2
0
 -59.1 
RSiOH-(O-Si)2 T2
1
 -58.5 
RSi(OSi)3 T3 -67.4 
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The formulations tested using this technique were S4, S8 and S12 as these had the highest 
concentration of MAPTMS and would provide the clearest spectra (Figure 6.5).The spectra 
were taken 24 hours after preparation of the sol-gel solutions and the chemical shifts are 
calibrated to the internal standard tetramethylsilane (TMS) at 0 ppm. S4 was prepared using 
no HNO3 and the lack of an acidic environment should lead to little or no hydrolysis and no 
condensation. This is what is observed in the 
29
Si NMR spectrum with the single peak at -
42.2 ppm indicating only the T0
0 
species. S8 in contrast, prepared with 0.01M HNO3, shows 
no T0
0
 but a dominant signal at -40.6 ppm indicating the hydrolysed species T0
2
. This sample 
also presents a signal at -49.7 ppm indicating the oligomeric T1
0
 species. The signal at -43.4 
ppm was not identified. The final sample S12, prepared with 0.1M HNO3, has its most 
significant signal at -49.7 ppm, again indicative of the T1
0
 species. The signal at -59.0 ppm 
indicates the more heavily condensed T2
0
 species and the T0
2
 species appears again at -40.7 
ppm. This data agrees with the expected trend in that an increase in acidity leads to more 
advanced degrees of hydrolysis and then condensation. 
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Figure 6.5: 
29
Si NMR spectra of sol-gel pre-treatment formulations. 
6.3.2  Infrared spectroscopy 
IR spectra were recorded for selected sol-gels as applied to the aluminium 2024 panels before 
the parylene N coating was applied (Figure 6.6). An increase in absorption band intensities in 
the 800-1100 cm
-1
 region is indicative of a thicker coating, as seen most prominently in S12. 
This area represents the silicate network and contains several species such as various silanol 
stretches (Si-OH, 950 cm
-1
) and the Si-O-Si stretches (1000-1100 cm
-1
). This is what is 
expected as higher concentrations of acid lead to increased hydrolysis and condensation of 
alkoxysilanes, resulting in more condensed, thicker coatings. 
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Figure 6.6: IR spectra of applied sol-gel formulations before parylene N deposition. 
6.3.3  Adhesion Testing 
Adhesion testing is used in industry to determine if a coating will adhere efficiently to a given 
substrate. The most common method for adhesion testing is the cross hatch measurement. 
This measurement is taken by making 12 equally spaced cuts into the coating, down to the 
substrate, in a crosshatch pattern. At this point any detached fragments of the coating are 
removed with light brushing and a single piece of pressure sensitive tape is applied across the 
incisions. The tape is removed in one rapid motion and can then be discarded. The adhesion 
of the coating is then graded from 0B to 5B based on the level of delamination as shown in 
Figure 6.7.
10
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Figure 6.7: Cross hatch measurement scoring scale.
10
 
As mentioned previously, the standard industrial approach for the pre-treatment of aluminium 
2024 panels to be coated in parylene N is to add MAPTMS directly into the chamber. This is 
done by placing an absorbent which has soaked up MAPTMS in with the panels and when 
the chamber is placed under vacuum the MAPTMS is dispersed. This approach can give 
coatings which score 3B using the cross hatch measurement. However there may be 
significant batch variation based on the location the absorbent is placed in indicating that the 
distribution of MAPTMS is not reliable.  
The adhesion results of the pre-treatment formulations shown in Table 6.3 indicate that 
thinner sol-gel pre-treatments are better adhesion promoters than their thicker counterparts. In 
all cases the adhesion promoters applied at 1000 rpm, which result in thinner coating layers, 
perform the same or better than their thicker counterparts deposited at 500 rpm. A general 
trend is also observed in increasing the acid concentration. Samples S1-S4 perform better 
than S5-S8 which in turn perform better than S9-S12. The concentration of MAPTMS in the 
sol affects the adhesion in some cases such as S1-S4 at 500rpm and S9-S12 at 1000rpm. 
However in S5-S8 at 500 rpm and S1-S4 at 1000 rpm it shows no apparent effect on the 
adhesion, hence no clear conclusion can be drawn about the effect of varying the MAPTMS 
concentration. In comparison to the standard industrial method every sample, with the 
exception of S12 performed as well or better. 
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Table 6.3: The cross hatch test results of the pre-treatment formulations used on aluminium 
2024 panels coated with parylene N. 
Sample Classification (500 rpm) Classification (1000 rpm) 
S1 4B 5B 
S2 5B 5B 
S3 3B 5B 
S4 3B 5B 
S5 3B 5B 
S6 3B 4B 
S7 3B 5B 
S8 3B 4B 
S9 3B 4B 
S10 3B 3B 
S11 3B 3B 
S12 1B 2B 
 
6.4  Conclusion 
A series of sol-gel formulations were prepared and applied to aluminium 2024 panels as pre-
treatments for the application of parylene N coatings. The formulations were designed to 
yield successively more hydrolysed and condensed sol-gel systems and this was supported by 
the 
29
Si NMR analysis. The pre-treatments also showed a successive increase in thickness and 
this was shown by IR spectroscopy. The adhesion capability of the coatings was assessed by 
the cross hatch measurement and the general trend showed that thinner sol-gels coatings were 
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better pre-treatments than their thicker counterparts. Of the 24 samples prepared 22 showed 
comparable or better adhesion performance in comparison to the industrial benchmark 
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7.0  Sol-gel Coating Additives 
7.1  Introduction 
The preparation of a range of additives for sol-gel coatings was briefly investigated. The 
additives are intended to be used in the production of hydrophobic sol-gel coatings. Two 
distinct classes of materials were prepared for this purpose, fluorinated triethoxysilane 
precursors and fluorinated mesoporous silicate particles. Following this there was also a brief 
investigation into the addition of organic dyes to hybrid sol-gel formulations. These hybrid 
sol-gels are prepared with a mixture of silicon and zirconium alkoxides. Molecular 
interactions between these materials and a dye molecule can impact the physicochemical 
properties of the dye and this was explored here. 
7.2  Hydrophobic surfaces and fluorocarbons 
Surface hydrophobicity is the property of a surface which makes it water repellent or difficult 
to wet. This property has long been recognised as important in self-cleaning technologies and 
was initially observed in nature, called the Lotus effect, in reference to the leaves of the Lotus 
flower. When water comes into contact with the Lotus leaf surface it remains in a spherical 
bead rather than spreading out evenly to wet the surface. This is a measurable property based 
on the angle of the water bead to the surface, known as contact angle.
1
 A perfectly 
hydrophobic surface will have a contact angle of 180°, so all surfaces will have contact angle 
values between 180° and 0°. This phenomenon can be attributed to a combination of physical 
and chemical properties of the surface. In the case of the Lotus leaf, the structure of Papillae, 
which are protrusions from the leaf surface, create surface roughness which produces a 
hydrophobic effect. This is because the material at the micrometre level is biphasic where it 
makes contact with the water, consisting of air which has a contact angle of 180° and the 
papillae. The contact angle on this surface can then be described using Cassie’s law which 
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describes the effective contact angle of a liquid on a composite surface. A successful use of 
this effect is the nanopin film.
2
 This material is covered with nanoscale cone structures 
perpendicular to a borosilicate glass substrate and yields a contact angle of 178°, only 2° 
below the maximum possible value for contact angle. Of greater interest here however, are 
the chemical properties of surfaces, and again, in the case of the Lotus leaf, the surface is 
covered in a waxy substance which is primarily long chain hydrocarbons. Such hydrocarbons 
are non-polar molecules and will repel water, thus making it energetically favourable for the 
water bead to stay in a spherical shape with the minimal surface contact. 
Much work has been done in creating hydrophobic surfaces for different applications. As 
such, many publications have reported fabrication methods such as vapour and particle 
deposition, plasma treatments and sol-gel methods.
3
 A common motif in many reports is the 
use of hydrophobic fluorocarbons, compounds composed primarily and sometimes 
exclusively of carbon and fluorine. The C-F bond is so polar that it possesses a degree of 
ionic character and the hold of fluorine on the electrons is so strong that they have a very 
limited ability to form the transitory dipoles necessary for Van der Waals forces. In fact, 
fluorine has the lowest polarisability of any element. It is this characteristic that accounts for 
fluorocarbon’s hydrophobicity.4 A water droplet on a coating surface will adopt the most 
favourable energetic arrangement and it is desirable to maintain the maximum amount of 
hydrogen bonding and limit the free or hydroxyl groups, keeping the droplet intact. Van der 
Waals forces can destabilise this network and interact with the water leading to surface 
wetting. Fluorocarbons, both alkyl and aryl, are also very stable compounds due to the 
strength of the C-F bond which may be above 500 KJ mol
-1
.
5
 This is due to the partial ionic 
character of the bond which shortens the bond length and provides favourable coulombic 
interactions. Additionally, having geminal C-F bonds adds further stability by increasing the 
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carbon’s partial charge and multiple C-F bonds can increase the strength of the molecules 
carbon backbone via the inductive effect. 
7.3  Preparation of fluorinated sol-gel additives 
7.3.1  Synthesis of fluorinated triethoxysilanes  
Silylation is a broad term used in organic synthesis to describe the addition of a silicon 
containing group to a molecule, usually a substituted silyl group. This type of reaction is most 
commonly utilised in protecting group chemistry however it also provides the most 
straightforward route to the preparation of sol-gel precursors in the form of alkoxysilanes.
6
 
The aryl silylation shown in Scheme 7.1 was carried out to prepare several derivatives with 
varying levels of fluorination. The products were isolated in yields up to 34% via vacuum 
distillation and the mono and trifluoro derivatives have not been previously reported. This 
purification method was chosen because alkoxy silanes are not generally amenable to 
chromatography as they may irreversibly bind to silica. 
 
Scheme 7.1: The synthesis of fluorophenyl triethoxysilanes. 
In the case of the perfluoro derivative 1, it was isolated as a mixture with the by-product 2 
(Scheme 7.2). Attempts to separate these two compounds were not successful. 
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Scheme 7.2: The synthesis of perfluorophenyl triethoxysilane and a disubstituted by-product. 
The other approach to aryl silylation is the use of transition metal catalysts, mainly palladium 
and rhodium. This has been demonstrated in several reports via the coupling of 
triethoxysilane and various aryl halides.
7–9
 It has been shown to be an effective method with 
both activating and deactivating substituents including some fluorinated analogues.
10,11
 
However, no trifluoro or pentafluoro analogues have been synthesised by this method. 
7.3.2  Synthesis of fluorinated mesoporous silicates 
Mesoporous silicates (MPS) are silica particles that contain pores or cavities. They have a 
variety of applications such as catalysis, sensors and molecular filters.
12–15
 They are prepared 
by using a template which the precursor molecules, in this case tetraethyl orthosilicate 
(TEOS), condense around (Figure 7.1). The template used here is the surfactant 
cetyltrimethylammonium bromide (CTAB), which forms micelles in solution. Once the MPS 
have been formed the template is removed and this may be done thermally or chemically. 
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Figure 7.1: General preparation process for mesoporous silicates. 
In the procedure developed here the MPS are functionalised as they form by the addition of a 
fluorinating agent to the reaction mixture. The fluorinating agent used is 1H,1H,2H,2H-
perfluorooctyl triethoxysilane 3 (PFOTS) and this is incorporated into the silicate network 
(Scheme 7.3). Microwave heating is utilised which rapidly forms the MPS. The solvent is 
evaporated and the resulting solid is dried. This solid is then heated at reflux in a mixture of 
methanol and HCl to yield the final fluorinated MPS. This is the chemical method of 
removing the template. As mentioned previously, the template can also be removed 
thermally, by placing the particles in a furnace and heating to approximately 500 °C for 
several hours. This option is unsuitable here because it would also remove the fluorocarbon 
chains. 
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Scheme 7.3: The synthesis of fluorinated mesoporous silicates. 
Fluorinated MPS were prepared in quantities up to 50 g. The particles themselves are 
relatively uniform in size usually ranging from 400-500 nm as shown in scanning electron 
microscope (SEM) images (Figure 7.2). 
 
Figure 7.2: SEM images of fluorinated mesoporous silicates. 
Using energy-dispersive X-ray spectroscopy (EDX), an elemental map of the surface can be 
acquired. This has been used qualitatively in this case to confirm the presence of fluorine. 
The maps also show silicon and oxygen which are the component atoms of the silicate 
(Figure 7.3). 
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Figure 7.3: Elemental mapping of fluorinated mesoporous silicates using EDX. 
7.4  Dye doped hybrid sol-gels 
Hybrid sol-gels are prepared from a mixture of silicon and transition metal alkoxide 
precursors. Here, hybrid sol-gel materials were prepared from MAPTMS and zirconium (IV) 
propoxide (ZPO) along with the incorporation of an organic dye. The dye selected was trypan 
blue (TB) and this is commonly used as a biological stain. It is a heavily conjugated azo dye, 
and as the name suggests, it has a strong blue colour (Figure 7.4). The prepared hybrid sol-
gels and coatings prepared from them were examined by transmission electron microscopy 
(TEM), IR and UV-Vis spectroscopy. 
 
Figure 7.4: The structure of trypan blue dye. 
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7.4.1  Coating preparation and formulation 
The formulations described in Table 7.1 were used to prepare stable, homogenous hybrid sol-
gels. These formulations differ only in the concentration of methacrylic acid (MAAH). This 
material behaves as a bi-dentate ligand and complexes the zirconium centre. This chelation 
affects the subsequent hydrolysis and condensation reactions that occur in the sol-gel and 
results in significant morphological changes in the final materials. This effect will be 
discussed in detail in the following sections. 
Table 7.1: Hybrid sol-gel formulations
[a]
. 
Formulation MAPTMS ZPO
[b] 
Dye
[c] 
H2O 0.1M HNO3 MAAH 
A 15.00/60 7.07/15 0.15/0.15 1.26/70 0.80/0.08 1.31/15 
B 15.00/60 7.07/15 0.15/0.15 1.26/70 0.80/0.08 0.33/4 
C 15.00/60 7.07/15 0.15/0.15 1.26/70 0.80/0.08 ---- 
[a] All values are given in the format grams/millimoles (g/mmol). [b] Provided as a 70% wt. 
in propanol. [c]1 mol% with respect to zirconium. 
The procedure for preparing these hybrid sol-gels is illustrated in Figure 7.5. In one vessel the 
ZPO, dye and the MAAH are mixed for 45 minutes. This allows chelation of the zirconium 
centre to occur. Concurrently the MAPTMS and HNO3 are mixed in a separate vessel. This is 
referred to as pre-hydrolysis and converts the MAPTMS ethoxy groups to hydroxyl groups. 
The pre-hydrolysed solution is then slowly added to the chelated solution. After 3 minutes 
water is added and an exothermic reaction is observed. After 24 hours stirring the hybrid sol-
gels are ready to be coated onto an appropriate substrate. In this case they were applied to 
glass and aluminium substrates by a spin coating process at a rate of 1000 rpm for 40 
seconds. The samples were then cured at varying temperatures. 
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Figure 7.5: Procedure for the preparation of dye doped hybrid sol-gels. 
7.4.2  Structural characterisation of hybrid sol-gels 
7.4.2.1  Transmission electron microscopy 
Figure 7.6 shows TEM images of the three formulations. A progressive increase in the 
particle size is observed as the degree of chelation of the zirconium atom is decreased. For A, 
most of the particles are in the nanometre scale (<10 nm). The TEM image of B indicates that 
it is relatively homogeneous and dense with a particle size varying from 10 to 200 nm. 
However, the particle size of C is in the micron range with an apparent gradual decrease in 
the density from the centre to the surface, as observed by the change in the contrast of the 
image of the particle. These observations suggest that the formulation of these 3 materials has 
a direct impact on the reactivity of the hybrid systems to hydrolysis and condensation 
reactions, as well as on the subsequent structure and morphology of the formed particles. This 
has been identified in previous studies in catalysing the formation of siloxane bonds and 
participating to the formation of the inorganic backbone of the material.
16–18
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Figure 7.6: TEM images of hybrid sol-gel formulations A, B and C respectively (Provided by 
M. Oubaha). 
The only variable here is the concentration of MAAH and hence, the degree of chelation of 
the zirconium centre. In A the ligand is added in a stoichiometric amount with respect to 
zirconium so only 50% of propoxide groups can undergo hydrolysis and condensation. In B it 
is 75% of propoxide groups and in C all propoxide groups are available. So it can be 
definitively stated that the availability of the zirconium centre to participate in condensation 
reactions significantly impacts the structure of the hybrid sol-gels. 
7.4.2.2  Infrared spectroscopy 
IR spectroscopy may provide information about the nature of the chemical bonding in the 
surface coatings prepared from the formulations. Figure 7.7 shows the spectra of the 
formulations applied to aluminium substrates. The absorption bands have been identified 
based on the results presented in other studies.
19–21
 The broad band located at 800–1100 cm-1 
is characteristic of the silicate network resulting here mainly from the superimposition of the 
Si-OH vibration (950 cm
-1
), Si-O-Si and Si-O-Zr vibrations (1000–1100 cm-1). The Zr-OH 
and Zr-O-C bonds composing the zirconium complex are located in the region 1300–1650 
cm
-1
. The bands located at 1730, 2800–3000 and 3200–3600 cm-1 are due to the C=O 
(stretching), C-H (stretching) and residual Si-OH and Zr-OH groups (stretching), 
respectively. The intensities of the chemical vibrations due to the zirconium complex located 
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at 1300–1650 cm-1 are clearly seen to decrease along with the MAAH concentration. There is 
a corresponding increase in intensity at approximately 1100 cm
-1
, again corresponding to Si-
O-Zr vibrations. 
 
Figure 7.7: IR spectra of the formulations coated on an aluminium substrate and cured at 
100 °C. 
7.4.3  Photophysical changes of trypan blue 
The UV–Vis absorption spectrum of TB dispersed in isopropanol is shown in Figure 7.8. The 
dye exhibits one large band composed of two superimposed bands located in the 400–600 nm 
region and a large absorption extending from around 300-350 nm. TB is a symmetrical 
molecule that contains unsaturated and conjugated C=C and N=N bonds, in addition to 
amino, hydroxyl and sulfonyl groups. The absorption domain above 400 nm can be attributed 
to the n→π* electronic transitions of the amino, hydroxyl and sulfonyl groups. The absorption 
domain below 400 nm can be attributed to the π→π* electronic transitions of the unsaturated 
C=C and N=N bonds. 
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Figure 7.8: The UV-vis absorption spectrum of trypan blue dispersed in isopropanol. 
When incorporated into the 3 formulations, the λmax of the dye absorption is red shifted in all 
cases. The initial λmax of 610 nm is found to be 624, 620 and 617 in formulations A, B and C 
respectively (Figure 7.9). The smaller particles in the most heavily condensed networks (A) 
provide the greatest red shift and this decreased along with the chelation in B and C.  
 
Sol-gel Coating Additives  Chapter 7 
153 
   
 
Figure 7.9: UV-vis absorption spectra of the formulations coated on glass substrates cured at 
100 °C. 
What is also observed is a progressive decrease in the absorption intensity with the decrease 
in particle size (or the increase in chelation) so that absorption for A is lower than B which is 
lower than C. This trend follows the particle size (or the increase in chelation) so suggests 
that the more heavily condensed networks do not interact with the dye molecules to as great 
an extent. A possible coordination of the dye is shown in Figure 7.10. This would explain the 
decrease in the n→π* electronic transitions. It is suggested that this process is happening 
almost completely in formulation A hence the weak absorption in that spectral region. 
 
Figure 7.10: The proposed binding of dye molecules and the zirconium network. 
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When formulation C is applied to the substrate and cured at different temperatures it affects 
both the λmax and absorption intensity of the dye (Figure 7.11). When the curing temperature 
is increased from 100 °C to 120 °C the λmax is blue shifted from 617 to 613 nm. On increasing 
the curing temperature to 150 °C the λmax is further blue shifted to 588 nm. This curing 
temperature also shows a significant increase in absorption in π→π* region of 300-400 nm. 
Each successive increase in curing temperature gives reduced absorption in the n→π* region 
indicating more coordination of the dye and the zirconium centre. Presently no explanation is 
offered for the blue shifting of the λmax between samples. 
 
Figure 7.11: UV-vis absorption spectra of formulation C coated on glass substrates at three 
different curing temperatures. 
7.5  Conclusion 
A range of fluorinated aryl triethoxysilanes were prepared in yields up to 34% for application 
in hydrophobic surface coatings. Fluorinated MPS were also prepared for the same 
application and these were evaluated to show that they had been successfully fluorinated. 
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Finally, the addition of a dye in hybrid silicon-zirconium sol-gels was investigated. 
Manipulation of the coating morphology was demonstrated by using varying concentrations 
of chelating ligand. This morphology subsequently altered the physicochemical properties of 
the dye, both the UV-vis absorption intensity and λmax values. 
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8.0  Conclusions and Future Work 
This chapter summarises the outcomes of this thesis and details suggestions for future work 
and further development of certain aspects of the work. 
8.1  Preparation of asymmetric ligands based on [2.2]paracyclophane 
The aim of the work with regard to [2.2]paracyclophane (Pc) was to prepare novel 
asymmetric ligands based on the Pc framework. To begin, the Pc framework was 
functionalised and 5 monosubstituted analogues were successfully prepared. Subsequent 
functionalisation garnered 4 disubstituted derivatives, two of which have not been previously 
reported. Attempts were made at the resolution of two selected monosubstituted derivatives, 
namely the amino and bromo analogues. The amino derivative was resolved but the yields 
were not satisfactory at 5%. The bromo derivative was successfully resolved using a novel 
procedure and proceeded in a moderate yield of 35%. A range of 7 phenyl-oxazoline 
compounds were prepared via the Witte-Seeliger reaction, two of which have not been 
previously reported. A selection of these analogues were coupled to the Pc framework via the 
palladium catalysed Buchwald-Hartwig amination. Column chromatography and 
recrystallisation allowed a one-pot synthesis and resolution procedure which garnered two 
novel enantiopure ligands. These compounds were characterised and X-Ray crystallography 
allowed determination of the absolute configuration of one of the ligands. The yields however 
were not satisfactory at <10% so alternative synthetic routes were investigated. This did not 
prove successful in the preparation of the desired ligands but did afford another previously 
unreported Pc analogue. 
Further work should first be aimed at increasing the yields of the final Buchwald-Hartwig 
coupling. It is suggested that microwave heating, as shown in Scheme 8.1, may provide 
improved yields along with shorter reaction times. Toluene is not an ideal solvent for 
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microwave assisted reactions because of its low susceptibility to microwave heating. The 
structurally similar trifluoromethylbenzene (or benzotrifluoride, BTF) is more efficiently 
heated by this method and has been shown to provide increased yields, as well as 
significantly shorter reaction times, in comparison to thermal heating using toluene.
1,2
 
Increased yields when using microwave heating has been demonstrated previously in the 
Buchwald-Hartwig coupling of phenyl-oxazolines.
3
 If successful this may then be extended 
to other analogues. 
 
Scheme 8.1: Proposed microwave assisted route for the optimisation of ligand synthesis. 
Another approach would be the use of thiophene-oxazoline compounds for coupling. Such 
derivatives have been prepared previously and may be more amenable for coupling to the Pc 
framework to prepare asymmetric Pc ligands.
4
 The routes presented in Scheme 8.2 may 
afford these ligands. 
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Scheme 8.2: Proposed synthetic routes for the preparation of thiophene-oxazoline 
[2.2]paracyclophane ligands. 
Once a suitable procedure for the preparation of these ligands is established the next course 
of action is to model their ability to bind metals. The best way to model this would be to 
isolate the ligand-metal complexes and obtain their crystal structures for study. The suggested 
metals for this are palladium and zinc. These metals are used in reactions of interest such as 
the asymmetric addition of diethyl zinc to aldehydes and asymmetric allylic alkylations. 
8.2  Preparation of asymmetric ligands based on 
octafluoro[2.2]paracyclophane 
Two synthetic routes were investigated towards the preparation of 
octafluoro[2.2]paracyclophane (OPc). The first route was a two-step synthesis beginning with 
a silylation followed by a fluoride catalysed 1,6 elimination. This final step allowed isolation 
of OPc in 18%. The other synthetic route consisted of three steps beginning with the 
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preparation of germinal difluoride from an aldehyde and a subsequent radical chlorination. 
The final step was a zinc catalysed homo-coupling which was reported to garner OPc in 
yields up to 60%. However, this procedure could not be reproduced here. Different batches of 
zinc and several washing procedures for the catalyst were utilised with no success. A recent 
patent reports this reaction but with an additional additive included. A large range of 
additives were tested and KI proved the most efficacious garnering OPc in 46%.
5
 This 
method may be useful for a higher yielding synthesis of OPc. 
The OPc prepared was subsequently nitrated and reduced to the corresponding amine. This 
material was utilised in the Buchwald-Hartwig amination along with an iodo phenyl-
oxazoline, however none of the desired product was detected. It is proposed that if a system 
for the preparation of the hydrocarbon Pc analogues is optimised that this be extended to the 
OPc framework. 
8.3  Parylene coating pre-treatment and adhesion promotion 
A series of sol-gel formulations were prepared and used as pre-treatments for aluminium 
substrates. The sol-gel formulations were characterised by 
29
Si NMR to show the difference 
in the extent of hydrolysis and condensation which had occurred. IR spectroscopy was carried 
out on the pre-treated aluminium substrates and a progressive increase in coating thickness 
was shown. These substrates were subsequently coated in parylene N and the adhesion of the 
parylene was assessed using the cross hatch measurement. In all formulations, with the 
exception of one, the parylene coatings showed better adhesion than the industrial 
benchmark. Generally it was found that thinner sol-gel coatings were better pre-treatments 
than their thicker counterparts. This pre-treatment method should also allow better 
reproducibility over a large number of samples. Future investigations in this area should be 
aimed at optimising adhesion on other substrates. Parylene coatings have a wide variety of 
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applications so effective pre-treatments for different substrates would be industrially 
valuable. 
8.4  Sol-gel coating additives 
Two classes of fluorinated additives were prepared, intended to be used in the preparation of 
hydrophobic sol-gel coatings. These were three fluorinated aryl triethoxysilanes, two of 
which have not been previously reported, and fluorinated mesoporous silicate particles. The 
fluorinated silanes were prepared via a modified Grignard reaction and isolated by vacuum 
distillation. The fluorinated particles were prepared using a modified microwave assisted 
Stöber process. The particles were characterised with SEM imaging and EDX spectroscopy. 
The incorporation of the dye trypan blue into hybrid sol-gel formulations, prepared from 
silicon and zirconium precursors, was also briefly investigated. It was shown that the addition 
of varying amounts of a chelate could alter the size of particles formed in the sol-gel. These 
varied from 10 nm to 1 micron in size as shown in TEM imaging. The organic dye 
demonstrated molecular interactions with the zirconium centre and these interactions were 
shown to be affected by the particle size. Changes in the UV-Vis absorption spectra in both 
the absorption intensity and λmax values were found across the formulations. It is proposed 
that smaller particle sizes result in more efficient interaction of the dye species with the 
zirconium centre. It was found curing temperatures also impacted the UV-Vis absorption of 
the dye, and that higher curing temperatures led to a decrease in absorption. Again, this 
implies more efficient interaction of the dye and the zirconium centre. Future work could 
examine the use of different metals such as titanium and tantalum and also different organic 
dyes. Coloured sol-gel coatings are industrially desirable for simple aesthetics however 
coatings with tuneable optical properties may have applications. 
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9.0  Experimental 
9.1  General experimental 
1
H NMR (400 MHz), 
19
F NMR (376 MHz), 
13
C NMR (100 MHz) and 
29
Si NMR (79 MHz) 
spectra were recorded on a Bruker Avance 400 MHz spectrometer at room temperature in 
deuterated solvents using tetramethylsilane as an internal standard. Chemical shifts (δ) are 
given in parts per million and coupling constants are given as absolute values in Hertz. 
Infrared spectra were recorded on a Perkin Elmer Spotlight 400N FT-IR. UV-vis spectra were 
recorded on a Perkin Elmer Lambda 900 UV/VIS/NIR spectrometer. UV-vis spectra were 
collected both in the solution phase using plastic cuvettes and in solid phase as coatings on 
glass slides (coating procedure described in section 7.4.1). Mass spectra were collected using 
a Maldi-Q-TOF premier mass spectrometer. SEM images were obtained on a Hitachi SU-70 
field emission scanning electron microscope. X-ray crystal structures were taken using a 
Rigaku Saturn-724 instrument. Melting points were determined in open capillary tubes in a 
Stuart melting point apparatus and are uncorrected. Thin layer chromatography (TLC) was 
carried out on aluminium sheets pre-coated with silica gel 60 F254 (Sigma). Column 
chromatography separations were performed using Davisil LC60A (0.035-0.070 mm). All 
reagents and solvents were purchased from Sigma-Aldrich and Apollo Scientific and used as 
received unless otherwise stated. Oxygen free argon was obtained from BOC gases and was 
used as received.  
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9.2  Monosubstituted [2.2]paracyclophanes 
9.2.1  (rac)-4-Bromo[2.2]paracyclophane 
 
A solution of [2.2]paracyclophane (5.00 g, 24 mmol) and iron powder (0.34 g, 6 mmol) in 
DCM (250 ml) was stirred for one hour at room temperature. To this was added bromine 
(3.84 g, 24 mmol) and the mixture was heated at reflux for 20 hours. The organic phase was 
washed with 10% Na2S2O3 (2 x 100 ml), water (100 ml), dried over MgSO4 and the solvent 
removed in vacuo to yield the title compound as a white solid (6.61 g, 96%); mp = 134-136 
°C; Rf = 0.55 (8:2 Cy/DCM); 
1
H NMR (400 MHz, CDCl3): δ = 7.16 (dd, J = 8, 1.6, 1H), 
6.44-6.57 (m, 6H), 3.45 (ddd, J = 15.6, 10, 2, 1H), 2.78-3.23 (m, 7H); 
13
C NMR (100 MHz): 
δ = 141.6, 139.6, 139.3, 139.1, 137.3, 135.1, 133.3, 132.9, 132.3, 131.5, 128.7, 127.0, 35.7, 
35.5, 34.8, 33.5; IR: 2923, 1586, 1493, 1391, 1035 cm
-1
 (See Section 3.2.1 and Appendix 1-
3). 
9.2.2  (rac)-4-Formyl[2.2]paracyclophane 
 
A solution of [2.2]paracylophane (4.52 g, 22 mmol) in DCM (200 ml) was cooled to 0 °C. To 
the solution was added TiCl4 (8.30 g, 44 mmol) followed by dichloromethoxymethane (2.54 
g, 22 mmol). The mixture was warmed to room temperature and stirred for 20 hours. Water 
(100 ml) was added to the mixture and stirring was continued for 3 hours. The phases were 
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then separated and the aqueous phase was washed with DCM (100 ml). The combined 
organic phases were dried over MgSO4 and the solvent removed in vacuo. The title 
compound was isolated by flash column chromatography as a white solid (3.28 g, 63%); 
decomp. = 142-144 °C (151-152 °C)
1
; Rf = 0.57 (9:1 Cy/EtOAc); 
1
H NMR (400 MHz, 
CDCl3): δ = 9.94 (s, 1H), 7.01 (d, J = 2, 1H), 6.73 (dd, J = 8, 2, 1H), 6.59 (d, J = 8, 1H), 6.56 
(dd, J = 8, 2, 1H), 6.50 (dd, J = 8, 2, 1H) 6.43 (dd, J = 8, 2, 1H), 6.37 (dd, J = 8, 2, 1H), 4.07-
4.13 (m, 1H), 2.91-3.30 (m, 7H); 
13
C NMR (100 MHz): δ = 192.0, 143.3, 140.7, 139.5, 139.4, 
138.1, 136.6, 136.4, 136.1, 133.3, 132.9, 132.4, 132.2, 35.3, 35.2, 35.0, 33.7; IR: 2925, 2855, 
1676, 1589, 1226, 1143 cm
-1
 (See Section 3.2.2 and Appendix 4-6). 
9.2.3  (rac)-4-Hydroxy[2.2]paracyclophane 
 
To a solution of 4-formyl[2.2]paracyclophane (1.00 g, 4.2 mmol) in MeOH/DCM (40 ml) 
was added conc. H2SO4 (0.10 g, 1 mmol) and 30% H2O2 (0.67 g, 6 mmol). This mixture was 
stirred at room temperature for 20 hours. The solvent was evaporated and the residue 
dissolved in DCM (50 ml) and washed with water (50 ml). The aqueous phase was washed 
again with DCM (50 ml) and the combined organic phases were dried over MgSO4.  The 
solvent was removed in vacuo and the title compound was isolated by flash column 
chromatography as an orange solid (0.52 g, 55%); decomp. = 224-227 °C (lit. 229-232 °C)
2
; 
Rf = 0.37 (9:1 Cy/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.00 (dd, J = 8, 2, 1H), 6.55 (dd, 
J = 8, 2, 1H), 6.44 (dd, J = 8, 2, 1H), 6.37-6.40 (m, 2H), 6.25 (dd, J = 8, 2, 1H), 5.54 (d, J = 
2, 1H), 4.42 (s, 1H), 3.29-3.36 (m, 1H), 2.86-3.11 (m, 6H), 2.61-2.69 (m, 1H); 
13
C NMR (100 
MHz): δ = 153.7, 142.0, 139.6, 138.8, 135.5, 133.6, 132.8, 131.9, 127.9, 125.4, 125.0, 122.6, 
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35.3, 34.8, 33.8, 31.1; IR: 3416, 2921, 2849, 1566, 1493, 1416, 1087 cm
-1
 (See Section 3.2.3 
and Appendix 7-9). 
9.2.4  (rac)-4-Nitro[2.2]paracyclophane 
 
A mixture of [2.2]paracyclophane (20.00 g, 96 mmol) in AcOH (300 ml) was heated to 90 
°C. The solution was allowed to cool to 70 °C and fuming HNO3 (30 ml, 720 mmol) was 
carefully added in one portion. The mixture was stirred for approximately 45 seconds and 
immediately poured onto ice. The aqueous phase was extracted with DCM (3 x 150 ml). The 
combined organic phases were washed with 1M NaOH (3 x 250 ml), dried over MgSO4 and 
the solvent was removed in vacuo and the title compound was isolated by flash column 
chromatography as a pale yellow solid (6.56 g, 27 %); mp = 154-155 °C (156-157 °C)
3
; Rf = 
0.30 (7:3 Cy/DCM); 
1
H NMR (400 MHz, CDCl3): δ = 7.22 (s, 1H), 6.79 (d, J = 8, 1H), 6.54-
6.63 (m, 4H), 6.48 (d, J = 8, 1H), 4.00-4.06 (m, 1H), 3.03-3.25 (m, 6H), 2.85-2.94 (m, 1H); 
13C NMR (100 MHz): δ = 142.1, 139.8, 139.3, 137.8, 137.4, 136.5, 133.2, 133.1, 132.4, 
130.0, 129.6, 36.0, 35.0, 34.8, 34.5; IR: 2923, 1735, 1513, 1331 cm
-1
 (See Section 3.2.4 and 
Appendix 10-12). 
9.2.5  (rac)-4-Amino[2.2]paracyclophane 
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A solution of 4-nitro[2.2]paracylophane (3.00 g, 11.8 mmol) in H2O/EtOH (150 ml) was 
stirred for 30 minutes followed by the addition of iron powder (1.80 g, 32 mmol). The 
mixture was heated to reflux and conc. HCl (20 ml) was added over 5 minutes. The 
temperature was maintained for 1 hour after which time the mixture was poured onto ice and 
1M NaOH (300 ml). The mixture was extracted with DCM (3 x 40 ml), dried over MgSO4 
and the solvent removed in vacuo to yield the title compound as a yellow solid (2.19 g, 83%); 
decomp. = 227-230 °C (lit. 239-242 °C)
3
; Rf = 0.43 (8:2 Cy/EtOAc); 
1
H NMR (400 MHz, 
CDCl3): δ = 7.16 (dd, J = 8, 2, 1H), 6.58 (dd, J = 8, 2, 1H), 6.38 (dd, J = 8, 2, 2H), 6.26 (d, J 
= 8, 1H), 6.12 (dd, J = 8, 2, 1H), 5.39 (d, J = 2, 1H), 3.57 (s, 2H), 2.91-3.16 (m, 6H), 2.78-
2.86 (m, 1H), 2.60-2.71 (m, 1H); 
13C NMR (100 MHz): δ = 144.8, 141.1, 139.0, 138.9, 135.3, 
133.5, 132.4, 131.5, 126.8, 124.6, 123.0, 122.3, 35.4, 35.0, 33.0, 32.3; IR: 3463, 3382, 2920, 
2849, 1735, 1611, 1498, 1425 cm
-1
 (See Section 3.2.5 and Appendix 13-15). 
9.2.6  (RP)-4-Amino[2.2]paracyclophane 
 
To a stirred solution of 4-amino[2.2]paracyclophane (2.50 g, 11.2 mmol) in EtOAc (80 ml) 
was added (1S)-(+)-10-camphorsulfonic acid (2.50 g, 11 mmol), and the mixture was kept at 
0 °C for 4 days. After filtration, the resulting solid was poured into fresh ethyl acetate (35 ml) 
and stirred for 3 days at room temperature. The last treatment was then repeated. The salt was 
filtered and treated with 0.1 M NaOH to give (RP)-4-amino[2.2]paracyclophane (0.12 g, 5%). 
NMR data was in agreement with that collected for the racemate (See Section 3.4.1 and 
Appendix 22). 
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9.2.7  4-(4-Tolylsulfinyl)-[2.2]paracyclophane 
 
n-BuLi (2.5 M in hexanes, 13.3 ml, 33.25 mmol) was added dropwise to a solution of 4-
bromo[2.2]paracyclophane (9.08 g, 31.6 mmol) in dry THF (175 ml) at -78 °C under argon. 
The resulting solution was stirred for 2 hours and then a solution of (1R,2S,5R)-(-)-
menthyl(S)-p-toluenesulfinate (9.80 g) in dry THF (175 ml) was added, maintaining a 
temperature of -78 °C. The solution was slowly warmed to room temperature over 24 hours. 
Saturated NH4Cl (150 ml) was added to the solution and the organic phase was extracted. The 
aqueous phase was further extracted with Et2O (3 x 150 ml) and the combined organic phases 
dried over Mg2SO4.  The solvent was removed in vacuo and the resulting residue purified by 
flash column chromatography (19:1 petrol/EtOAc) to give the title compounds (See Section 
3.4.2). 
(SPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane: white solid (3.00 g, 26%); mp = 153-158 °C 
(lit. 148-150 °C)
1
; Rf 0.20 (9:1 petrol/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.36 (d, J = 
8, 2H), 7.15 (d, J = 8, 2H), 7.11 (d, J = 2, 1H), 6.96 (d, J = 7.6, 1H), 6.59-6.62 (m, 2H), 6.51-
6.52 (m, 2H), 6.43 (d, J = 8, 1H), 3.47-3.53 (m, 1H), 3.33 (ddd, J = 5.2, 10, 13.2, 1H), 3.03-
3.20 (m, 5H), 2.86 (ddd, J = 5.2, 10.4, 13.6, 1H), 2.29 (s, 3H); 
13C NMR (100 MHz): δ = 
144.4, 142.2, 141.9, 141.3, 139.6, 139.0, 136.6, 135.8, 135.4, 133.1, 133.0, 131.5, 129.9, 
127.8, 125.7, 35.3, 35.2, 34.7, 32.9, 21.4; IR: 2924, 2848, 1594, 1081, 1059, 1028, 909, 808, 
719 cm
-1
 (See Appendix 16-18). 
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(RPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane: white solid (2.88 g, 25%); mp = 149-145 °C 
(lit. 175-177 °C)
1
; Rf 0.30 (9:1 petrol/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.39 (d, J = 
8.4, 2H), 7.25 (d, J = 8, 2H), 6.79 (d, J = 8, 1H), 6.52-6.59 (m, 4H), 6.46 (d, J = 8.4, 1H), 
6.38 (d, J = 8.4, 1H), 3.81-3.88 (m, 1H), 3.36 (ddd, J = 4.8, 10.4, 12.8, 1H), 2.92-3.20 (m, 
5H), 2.79 (ddd, J = 5.2, 10.8, 13.2, 1H), 2.38 (s, 3H); 
13C NMR (100 MHz): δ = 142.0, 141.3, 
141.1, 140.8, 140.7, 140.0, 139.1, 137.6, 136.6, 133.2, 132.7, 132.6, 132.5, 132.4, 129.6, 
125.2, 35.5, 35.2, 34.9, 32.9, 21.4; IR: 2924, 2853, 1585, 1079, 1036, 817, 718 cm
-1
 (See 
Appendix 19-21). 
9.2.8  (SP)-4-Bromo[2.2]paracyclophane 
 
t-BuLi (1.7 M in pentane, 9 ml, 15.3 mmol) was added dropwise to a solution of (SPS)- 4-(4-
Tolylsulfinyl)-[2.2]paracyclophane (1.05 g, 3.0 mmol) in dry THF (30 ml) at -78 °C. The 
solution was stirred for 10 minutes followed by the addition of bromobenzene (4.49 g, 28.6 
mmol). The solution was slowly returned to room temperature and stirred for 2 days. 
Saturated NH4Cl (50 ml) was added to the solution and the organic phase was extracted. The 
aqueous phase was further extracted with Et2O (3 x 50 ml) and the combined organic phases 
dried over Mg2SO4. The solvent was removed in vacuo and the resulting residue purified by 
flash column chromatography (Cy) to give the title compound as a white solid (0.30 g, 35%). 
NMR data was in agreement with that collected for the racemate (See Section 3.4.2 and 
Appendix 23). 
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9.3  Disubstituted [2.2]paracyclophanes 
9.3.1  (rac)-4-Bromo-13-nitro[2.2]paracyclophane 
 
A solution of 4-nitro[2.2]paracylophane (1.00 g, 3.9 mmol), iron powder (0.02 g, 0.4 mmol) 
and bromine (0.63g, 4.0 mmol) in DCM (50 ml) was heated at reflux for 20 hours. The 
mixture was cooled to room temperature and washed with 10% Na2S2O3 (2 x 50 ml). The 
organic phase was dried over MgSO4 and the solvent removed in vacuo. The title compound 
was isolated by flash column chromatography as a pale yellow solid (0.36 g, 28%); Rf = 0.27 
(8:2 Cy:DCM); 
1
H NMR (400 MHz, CDCl3): δ = 7.58 (d, J = 2, 1H), 6.77 (dd, J = 7.6, 2, 
1H), 6.71 (d, J = 1.2, 1H), 6.65-6.58 (m, 3H), 4.35-4.42 (m, 1H), 3.63-3.70 (m, 1H), 2.99-
3.21 (m, 6H); 
13C NMR (100 MHz): δ = 141.1, 138.8, 138.0, 137.7, 136.5, 136.2, 134.8, 
131.5, 128.0, 127.4, 35.4, 34.7, 34.4, 32.7 (See Section 3.3.1 and Appendix 24-25). 
9.3.2  (rac)-4-Bromo-13-amino[2.2]paracyclophane 
 
A solution of 4-bromo-13-nitro[2.2]paracylophane (1.00 g, 3.0 mmol) in water/EtOH (50 ml) 
was stirred for 30 minutes followed by the addition of iron powder (1.80 g, 32 mmol). The 
mixture was heated to reflux and conc. HCl (7 ml) was added dropwise over 10 minutes. The 
temperature was maintained for 4 hours at which time the mixture was poured onto ice and 
sat. NaHCO3 (50 ml). The mixture was extracted with DCM (3 x 40 ml), dried over MgSO4 
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and the solvent removed in vacuo. The title compound was isolated by flash column 
chromatography as an off white solid (0.62 g, 68%); Rf = 0.46 (8:2 Cy/EtOAc); 
1
H NMR 
(400 MHz, CDCl3): δ = 6.83 (d, J = 1.6, 1H), 6.42-6.49 (m, 2H), 6.38 (d, J = 8, 1H), 6.11 (dd, 
J = 7.6, 1.6, 1H), 5.69 (d, J = 1.6, 1H), 3.66-3.73 (m, 3H), 3.33 (ddd, J = 14.4, 10, 2.4, 1H), 
2.83-3.15 (m, 6H); 
13C NMR (100 MHz): δ = 147.0, 141.0, 140.6, 138.1, 135.4, 135.3, 135.2, 
132..7, 123..4, 123.1, 122.4, 121.0, 34.9, 34.7, 33.1, 31.5; IR: 3480, 3394, 2921, 2850, 1738, 
1611, 1422 cm
-1
 (See Section 3.3.2 and Appendix 26-28). 
9.3.3  (rac)-4-Nitro-13-formyl[2.2]paracyclophane 
 
A solution of 4-nitro[2.2]paracyclophane (2.73 g, 10.8 mmol) in DCM (100 ml) was cooled 
to 0 °C. To this solution was added TiCl4 (4.17 g, 22 mmol) and dichloromethoxymethane 
(1.38 g, 11.2 mmol) and the mixture was warmed to room temperature. After 20 hours 
stirring, water (100 ml) was added and stirring was continued for an additional 2 hours.  The 
organic layer was extracted, dried over MgSO4 and the solvent removed in vacuo. The title 
compound was isolated by flash column chromatography as a pale yellow solid (0.55 g, 
18%); Rf = 0.38 (9:1 DCM:Cy); 
1
H NMR (400 MHz, CDCl3): δ = 9.94 (s, 1H, CHO), 7.15 (d, 
J = 2, 1H, Ar-CH), 7.10 (d, J = 2, 1H, Ar-CH), 6.83 (dd, J = 7.6, 1.6, 1H, Ar-CH), 6.78 (dd, J 
= 7.6, 2, 1H, Ar-CH), 6.74 (d, J = 7.6, 1H, Ar-CH), 6.67 (d, J = 8, 1H, Ar-CH), 4.15-4.23 (m, 
1H, CH2), 3.98-4.06 (m, 1H, CH2), 3.05-3.24 (m, 6H, CH2); 
13C NMR (100 MHz): δ = 190.4 
(CHO), 149.5 (Ar-C), 142.6 (Ar-C), 141.9 (Ar-C), 140.1 (Ar-C), 137.9 (Ar-C), 137.5 (Ar-C), 
137.4 (Ar-C), 136.2 (Ar-C), 136.1 (Ar-C), 135.6 (Ar-C), 134.7 (Ar-C), 128.2 (Ar-C), 34.5 
(CH2), 34.2 (CH2), 31.7 (CH2) (See Section 3.3.3 and Appendix 29-30). 
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9.3.4  (rac)-4-Amino-7-formyl[2.2]paracyclophane 
 
A solution of 4-amino[2.2]paracyclophane (0.50 g, 2.2 mmol) in DCM (25 ml) was cooled to 
0°C. To this solution was added TiCl4 (0.83 g, 4.4 mmol) and dichloromethoxymethane (0.25 
g, 2.2 mmol) and the mixture was warmed to room temperature. After 20 hours stirring, water 
(25 ml) was added and stirring was continued for an additional 2 hours.  The organic layer 
was extracted, dried over MgSO4 and the solvent removed in vacuo. The title compound was 
isolated by flash column chromatography as a yellow solid (0.15 g, 26%); Rf = 0.74 (7:3 
EtOAc:Cy); 
1
H NMR (400 MHz, CDCl3): δ = 9.76 (s, 1H, CHO), 7.11 (dd, J = 8, 2, 1H, Ar-
CH), 6.83 (s, 1H, Ar-CH), 6.51 (dd, J = 8, 2, 1H, Ar-CH), 6.47 (dd, J = 8, 2, 1H, Ar-CH), 
6.40 (dd, J = 8, 2, 1H, Ar-CH), 5.40 (s, 1H, Ar-CH), 4.11 (s, 2H, NH2), 3.97-4.03 (m, 1H, 
CH2), 2.97-3.23 (m, 5H, CH2), 2.61-2.77 (m, 2H, CH2); 
13C NMR (100 MHz): δ = 189.9 
(CHO), 150.6 (Ar-C), 146.3 (Ar-C), 140.3 (Ar-C), 138.9 (Ar-C), 138.7 (Ar-C), 132.5 (Ar-C), 
132.2 (Ar-C), 131.3 (Ar-C), 128.3 (Ar-C), 127.3 (Ar-C), 123.3 (Ar-C), 35.3 (CH2), 33.2 
(CH2), 32.6 (CH2), 31.8 (CH2) (See Section 3.3.4 and Appendix 31-32). 
9.4  General procedure for the preparation of substituted aryl-oxazolines 
 
The appropriate aryl nitrile (13 mmol) and the appropriate amino alcohol (11 mmol) were 
dissolved in dry chlorobenzene (20 ml) under an atmosphere of argon. The solution was 
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stirred for 20 minutes at 60 °C followed by the addition of ZnCl2 (1 M solution in Et2O, 4 
ml). The solution was heated to 145 °C for 4 days, cooled and the solvent evaporated, with 
the title compounds being isolated by flash column chromatography (See section 3.5). 
9.4.1  2-(4,5-Dihydrooxazol-2-yl)aniline 
 
Flash column solvent system (19:1 petrol/EtOAc); yellow solid (0.43 g, 24%); mp = 53-55 
°C; Rf = 0.39 (9:1 petrol/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.69 (dd, J = 8, 1.6, 1H), 
7.19 (ddd, J = 8, 7.2, 1.6, 1H), 6.69 (dd, J = 8, 7.2, 1.2, 1H), 6.05 (s, 2H), 4.29-4.34 (m, 2H), 
4.07-4.12 (m, 2H); 
13C NMR (100 MHz): δ = 164.9, 148.5, 132.0, 129.6, 116.1, 115.7, 109.2, 
65.8, 55.0; IR: 3416, 3298, 2926, 2880, 1627, 1251, 1049, 943 cm
-1
 (See Appendix 33-35). 
9.4.2  (S)-2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)aniline 
 
Flash column solvent system (19:1 petrol/EtOAc); yellow solid (1.84 g, 82%); mp = 66-68 
°C (lit. 67-69 °C)
4
; Rf = 0.50 (9:1 petrol/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.68 (dd, 
J = 8, 1.6, 1H), 7.19 (ddd, J = 8.4, 7.2, 1.6, 1H), 6.68 (dd, J = 8, 0.8, 1H), 6.64 (ddd, 8, 7.2, 
0.8, 1H), 6.13 (s, 2H), 4.31 (dd, J = 9.6, 8, 1H) 4.07-4.13 (m, 1H), 3.99 (app. t, J = 8, 1H), 
1.72-1.83 (m, 1H), 1.02 (d, J = 6.8, 3H), 0.93 (d, J = 6.8, 3H); 
13C NMR (100 MHz): δ = 
163.52, 148.6, 131.9, 129.6, 116.0, 115.6, 109.2, 72.9, 68.8, 33.2, 19.0, 18.6; IR: 3387, 3252, 
2957, 2951, 2879, 1631, 1491, 1254 cm
-1
 (See Appendix 36-38). 
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9.4.3  (S)-2-(2-Bromophenyl)-4-isopropyl-4,5-dihydrooxazole 
 
Flash column solvent system (8:2 DCM/Cy); clear oil (1.24 g, 42%); Rf = 0.22 (8:2 
DCM/Cy); 
1
H NMR (400 MHz, CDCl3): δ = 7.67 (dd, J = 8, 1.6, 1H), 7.63 (d, J = 8, 1H), 
7.33 (t, J = 7.6, 1H), 7.26 (dt, J = 7.6, 1.6, 1H), 4.40-4.46 (m, 1H), 4.13-4.19 (m, 2H), 1.85-
1.97 (m, 1H), 1.05 (d, J = 6.8, 3H), 0.98 (d, J = 6.8, 3H); 
13C NMR (100 MHz): δ = 162.9, 
133.7, 131.5, 131.3, 130.2, 127.1, 121.8, 73.0, 70.4, 32.7, 18.8, 18.3; IR: 2960, 1655, 1352, 
1242, 1094, 1024, 952 cm
-1
 (See Appendix 39-41). 
9.4.4  (S)-2-(2-Iodophenyl)-4-isopropyl-4,5-dihydrooxazole 
 
Flash column solvent system (8:2 DCM/Cy); yellow oil (1.66 g, 48%); Rf = 0.22 (8:2 
DCM/Cy); 
1
H NMR (400 MHz, CDCl3): δ = 7.92 (dd, J = 8, 1.2, 1H, Ar-CH), 7.61 (dd, J = 
8, 1.6, 1H, Ar-CH), 7.36 (dd, J = 7.2, 1.2, 1H, Ar-CH), 7.09 (dd, J = 7.6, 1.6, 1H, Ar-CH), 
4.41-4.47 (m, 1H, N-CH), 4.11-4.18 (m, 2H, O-CH2), 1.85-1.97 (m, 1H, CH(CH3)2), 1.07 (d, 
J = 6.8, 3H, CH3), 0.99 (d, J = 6.8, 3H, CH3); 
13C NMR (100 MHz): δ = 163.8 (Ar-C), 140.4 
(Ar-C), 133.9 (Ar-C), 131.5 (Ar-C), 130.7 (Ar-C), 127.8 (Ar-C), 94.7 (O-C=N), 73.1 (O-
CH2), 70.5 (N-CH), 32.8 (CH(CH3)2), 19.0 (CH3), 18.5 (CH3); IR: 2960 (C-H), 1654 (C=N), 
1468 (C=C), 1351, 1242, 1013 (C-O) cm
-1
 (See Appendix 42-44). 
9.4.5  (S)-2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-4,5-dimethoxyaniline 
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Flash column solvent system (8:2 Cy/EtOAc); off white solid (1.31 g, 45%); mp = 122-123 
°C; Rf = 0.40 (7:3 Cy/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.15 (s, 1H, Ar-CH), 6.23 (s, 
1H, Ar-CH), 5.95 (s, 2H, Ar-NH2), 4.30 (dd, J = 9.2, 8, 1H, N-CH), 4.05-4.11 (m, 1H, O-
CH2), 3.98 (app. t, J = 8, 1H, O-CH2), 3.85 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 1.70-1.82 (m, 
1H, CH(CH3)2), 1.01 (d, J = 6.8, 3H, CH3), 0.92 (d, J = 6.8, 3H, CH3); 
13
C NMR (100 MHz): 
δ = 163.3 (Ar-C), 152.7 (Ar-C), 144.5 (Ar-C), 140.4 (Ar-C), 111.7 (Ar-C), 100.6 (Ar-C), 
99.2 (O-C=N), 72.9 (O-CH2), 68.7 (N-CH), 56.4 (OCH3), 55.7 (OCH3), 33.3 (CH(CH3)2), 
19.0 (CH3), 18.6 (CH3); IR: 3391 (N-H), 2968 (C-H), 1637 (C=N), 1514 (C=C), 1209 (C-N), 
1003 (C-O) cm
-1
 (See Appendix 45-47). 
9.4.6  (S)-2-(4-Benzyl-4,5-dihydrooxazol-2-yl)aniline 
 
Flash column solvent system (19:1 petrol/EtOAc); yellow solid (1.61 g, 58%); mp = 55-57 
°C (lit. 54-56 °C)
4
; Rf = 0.59 (9:1 petrol/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.67 (dd, 
J = 8, 1.6, 1H), 7.17-7.32 (m, 6H), 6.62-6.70 (m, 2H), 6.09 (s, 2H), 4.56-4.64 (m, 1H), 4.27 
(app. t, J = 9.2, 1H), 4.02 (dd, J = 8.4, 7.2, 1H), 3.12 (dd, J = 13.6, 6, 1H), 2.76 (dd, J = 13.6, 
8, 1H); 
13C NMR (100 MHz): δ = 164.1, 148.7, 138.4, 132.1, 129.6, 129.3, 128.5, 126.5, 
116.0, 115.7, 109.0, 70.3, 68.1, 42.3; IR: 3389, 3266, 2906, 1625, 1488, 1453, 1362, 1263 
cm
-1
 (See Appendix 48-50). 
9.4.7  (S)-2-(4-(Tert-butyl)-4,5-dihydrooxazol-2-yl)aniline 
 
Flash column solvent system (19:1 petrol/EtOAc); yellow solid (0.95 g, 40%); mp = 63-65 
°C (lit. 65-66 °C)
4
; Rf = 0.59 (9:1 petrol/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.67 (dd, 
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J = 8, 1.6, 1H), 7.19 (ddd, J = 8, 7.2, 1.6, 1H), 6.70 (dd, J = 8, 1.2, 1H), 6.64 (ddd, 8, 7.2, 1.2, 
1H), 6.15 (s, 2H), 4.21-4.27 (m, 1H), 4.07-4.13 (m, 2H), 0.94 (s, 9H); 
13
C NMR (100 MHz): 
δ = 163.5, 148.7, 131.9, 129.6, 115.9, 115.6, 109.2, 76.4, 66.9, 33.9, 25.9; IR: 3426, 3272, 
2960, 2863, 1635, 1360, 1256 cm
-1
 (See Appendix 51-53). 
9.5 General procedure for preparation of substituted phenyl–oxazoline-
[2.2]paracyclophanes 
 
A Schlenk tube was charged with the appropriate oxazoline (1 mmol), 4-
bromo[2.2]paracyclophane (0.345 g, 1.2 mmol), BINAP (0.126 g, 0.2 mmol), Pd(dba)2 
(0.092 g, 0.1 mmol) and KOtBu (0.224 g, 2 mmol) under an atmosphere of argon. Freshly 
distilled toluene (15 ml) was then added and the mixture was heated at 120 °C for 5 days. The 
solvent was removed in vacuo and the product was isolated by flash column chromatography. 
The product was further purified by recrystallisation from EtOAc (See Section 3.6). 
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9.5.1 (SPS)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine 
 
Flash column solvent system (8:2 Cy/DCM); Appears as a white crystalline solid (0.025 g, 
6%); Rf = 0.57 (6:4 Cy/DCM); 
1
H NMR (400 MHz, CDCl3): δ = 10.34 (s, 1H, Ar-NH), 7.81 
(dd, J = 8, 1.6, 1H, Ar-CH), 7.20 (dd, J = 8, 2, 1H, Ar-CH), 7.14-7.18 (m, 1H, Ar-CH), 6.87 
(dd, J = 8.4, 0.8, 1H, Ar-CH), 6.67-6.71 (m, 1H, Ar-CH), 6.56 (dd, J = 8, 2, 1H, Ar-CH), 
6.44-6.52 (m, 4H, Ar-CH), 6.01 (d, J = 1.2, 1H, Ar-CH), 4.46 (dd, J = 9.6, 8,1H, N-CH), 
4.29-4.35 (m, 1H, O-CH2), 4.11 (app. t, J = 8, 1H, O-CH2), 2.86-3.11 (m, 7H, CH2), 2.66 
(ddd, J = 13.2, 10, 6.8, 1H, CH2), 1.88-2.00 (m, 1H, CH(CH3)2), 1.22 (d, J = 6.8, 3H, CH3), 
1.08 (d, J = 6.8, 3H, CH3); 
13C NMR (100 MHz): δ = 163.9 (Ar-C), 145.8 (Ar-C), 141.2 (Ar-
C), 139.9 (Ar-C), 139.2 (Ar-C), 139.0 (Ar-C), 135.7 (Ar-C), 135.0 (Ar-C), 133.5 (Ar-C), 
132.9 (Ar-C), 132.0 (Ar-C), 131.4 (Ar-C), 130.7 (Ar-C), 129.8 (Ar-C), 128.6 (Ar-C), 128.4 
(Ar-C), 116.1 (Ar-C), 112.3 (Ar-C), 108.9 (O-C=N), 73.3 (O-CH2), 69.0 (N-CH), 35.3 (CH2), 
34.9 (CH2), 34.3 (CH2), 33.9 (CH2), 33.4 (CH(CH3)2), 19.3 (CH3), 18.9 (CH3); IR: 3232 (N-
H), 2957 (C-H), 2926 (C-H), 2853 (C-H), 1630 (C=N), 1583 (C=C), 1520, 1450 (C-H), 1276 
(C-N), 1050 (C-O), 906, 729 cm
-1
; HRMS (ES
+
) calculated for C28H31N2O [M+H]
+
: 
411.2436, found: 411.2433 (See Appendix 54-56 and 106). 
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9.5.2 (SPS)-N-(2-(4-Benzyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine 
 
Flash column solvent system (8:2 Cy/DCM); Appears as a white solid (0.032 g, 7%); Rf = 
0.47 (6:4 Cy/DCM); 
1
H NMR (400 MHz, CDCl3): δ = 10.29 (s, 1H, Ar-NH), 7.83 (dd, J = 8, 
2, 1H , Ar-CH), 7.34-7.46 (m, 5H, Ar-CH), 7.17-7.21 (m, 1H, Ar-CH), 6.96 (dd, J = 8, 2, 1H, 
Ar-CH), 6.91 (dd, J = 8.4, 0.8, 1H, Ar-CH), 6.69-6.73 (m, 1H, Ar-CH), 6.51 (dd, 8, 2, 1H, 
Ar-CH), 6.38-6.48 (m, 3H, Ar-CH), 5.93 (dd, J = 8, 2, 1H, Ar-CH), 5.91 (d, J = 1.6, 1H, Ar-
CH), 4.80-4.88 (m, 1H, N-CH), 4.49 (app. t, J = 8.8, 1H, O-CH2), 4.16 (dd, J = 8, 7.2, 1H, O-
CH2), 2.92-3.14 (m, 8H, CH2), 2.79-2.86 (m, 1H, CH2), 2.61-2.68 (m, 1H, CH2); 
13
C NMR 
(100 MHz): δ = 164.3, 145.5, 141.1, 139.6, 139.1, 138.8, 138.7, 135.7, 134.0, 133.3, 132.6, 
132.1, 131.4, 129.9, 129.8, 129.4, 128.7, 128.2, 126.6, 116.2, 112.5, 108.8, 70.7, 68.4, 43.0, 
35.1, 34.8, 34.2, 33.7, 29.7; IR: 3190 (N-H), 3030 (C-H), 2923 (C-H), 2890 (C-H), 2855 (C-
H), 1636 (C=N), 1593 (C=C), 1527, 1492, 1453 (C-H), 1284 (C-N), 1055 (C-O), 960, 744 
cm
-1
; HRMS (ES
+
) calculated for C32H31N2O [M+H]
+
: 459.2436, found: 459.2428 (See 
Appendix 57-59). 
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9.6  (rac)-2-(4-Amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile 
 
To a Schlenk tube was added 2-amino-4,5-dimethoxybenzonitrile (0.178 g, 1 mmol), 4-
bromo[2.2]paracyclophane (0.345 g, 1.2 mmol), BINAP (0.063 g, 0.1 mmol), Pd(dba)2 
(0.046, 0.05 mmol) and KOtBu (0.224 g, 2 mmol) under an atmosphere of argon. Freshly 
distilled toluene (15 ml) was added and the mixture was heated at 120 °C for 2 days. The 
resulting mixture was diluted with DCM (50ml) and filtered, followed by aqueous extraction. 
The aqueous layer was then extracted with DCM (3 x 25 ml) and the combined organic layers 
were dried over MgSO4. The title compound was isolated by flash column chromatography 
(8:2 Cy/EtOAc) as a waxy solid (0.12 g, 32%); Rf = 0.66 (6:4 Cy/EtOAc); 
1
H NMR (400 
MHz, CDCl3): δ = 7.15 (dd, J = 2, 8, 1H, Ar-CH), 6.23 (s, 1H, Ar-CH), 6.57 (dd, J = 2, 8, 
1H, Ar-CH), 6.43-6.53 (m, 5H, Ar-CH), 6.01 (s, 1H, Ar-NH), 5.92 (d, J = 1.2, 1H, Ar-CH), 
3.84 (s, 3H, OCH3), 3.66 (s, 3H, OCH3), 2.90-3.12 (m, 7H, CH2), 2.64-2.74 (m, 1H, CH2); 
13C NMR (100 MHz): δ = 154.3 (Ar-C), 143.7 (Ar-C), 142.6 (Ar-C), 142.0 (Ar-C), 139.3 
(Ar-C), 138.9 (Ar-C), 138.3 (Ar-C), 136.2 (Ar-C), 133.6 (Ar-C), 132.9 (Ar-C), 132.8 (Ar-C), 
131.3 (Ar-C), 128.8 (Ar-C), 128.0 (Ar-C), 127.4 (Ar-C), 118.5 (Ar-C), 113.6 (C≡N), 98.3 
(Ar-C), 88.1 (Ar-C), 56.5 (OCH3), 55.9 (OCH3), 35.2 (CH2), 34.8 (CH2), 33.8 (CH2); IR: 
3319 (N-H), 2926 (C-H), 2853 (C-H), 2203 (C≡N), 1584 (C=C), 1499, 1449, 1410, 1256, 
1210 (C-O) cm
-1
; HRMS (ES
-
) calculated for C25H23N2O2 [M-H]
-
: 383.1760, found: 383.1771 
(See Section 3.7 and Appendix 60-63). 
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9.7  Octafluoro[2.2]paracyclophane and precursors 
9.7.1  1,4-bis-Dichloromethylbenzene 
 
Procedure A: A mixture of terephthaldehyde (14.4 g, 107 mmol), DMF (1.9 g, 26 mmol) and 
SOCl2 (24.5 g, 206 mmol) was heated at 90 
°
C for 1 hour under an atmosphere of argon. The 
same quantities of DMF and SOCl2 were again added to the mixture and the temperature 
maintained for an additional 2 hours. The mixture was then poured onto cold water (600 ml) 
forming a precipitate. The precipitate was filtered, dissolved in DCM (200 ml) and washed 
with water (2 x 100 ml). The organic layer was dried over MgSO4 and the solvent was 
removed in vacuo to yield the title compound as a white solid (18.29 g, 70%); mp 91-93 °C 
(lit. 92-93 °C)
5
; Rf = 0.57 (9:1 petrol/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.63 (s, 4H), 
6.71 (s, 2H); 
13
C NMR (100 MHz): δ = 141.8, 126.7, 70.8; IR: 1422, 1310, 1214, 800 cm-1 
(See Section 5.2.1 and Apendix 64-66). 
Procedure B: Terephthaldehyde (1 g, 7.5 mmol) was dissolved in dry hexane (50 ml) under 
an atmosphere of argon and 1M BCl3 in pentane (15 ml, 15mmol) was added. The solution 
was heated at reflux for 4 hours and quenched with water (25 ml). The organic layer was 
separated and dried over MgSO4. The solvent was removed in vacuo. The crude material was 
purified using flash column chromatography and yielded the title compound as a white solid 
(0.82 g, 45%). 
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9.7.2  1,4-bis-Difluoromethylbenzene 
 
Terephthaldehyde (0.5 g, 3.7 mmol) was dissolved in dry DCM (20 ml) under an atmosphere 
of argon. DAST (1.83 g, 11.4 mmol) was added dropwise followed by a catalytic amount of 
absolute EtOH. The reaction was heated at reflux for 20 hours, cooled to room temperature 
and quenched with water (20 ml). The organic layer was extracted and the aqueous layer was 
washed with DCM (20 ml). The combined organic layers were dried over MgSO4 and the 
solvent removed in vacuo to give an orange oil which was purified by flash column 
chromatography to yield the title compound as a colourless clear oil (0.44 g, 67%); Rf = 0.5 
(9:1 petrol/EtOAc); 
1
H NMR (400 MHz, CDCl3): δ = 7.59 (s, 4H), 6.67 (t, J = 56, 2H); 
19
F 
NMR (376 MHz): δ = -111.7 (d, J = 56, 4F); 13C NMR (100 MHz): δ = 136.7 (t, J = 23), 
126.0 (t, J = 6), 114.0 (t, J = 238); IR: 1430, 1370, 1220, 1018, 809 cm
-1
 (See Section 5.2.2 
and Appendix 67-70). 
9.7.3  1,4-bis-Chlorodifluoromethylbenzene 
 
1,4-bis-Difluoromethylbenzene (3 g, 16.8 mmol) was added to a solution of AIBN (0.2 g, 1.2 
mmol) and SO2Cl2 (30 ml) under an atmosphere of argon. This solution was heated at reflux 
for 5 days, cooled to room temperature, then added to water (150 ml) and allowed to stir for 1 
hour. The mixture was extracted with DCM (3 x 40 ml) and the organic phase dried over 
MgSO4 and the solvent removed in vacuo. The crude oil was purified using flash column 
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chromatography to yield the title compound as a colourless clear oil (0.83 g, 20%); Rf = 0.65 
(petrol); 
1
H NMR (400 MHz, CDCl3): δ = 7.75 (s, 4H); 
19F NMR (376 MHz): δ = -50.0 (s, 
4F); 
13C NMR (100 MHz): δ = 139.0 (t, J = 27), 125.6 (t, J = 289), 125.2 (t, J = 5); IR: 1413, 
1272, 1053, 912, 822, 730 cm
-1
 (See Section 5.2.3 and Appendix 71-74). 
9.7.4  1-(Trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene 
 
Magnesium turnings (1.73 g, 72 mmol) were added to dry DMF (80 ml) under an atmosphere 
of argon. Chlorotrimethylsilane (15.6 g, 144 mmol) was added to the mixture followed by the 
dropwise addition of 1,4-bis-trifluoromethylbenzene (7.7 g, 36 mmol) over 1 hour. The 
mixture was then allowed stir for an additional 30 minutes. The reaction was quenched with 
water (80 ml) and extracted with hexane (3 x 60 ml). The organic phase was dried over 
MgSO4 and the solvent removed in vacuo to give a brown oil which was purified by flash 
column chromatography to yield the product as a colourless clear oil (3.09 g, 32%); Rf = 0.44 
(petrol); 
1
H NMR (400 MHz, CDCl3): δ = 7.55 (d, J = 8, 2H), 7.33 (d, J = 8, 2H), 0.015 (s, 
9H); 
19F NMR (376 MHz): δ = -113.2 (s, 2F), -62.8 (s, 3F); 13C NMR (100 MHz): δ = 142.0 
(t, J = 21), 131.0 (q, J = 32), 126.3 (q, J = 264), 125.3 (q, J = 4), 125.2 (t, J = 8), 123.9 (t, J = 
402), -5.0; IR: 1411, 1323, 1128, 1068, 998, 827 cm
-1
 (See Section 5.2.4 and Appendix 75-
78). 
9.7.5  1,1,2,2,9,9,10,10-Octafluoro[2,2]paracyclophane 
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A mixture of 1-(Trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene (1 g, 3.7 mmol), 
CsF (0.060 g, 0.4 mmol) and Pd2(dba)3 (20 mg, 0.02 mmol) in dry anisole (80 ml) was heated 
at reflux for 24 hours under an atmosphere of argon. The solvent was removed in vacuo and 
the title compound was isolated by flash column chromatography as a white crystalline solid 
(0.12 g, 18%); mp 261-263 °C (lit. 261 °C)
6
; Rf = 0.62 (6:4 Cy/DCM); 
1
H NMR (400 MHz, 
CDCl3): δ = 7.16 (s, 8H); 
19F NMR (376 MHz): δ = -118.2 (s, 8F); 13C NMR (100 MHz): δ = 
134.9 (t, J = 27), 129.8, 118.6 (t, J = 272); IR: 1401, 1257, 1130, 1086, 923, 823, 712 cm
-1
 
(See Section 5.2.5 and Appendix 79-82). 
9.8  Monosubstituted octafluoro[2.2]paracyclophanes 
9.8.1  (rac)-4-Nitro-1,1,2,2,9,9,10,10-octafluoro[2,2]paracyclophane 
 
Octafluoro[2,2]paracyclophane (2 g, 5.7 mmol) was added to a solution of 67% HNO3 (22 
ml) and H2SO4 (3 ml) and heated at 100 °C for 24 hours. The suspension was cooled to room 
temperature and added to ice water (200 ml). The resulting solid was isolated by filtration and 
flash column chromatography yielded the title compound as an off-white solid (0.59 g, 26%); 
mp 117-119 °C (lit. 119-129 °C)
7
; Rf = 0.44 (6:4 Cy/DCM); 
1
H NMR (400 MHz, (CD3)2CO): 
δ = 7.70 (m, 4H), 7.54 (m, 2H), 7.33 (d, J = 8.8, 1H); 19F NMR (376 MHz): δ = -111.08 (d, J 
= 264, 1F), -113.73 (d, J = 264, 1F), -116.08 (m, 4F), -117.75 (m, 2F); IR: 1537, 1402, 1349, 
1241, 1126, 1092 cm
-1
 (See Section 5.3.1 and Appendix 83-86). 
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9.8.2  (rac)-4-Amino-1,1,2,2,9,9,10,10-octafluoro[2,2]paracyclophane 
 
A solution of 4-nitro-octafluoro[2.2]paracylophane (1.00 g, 2.5 mmol) in H2O/EtOH (50 ml) 
was stirred for 30 minutes followed by the addition of iron powder (1.40 g, 25 mmol). The 
mixture was heated to reflux and conc. HCl (7 ml) was added in one portion. The temperature 
was maintained for 8 hours at which time the mixture was poured onto ice and 1M NaOH 
(100 ml). The mixture was extracted with DCM (3 x 40 ml), dried over MgSO4 and the 
solvent removed in vacuo to yield the title compound as a white solid (0.73 g, 80%); mp 219-
221 °C (lit. 221-223 °C)
7
; Rf = 0.28 (6:4 Cy/DCM); 
1
H NMR (400 MHz, (CD3)2CO): δ = 
7.99 (dd, J = 8.0, 1.6, 1H), 7.40 (dd, J = 8.8, 1.6, 1H), 7.19 (d, J = 8.4, 1H), 7.11 (d, J = 8.0, 
1H), 6.95 (dd, J = 8.8, 1.2, 1H), 6.54 (dd, J = 8.8, 1.2, 1H), 6.09 (d, J = 1.2, 1H), 5.60 (s, 2H); 
19F NMR (376 MHz): δ = -105.40 (d, J = 252, 1F), -107.90 (d, J = 252, 1F), -111.56 (d, J = 
232, 1F), -112.30 (d, J = 240, 1F), -114.34 (d, J = 252, 1F), -115.84 (d, J = 252, 1F), -116.81 
(d, J = 256, 1F), -117.82 (d, J = 248, 1F); IR: 3534, 3438, 1629, 1437, 1236, 1082 cm
-1
 (See 
Section 5.3.2 and Appendix 87-90). 
9.9  General procedure for the preparation of fluorinated aryl triethoxysilanes 
 
A mixture of magnesium turnings (1.27 g, 52 mmol) and 2 crystals of iodine were placed 
under an atmosphere of argon. To this was added TEOS (10.9 g, 52 mmol) followed by the 
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appropriate fluorobromobenzene (48 mmol) with stirring. To this solution was added dry 
Et2O (30 ml) at 0 °C and an exothermic event is observed. After approximately 20 minutes 
the solution was allowed to return to room temperature and was subsequently heated at reflux 
for 20 hours. An excess of heptane was added until a precipitation of salts is observed. The 
precipitate was removed by filtration and the solvent was removed in vacuo. The resulting oil 
is purified by vacuum distillation to yield the title compounds (See Section 7.3.1). 
9.9.1  4-Fluorophenyltriethoxysilane 
 
Clear oil (4.22 g, 34 %);
 1
H NMR (400 MHz, CDCl3): δ = 7.67 (q, J = 6.4, 2H, Ar-CH), 7.06 
(t, J = 8.8, 2H, Ar-CH), 3.87 (g, J = 7.2, 6H, OCH2CH3), 1.24 (t, J = 7.2, 9H, OCH2CH3); 
19
F 
NMR (376 MHz): δ = -109.80 (s, 1F); 13C NMR (100 MHz): δ = 164.5 (d, J = 248, Ar-CF), 
136.8 (d, J = 8, Ar-CH), 126.7 (d, J = 4, Ar-C-Si), 114.9 (d, J = 20, Ar-CH), 58.6 
(OCH2CH3), 18.0 (OCH2CH3) (See Appendix 91-93). 
9.9.2  3,4,5-Trifluorophenyltriethoxysilane 
 
Clear oil (4.24 g, 30 %);
 1
H NMR (400 MHz, CDCl3): δ = 7.16 (t, J = 7.2, 2H, Ar-CH), 3.78 
(q, J = 7.2, 6H, OCH2CH3), 1.16 (t, J = 7.2, 9H, OCH2CH3); 
19F NMR (376 MHz): δ = -
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135.26 (d, J = 23, 2F, Ar-CF), -158.53 (t, J = 23, 1F, Ar-CF); 
13C NMR (100 MHz): δ = 
150.4 (dd, J = 51, 9, (Ar-CF), 140.5 (dd, J = 53, 14, (Ar-CF), 127.4, (Ar-CH), 117.4 (d, J = 
14, (Ar-CH), 58.1 (OCH2CH3), 17.1 (OCH2CH3) (See Appendix 94-96). 
9.9.3  Perfluorophenyltriethoxysilane 
 
Clear oil (4.28 g, 27 %) yield calculated based on desired product; Isolated as a mixture 
which could not be separated. 
1
H, 
19
F and 
13
C NMR spectra of the mixture provided in 
appendices (See Appendix 97-99). 
9.10  Fluorinated mesoporous silicate particles 
To a beaker was added EtOH (1000 ml), CTAB (55 g, 0.151 mol), H2O (290 g, 16.1 mol) and 
28% ammonium hydroxide solution (50 ml, 14 g, 0.4 mol) with stirring. In a second vessel a 
mixture of TEOS (186 g, 0.89 mol) and PFOTES (4.57 g, 9 mmol) was prepared. The silane 
solution was added to the EtOH solution in one portion and immediately heated using 
microwave (10 min, 100 W). The resulting suspension was left to evaporate at 90 °C for 
approximately 24 hours. The resulting solid was added to a solution of MeOH (1250 ml) and 
conc. HCl (65 ml) and heated at reflux for approximately 24 hours. The resulting particles 
were isolated by filtration and washed with a mixture of methanol (500 ml) and conc. HCl 
(25 ml) followed by ethanol (250 ml). The particles were then dried under vacuum at room 
temperature (See Section 7.3.2). 
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9.11  Unsuccessful procedures 
9.11.1  4-Amino-13-formyl[2.2]paracyclophane 
A solution of 4-nitro-13-formyl[2.2]paracylophane (0.10 g,  0.36 mmol) in H2O/EtOH (5 ml) 
was stirred for 30 minutes followed by the addition of iron powder (0.06 g,  1.1 mmol). The 
mixture was heated to reflux and conc. HCl (0.6 ml) was added in one portion. The starting 
material was observed to degrade almost immediately (See Section 3.3.4). 
9.11.2  1,4-bis-Difluoromethylbenzene by solid phase reaction 
1,4-bis-dichloromethylbenzene (2.0 g, 8.2 mmol) and CsF (7.47 g, 49 mmol) were ground in 
a mortar and pestle and added to a sealed glass vessel. This was heated without mixing at 180 
°C for 8 hours. The resulting mixture was dissolved in DCM (100 ml) and washed with water 
(3 x 50 ml). The organic phase was dried over MgSO4 and removed in vacuo. No product 
was isolated from the resulting material (See Section 5.2.2). 
9.11.3  1,4-bis-Difluoromethylbenzene by phase transfer catalysis 
Procedure A: To a mixture of benzene/water (10 ml) was added 1,4-bis-
dichloromethylbenzene (0.25 g, 1 mmol), CsF (0.8 g, 5.3 mmol) and TBAB (0.02 g, 0.06 
mmol). This mixture was heated at 100 °C with vigorous stirring, for 24 hours. The organic 
phase was extracted, dried over MgSO4 and removed in vacuo. No product was isolated from 
the resulting material. 
Procedure B: To dry DMF (10 ml) under an atmosphere of argon was added 1,4-bis-
dichloromethylbenzene (0.25 g, 1 mmol), CsF (0.8 g, 5.3 mmol) and TBAB (0.02 g, 0.06 
mmol). The mixture was heated at reflux for 24 hours. The resulting solution was diluted 
with water (40ml) and washed with DCM (2 x 25 ml). The organic phase was dried over 
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MgSO4 and the solvent removed in vacuo. No product was isolated from the resulting 
material (See Section 5.2.2). 
9.11.4  1,1,2,2,9,9,10,10-Octafluoro[2.2]paracyclophane by zinc coupling 
A mixture of zinc (2.0 g, 30.6 mmol) in dry DMA (20 ml) was prepared under an atmosphere 
of argon. To this was added 1,4,-bis-chlorodifluoromethylbenzene (2.0 g, 8.1 mmol) with 
stirring. The mixture was heated to 100 °C over 40 minutes and was maintained at this 
temperature for 24 hours. 
19
F NMR indicated only starting material was present in the 
reaction mixture and no traces of product were detected (See Section 5.2.5). 
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Appendix 1: 
1
H NMR of (rac)-4-bromo[2.2]paracyclophane 
 
Appendix 2: 
13
C NMR of (rac)-4-bromo[2.2]paracyclophane 
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Appendix 3: IR of (rac)-4-bromo[2.2]paracyclophane 
 
Appendix 4: 
1
H NMR of (rac)-4-formyl[2.2]paracyclophane 
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Appendix 5: 
13
C NMR of (rac)-4-formyl[2.2]paracyclophane 
  
Appendix 6: IR of (rac)-4-formyl[2.2]paracyclophane 
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Appendix 7: 
1
H NMR of (rac)-4-hydroxy[2.2]paracyclophane 
 
Appendix 8: 
13
C NMR of (rac)-4-hydroxy[2.2]paracyclophane 
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Appendix 9: IR of (rac)-4-hydroxy[2.2]paracyclophane 
 
Appendix 10: 
1
H NMR of (rac)-4-nitro[2.2]paracyclophane  
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Appendix 11: 
13
C NMR of (rac)-4-nitro[2.2]paracyclophane 
 
Appendix 12: IR of (rac)-4-nitro[2.2]paracyclophane 
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Appendix 13: 
1
H NMR of (rac)-4-amino[2.2]paracyclophane 
 
Appendix 14: 
13
C NMR of (rac)-4-amino[2.2]paracyclophane 
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Appendix 15: IR of (rac)-4-amino[2.2]paracyclophane 
 
Appendix 16: 
1
H NMR of (SPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane 
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Appendix 17: 
13
C NMR of (SPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane 
 
Appendix 18: IR of (SPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane 
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Appendix 19: 
1
H NMR of (RPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane 
 
Appendix 20: 
13
C NMR of (RPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane 
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Appendix 21: IR of (RPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane 
 
Appendix 22: 
1
H NMR of (RP)-4-amino[2.2]paracyclophane 
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Appendix 23: 
1
H NMR of (SP)-4-bromo[2.2]paracyclophane 
 
Appendix 24: 
1
H NMR of (rac)-4-bromo-13-nitro[2.2]paracyclophane 
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Appendix 25: 
13
C NMR of (rac)-4-bromo-13-nitro[2.2]paracyclophane 
 
Appendix 26: 
1
H NMR of (rac)-4-bromo-13-amino[2.2]paracyclophane  
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Appendix 27: 
13
C NMR of (rac)-4-bromo-13-amino[2.2]paracyclophane 
 
Appendix 28: IR of (rac)-4-bromo-13-amino[2.2]paracyclophane 
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Appendix 29: 
1
H NMR of (rac)-4-nitro-13-formyl[2.2]paracyclophane  
 
Appendix 30: 
13
C NMR of (rac)-4-nitro-13-formyl[2.2]paracyclophane 
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Appendix 31: 
1
H NMR of (rac)-4-amino-7-formyl[2.2]paracyclophane 
 
Appendix 32: 
13
C NMR of (rac)-4-amino-7-formyl[2.2]paracyclophane 
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Appendix 33: 
1
H NMR of 2-(4,5-dihydrooxazol-2-yl)aniline 
 
Appendix 34: 
13
C NMR of 2-(4,5-dihydrooxazol-2-yl)aniline 
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Appendix 35: IR 2-(4,5-dihydrooxazol-2-yl)aniline 
 
Appendix 36: 
1
H NMR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)aniline 
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Appendix 37: 
13
C NMR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)aniline 
 
Appendix 38: IR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)aniline 
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Appendix 39: 
1
H NMR of (S)-2-(2-bromophenyl)-4-isopropyl-4,5-dihydrooxazole  
 
Appendix 40: 
13
C NMR of (S)-2-(2-bromophenyl)-4-isopropyl-4,5-dihydrooxazole 
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Appendix 41: IR of (S)-2-(2-bromophenyl)-4-isopropyl-4,5-dihydrooxazole 
 
Appendix 42: 
1
H NMR of (S)-2-(2-iodophenyl)-4-isopropyl-4,5-dihydrooxazole 
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Appendix 43: 
13
C NMR of (S)-2-(2-iodophenyl)-4-isopropyl-4,5-dihydrooxazole 
 
Appendix 44: IR of (S)-2-(2-iodophenyl)-4-isopropyl-4,5-dihydrooxazole 
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Appendix 45: 
1
H NMR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)-4,5-dimethoxyaniline 
 
Appendix 46: 
13
C NMR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)-4,5-dimethoxyaniline 
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Appendix 47: IR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)-4,5-dimethoxyaniline 
 
Appendix 48: 
1
H NMR of (S)-2-(4-benzyl-4,5-dihydrooxazol-2-yl)aniline 
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Appendix 49: 
13
C NMR of (S)-2-(4-benzyl-4,5-dihydrooxazol-2-yl)aniline 
 
Appendix 50: IR of (S)-2-(4-benzyl-4,5-dihydrooxazol-2-yl)aniline 
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Appendix 51: 
1
H NMR of (S)-2-(4-(tert-butyl)-4,5-dihydrooxazol-2-yl)aniline 
 
Appendix 52: 
13
C NMR of (S)-2-(4-(tert-butyl)-4,5-dihydrooxazol-2-yl)aniline 
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Appendix 53: IR of (S)-2-(4-(tert-butyl)-4,5-dihydrooxazol-2-yl)aniline 
 
Appendix 54: 
1
H NMR of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine 
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Appendix 55: 
13
C NMR of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine 
 
Appendix 56: HRMS of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine 
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Appendix 57: 
1
H NMR of (SPS)-N-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine 
 
Appendix 58: 
13
C NMR of (SPS)-N-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine 
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Appendix 59: HRMS NMR of (SPS)-N-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)-
[2.2]paracyclophane-4-amine 
 
Appendix 60: 
1
H NMR of (rac)-2-(4-amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile 
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Appendix 61: 
13
C NMR of (rac)-2-(4-amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile 
 
Appendix 62: IR of (rac)-2-(4-amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile 
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Appendix 63: HRMS of (rac)-2-(4-amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile 
 
Appendix 64: 
1
H NMR of 1,4-bis-dichloromethylbenzene 
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Appendix 65: 
13
C NMR of 1,4-bis-dichloromethylbenzene 
 
Appendix 66: IR of 1,4-bis-dichloromethylbenzene 
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Appendix 67: 
1
H NMR of 1,4-bis-difluoromethylbenzene 
 
Appendix 68: 
13
C NMR of 1,4-bis-difluoromethylbenzene 
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Appendix 69: 
19
F NMR of 1,4-bis-difluoromethylbenzene 
 
Appendix 70: IR of 1,4-bis-difluoromethylbenzene 
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Appendix 71: 
1
H NMR of 1,4-bis-chlorodifluoromethylbenzene 
 
Appendix 72: 
13
C NMR of 1,4-bis-chlorodifluoromethylbenzene 
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Appendix 73: 
19
F NMR of 1,4-bis-chlorodifluoromethylbenzene 
 
Appendix 74: IR of 1,4-bis-chlorodifluoromethylbenzene 
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Appendix 75: 
1
H NMR of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene 
 
Appendix 76: 
13
C NMR of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene 
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Appendix 77: 
19
F NMR of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene 
 
Appendix 78: IR of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene 
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Appendix 79: 
1
H NMR of octafluoro[2.2]paracyclophane 
 
Appendix 80: 
13
C NMR of octafluoro[2.2]paracyclophane 
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Appendix 81: 
19
F NMR of octafluoro[2.2]paracyclophane 
 
Appendix 82: IR of octafluoro[2.2]paracyclophane 
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Appendix 83: 
1
H NMR of (rac)-4-nitro-octafluoro[2.2]paracyclophane 
 
Appendix 84: 
13
C NMR of (rac)-4-nitro-octafluoro[2.2]paracyclophane 
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Appendix 85: 
19
F NMR of (rac)-4-nitro-octafluoro[2.2]paracyclophane 
 
Appendix 86: IR of (rac)-4-nitro-octafluoro[2.2]paracyclophane 
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Appendix 87: 
1
H NMR of (rac)-4-amino-octafluoro[2.2]paracyclophane 
 
Appendix 88: 
13
C NMR of (rac)-4-amino-octafluoro[2.2]paracyclophane 
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Appendix 89: 
19
F NMR of (rac)-4-amino-octafluoro[2.2]paracyclophane 
 
Appendix 90: IR of (rac)-4-amino-octafluoro[2.2]paracyclophane 
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Appendix 91: 
1
H NMR of 4-fluorophenyltriethoxysilane  
 
Appendix 92: 
13
C NMR of 4-fluorophenyltriethoxysilane 
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Appendix 93: 
19
F NMR of 4-fluorophenyltriethoxysilane 
 
Appendix 94: 
1
H NMR of 3,4,5-trifluorophenyltriethoxysilane 
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Appendix 95: 
13
C NMR of 3,4,5-trifluorophenyltriethoxysilane 
 
Appendix 96: 
19
F NMR of 3,4,5-trifluorophenyltriethoxysilane 
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Appendix 97: 
1
H NMR of perfluorophenyltriethoxysilane 
 
Appendix 98: 
13
C NMR of perfluorophenyltriethoxysilane 
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Appendix 99: 
19
F NMR of perfluorophenyltriethoxysilane 
 
Appendix 100: 
1
H NMR of unidentified dibromo-nitro[2.2]paracyclophane regioisomer (a)  
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Appendix 101: 
13
C NMR of unidentified dibromo-nitro[2.2]paracyclophane regioisomer (a) 
 
Appendix 102: 
1
H NMR of unidentified dibromo-nitro[2.2]paracyclophane regioisomer (b) 
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Appendix 103: 
13
C NMR of unidentified dibromo-nitro[2.2]paracyclophane regioisomer (b) 
 
Appendix 104: 
1
H NMR of a mixture of diamino-octafluoro[2.2]paracyclophane isomers  
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Appendix 105: 
19
F NMR of a mixture of diamino-octafluoro[2.2]paracyclophane isomers 
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Appendix 106: Crystal data and structure refinement for (SPS)-N-(2-(4-Isopropyl-4,5-
dihydrooxazol-2-yl)phenyl)-[2.2]paracyclophane-4-amine 
Identification code  tcd334 
Empirical formula  C28H30N2O 
Formula weight  410.54 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 9.0508(4) Å  
 b = 20.3629(8) Å  
 c = 12.1504(5) Å  
Volume 2236.62(16) Å3 
Z 4 
Density (calculated) 1.219 Mg/m3 
Absorption coefficient 0.570 mm-1 
F(000) 880 
Crystal size 0.280 x 0.140 x 0.080 mm3 
Theta range for data collection 3.642 to 70.008°. 
Index ranges -10≤h≤11, -24≤k≤24, -14≤l≤14 
Reflections collected 31314 
Independent reflections 8372 [R(int) = 0.0346] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7533 and 0.6249 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8372 / 1 / 571 
Goodness-of-fit on F2 1.036 
Final R indices [I>2σ(I)] R1 = 0.0370, wR2 = 0.0967 
R indices (all data) R1 = 0.0376, wR2 = 0.0978 
Absolute structure parameter 0.15(7) 
Largest diff. peak and hole 0.241 and -0.195 e.Å-3 
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Table 1: Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for TCD334.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
___________________________________________________________________________  
 x y z U(eq) 
___________________________________________________________________________  
C(1) 3129(2) 311(1) 907(2) 21(1) 
C(2) 3607(2) 702(1) 57(2) 22(1) 
C(3) 4620(2) 1207(1) 273(2) 24(1) 
C(4) 5368(2) 1211(1) 1305(2) 27(1) 
C(5) 4894(2) 816(1) 2152(2) 27(1) 
C(6) 3655(2) 412(1) 1999(2) 24(1) 
C(7) 2732(3) 242(1) 2961(2) 31(1) 
C(8) 1629(4) 806(2) 3268(3) 48(1) 
C(9) 1567(3) 1366(1) 2449(2) 33(1) 
C(10) 2578(3) 1881(1) 2568(2) 33(1) 
C(11) 2962(3) 2244(1) 1662(2) 31(1) 
C(12) 2373(3) 2097(1) 617(2) 29(1) 
C(13) 1142(3) 1684(1) 548(2) 31(1) 
C(14) 738(3) 1327(1) 1453(2) 32(1) 
C(15) 3215(3) 2244(1) -396(2) 40(1) 
C(16) 4647(3) 1801(1) -473(2) 31(1) 
N(17) 1897(2) -107(1) 664(2) 23(1) 
C(18) 1847(2) -770(1) 842(2) 21(1) 
C(19) 3072(2) -1120(1) 1295(2) 24(1) 
C(20) 3016(3) -1792(1) 1419(2) 29(1) 
C(21) 1749(3) -2145(1) 1094(2) 31(1) 
C(22) 526(3) -1808(1) 679(2) 27(1) 
C(23) 540(2) -1126(1) 555(2) 21(1) 
C(24) -822(2) -791(1) 159(2) 22(1) 
O(25) -2034(2) -1180(1) 22(2) 38(1) 
C(26) -3252(3) -735(2) -220(4) 64(1) 
C(27) -2560(2) -63(1) -348(2) 29(1) 
N(28) -981(2) -177(1) -30(2) 25(1) 
C(29) -2754(3) 235(1) -1497(2) 30(1) 
C(30) -2059(3) 921(2) -1494(3) 51(1) 
C(31) -2128(4) -198(2) -2361(2) 61(1) 
C(32) 1743(2) 9007(1) 5781(2) 22(1) 
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C(33) 1398(2) 8634(1) 4845(2) 24(1) 
C(34) 381(3) 8119(1) 4862(2) 27(1) 
C(35) -499(3) 8080(1) 5759(2) 30(1) 
C(36) -147(3) 8444(1) 6703(2) 29(1) 
C(37) 1081(3) 8858(1) 6769(2) 25(1) 
C(38) 1872(3) 8981(1) 7873(2) 33(1) 
C(39) 3354(3) 8574(2) 8031(2) 43(1) 
C(40) 3366(3) 7980(1) 7287(2) 35(1) 
C(41) 2326(3) 7477(1) 7372(2) 39(1) 
C(42) 1911(3) 7092(1) 6474(2) 38(1) 
C(43) 2516(3) 7196(1) 5458(2) 36(1) 
C(44) 3767(3) 7591(1) 5447(2) 34(1) 
C(45) 4187(3) 7979(1) 6345(2) 33(1) 
C(46) 1639(4) 7024(2) 4411(3) 50(1) 
C(47) 468(3) 7565(1) 4041(2) 36(1) 
N(48) 2957(2) 9443(1) 5755(2) 24(1) 
C(49) 2981(2) 10091(1) 6046(2) 23(1) 
C(50) 1765(3) 10405(1) 6501(2) 26(1) 
C(51) 1809(3) 11062(1) 6774(2) 30(1) 
C(52) 3056(3) 11440(1) 6599(2) 33(1) 
C(53) 4261(3) 11147(1) 6140(2) 30(1) 
C(54) 4251(2) 10480(1) 5865(2) 24(1) 
C(55) 5533(2) 10202(1) 5338(2) 24(1) 
O(56) 6643(2) 10633(1) 5148(2) 33(1) 
C(57) 7705(3) 10270(1) 4533(2) 32(1) 
C(58) 7138(2) 9558(1) 4518(2) 26(1) 
N(59) 5700(2) 9609(1) 5034(2) 25(1) 
C(60) 6964(3) 9251(1) 3374(2) 32(1) 
C(61) 8453(3) 9241(2) 2826(2) 48(1) 
C(62) 6330(3) 8563(1) 3430(2) 40(1) 
 
 Table 2: Bond lengths [Å] and angles [°] for  TCD334. 
___________________________________________________________________________
C(1)-C(2)  1.390(3) 
C(1)-C(6)  1.403(3) 
C(1)-N(17)  1.421(3) 
C(2)-C(3)  1.394(3) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.395(3) 
C(3)-C(16)  1.512(3) 
C(4)-C(5)  1.390(3) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.395(3) 
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C(5)-H(5)  0.9500 
C(6)-C(7)  1.510(3) 
C(7)-C(8)  1.579(4) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(9)  1.513(4) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(14)  1.394(4) 
C(9)-C(10)  1.395(4) 
C(10)-C(11)  1.385(4) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.385(4) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.395(3) 
C(12)-C(15)  1.509(4) 
C(13)-C(14)  1.383(4) 
C(13)-H(13)  0.9500 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.586(4) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
N(17)-C(18)  1.370(3) 
N(17)-H(17)  0.90(3) 
C(18)-C(19)  1.407(3) 
C(18)-C(23)  1.417(3) 
C(19)-C(20)  1.379(3) 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.394(3) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.377(3) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.397(3) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.468(3) 
C(24)-N(28)  1.279(3) 
C(24)-O(25)  1.357(3) 
O(25)-C(26)  1.446(3) 
C(26)-C(27)  1.515(4) 
C(26)-H(26A)  0.9900 
C(26)-H(26B)  0.9900 
C(27)-N(28)  1.481(3) 
C(27)-C(29)  1.525(3) 
C(27)-H(27)  1.0000 
C(29)-C(31)  1.503(4) 
C(29)-C(30)  1.531(4) 
C(29)-H(29)  1.0000 
C(30)-H(30A)  0.9800 
C(30)-H(30B)  0.9800 
C(30)-H(30C)  0.9800 
C(31)-H(31A)  0.9800 
C(31)-H(31B)  0.9800 
C(31)-H(31C)  0.9800 
C(32)-C(33)  1.390(3) 
C(32)-C(37)  1.401(3) 
C(32)-N(48)  1.413(3) 
C(33)-C(34)  1.397(3) 
C(33)-H(33)  0.9500 
C(34)-C(35)  1.384(4) 
C(34)-C(47)  1.511(3) 
C(35)-C(36)  1.389(4) 
C(35)-H(35)  0.9500 
C(36)-C(37)  1.394(3) 
C(36)-H(36)  0.9500 
C(37)-C(38)  1.511(3) 
C(38)-C(39)  1.581(4) 
C(38)-H(38A)  0.9900 
C(38)-H(38B)  0.9900 
C(39)-C(40)  1.511(4) 
C(39)-H(39A)  0.9900 
C(39)-H(39B)  0.9900 
C(40)-C(45)  1.395(4) 
C(40)-C(41)  1.399(4) 
C(41)-C(42)  1.381(4) 
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C(41)-H(41)  0.9500 
C(42)-C(43)  1.391(4) 
C(42)-H(42)  0.9500 
C(43)-C(44)  1.388(4) 
C(43)-C(46)  1.507(4) 
C(44)-C(45)  1.385(4) 
C(44)-H(44)  0.9500 
C(45)-H(45)  0.9500 
C(46)-C(47)  1.579(4) 
C(46)-H(46A)  0.9900 
C(46)-H(46B)  0.9900 
C(47)-H(47A)  0.9900 
C(47)-H(47B)  0.9900 
N(48)-C(49)  1.367(3) 
N(48)-H(48)  0.90(3) 
C(49)-C(50)  1.409(3) 
C(49)-C(54)  1.422(3) 
C(50)-C(51)  1.379(3) 
C(50)-H(50)  0.9500 
C(51)-C(52)  1.392(4) 
C(51)-H(51)  0.9500 
C(52)-C(53)  1.385(4) 
C(52)-H(52)  0.9500 
C(53)-C(54)  1.399(3) 
C(53)-H(53)  0.9500 
C(54)-C(55)  1.466(3) 
C(55)-N(59)  1.274(3) 
C(55)-O(56)  1.363(3) 
O(56)-C(57)  1.449(3) 
C(57)-C(58)  1.537(3) 
C(57)-H(57A)  0.9900 
C(57)-H(57B)  0.9900 
C(58)-N(59)  1.476(3) 
C(58)-C(60)  1.525(3) 
C(58)-H(58)  1.0000 
C(60)-C(62)  1.518(4) 
C(60)-C(61)  1.532(3) 
C(60)-H(60)  1.0000 
C(61)-H(61A)  0.9800 
C(61)-H(61B)  0.9800 
C(61)-H(61C)  0.9800 
C(62)-H(62A)  0.9800 
C(62)-H(62B)  0.9800 
C(62)-H(62C)  0.9800 
 
C(2)-C(1)-C(6) 121.0(2) 
C(2)-C(1)-N(17) 117.22(19) 
C(6)-C(1)-N(17) 120.77(19) 
C(1)-C(2)-C(3) 120.6(2) 
C(1)-C(2)-H(2) 119.7 
C(3)-C(2)-H(2) 119.7 
C(2)-C(3)-C(4) 117.3(2) 
C(2)-C(3)-C(16) 120.5(2) 
C(4)-C(3)-C(16) 120.8(2) 
C(5)-C(4)-C(3) 120.5(2) 
C(5)-C(4)-H(4) 119.7 
C(3)-C(4)-H(4) 119.7 
C(4)-C(5)-C(6) 121.1(2) 
C(4)-C(5)-H(5) 119.4 
C(6)-C(5)-H(5) 119.4 
C(5)-C(6)-C(1) 116.5(2) 
C(5)-C(6)-C(7) 120.3(2) 
C(1)-C(6)-C(7) 121.5(2) 
C(6)-C(7)-C(8) 113.3(2) 
C(6)-C(7)-H(7A) 108.9 
C(8)-C(7)-H(7A) 108.9 
C(6)-C(7)-H(7B) 108.9 
C(8)-C(7)-H(7B) 108.9 
H(7A)-C(7)-H(7B) 107.7 
C(9)-C(8)-C(7) 113.3(2) 
C(9)-C(8)-H(8A) 108.9 
C(7)-C(8)-H(8A) 108.9 
C(9)-C(8)-H(8B) 108.9 
C(7)-C(8)-H(8B) 108.9 
H(8A)-C(8)-H(8B) 107.7 
C(14)-C(9)-C(10) 117.0(2) 
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C(14)-C(9)-C(8) 122.0(3) 
C(10)-C(9)-C(8) 119.7(3) 
C(11)-C(10)-C(9) 120.6(2) 
C(11)-C(10)-H(10) 119.7 
C(9)-C(10)-H(10) 119.7 
C(10)-C(11)-C(12) 120.9(2) 
C(10)-C(11)-H(11) 119.6 
C(12)-C(11)-H(11) 119.6 
C(11)-C(12)-C(13) 117.1(2) 
C(11)-C(12)-C(15) 121.2(2) 
C(13)-C(12)-C(15) 120.3(2) 
C(14)-C(13)-C(12) 120.7(2) 
C(14)-C(13)-H(13) 119.6 
C(12)-C(13)-H(13) 119.6 
C(13)-C(14)-C(9) 120.6(2) 
C(13)-C(14)-H(14) 119.7 
C(9)-C(14)-H(14) 119.7 
C(12)-C(15)-C(16) 112.5(2) 
C(12)-C(15)-H(15A) 109.1 
C(16)-C(15)-H(15A) 109.1 
C(12)-C(15)-H(15B) 109.1 
C(16)-C(15)-H(15B) 109.1 
H(15A)-C(15)-H(15B) 107.8 
C(3)-C(16)-C(15) 112.45(19) 
C(3)-C(16)-H(16A) 109.1 
C(15)-C(16)-H(16A) 109.1 
C(3)-C(16)-H(16B) 109.1 
C(15)-C(16)-H(16B) 109.1 
H(16A)-C(16)-H(16B) 107.8 
C(18)-N(17)-C(1) 126.06(18) 
C(18)-N(17)-H(17) 115(2) 
C(1)-N(17)-H(17) 119(2) 
N(17)-C(18)-C(19) 122.0(2) 
N(17)-C(18)-C(23) 119.97(19) 
C(19)-C(18)-C(23) 118.02(19) 
C(20)-C(19)-C(18) 120.8(2) 
C(20)-C(19)-H(19) 119.6 
C(18)-C(19)-H(19) 119.6 
C(19)-C(20)-C(21) 121.0(2) 
C(19)-C(20)-H(20) 119.5 
C(21)-C(20)-H(20) 119.5 
C(22)-C(21)-C(20) 118.9(2) 
C(22)-C(21)-H(21) 120.6 
C(20)-C(21)-H(21) 120.6 
C(21)-C(22)-C(23) 121.5(2) 
C(21)-C(22)-H(22) 119.2 
C(23)-C(22)-H(22) 119.2 
C(22)-C(23)-C(18) 119.6(2) 
C(22)-C(23)-C(24) 119.01(19) 
C(18)-C(23)-C(24) 121.35(19) 
N(28)-C(24)-O(25) 117.7(2) 
N(28)-C(24)-C(23) 126.75(19) 
O(25)-C(24)-C(23) 115.48(19) 
C(24)-O(25)-C(26) 105.3(2) 
O(25)-C(26)-C(27) 105.8(2) 
O(25)-C(26)-H(26A) 110.6 
C(27)-C(26)-H(26A) 110.6 
O(25)-C(26)-H(26B) 110.6 
C(27)-C(26)-H(26B) 110.6 
H(26A)-C(26)-H(26B) 108.7 
N(28)-C(27)-C(26) 103.3(2) 
N(28)-C(27)-C(29) 111.58(18) 
C(26)-C(27)-C(29) 115.1(2) 
N(28)-C(27)-H(27) 108.9 
C(26)-C(27)-H(27) 108.9 
C(29)-C(27)-H(27) 108.9 
C(24)-N(28)-C(27) 107.38(19) 
C(31)-C(29)-C(27) 112.0(2) 
C(31)-C(29)-C(30) 111.6(3) 
C(27)-C(29)-C(30) 109.4(2) 
C(31)-C(29)-H(29) 107.9 
C(27)-C(29)-H(29) 107.9 
C(30)-C(29)-H(29) 107.9 
C(29)-C(30)-H(30A) 109.5 
C(29)-C(30)-H(30B) 109.5 
H(30A)-C(30)-H(30B) 109.5 
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C(29)-C(30)-H(30C) 109.5 
H(30A)-C(30)-H(30C) 109.5 
H(30B)-C(30)-H(30C) 109.5 
C(29)-C(31)-H(31A) 109.5 
C(29)-C(31)-H(31B) 109.5 
H(31A)-C(31)-H(31B) 109.5 
C(29)-C(31)-H(31C) 109.5 
H(31A)-C(31)-H(31C) 109.5 
H(31B)-C(31)-H(31C) 109.5 
C(33)-C(32)-C(37) 119.6(2) 
C(33)-C(32)-N(48) 117.94(19) 
C(37)-C(32)-N(48) 121.4(2) 
C(32)-C(33)-C(34) 121.3(2) 
C(32)-C(33)-H(33) 119.3 
C(34)-C(33)-H(33) 119.3 
C(35)-C(34)-C(33) 117.4(2) 
C(35)-C(34)-C(47) 121.9(2) 
C(33)-C(34)-C(47) 119.7(2) 
C(34)-C(35)-C(36) 120.1(2) 
C(34)-C(35)-H(35) 119.9 
C(36)-C(35)-H(35) 119.9 
C(35)-C(36)-C(37) 121.3(2) 
C(35)-C(36)-H(36) 119.3 
C(37)-C(36)-H(36) 119.3 
C(36)-C(37)-C(32) 117.1(2) 
C(36)-C(37)-C(38) 119.5(2) 
C(32)-C(37)-C(38) 121.4(2) 
C(37)-C(38)-C(39) 112.51(19) 
C(37)-C(38)-H(38A) 109.1 
C(39)-C(38)-H(38A) 109.1 
C(37)-C(38)-H(38B) 109.1 
C(39)-C(38)-H(38B) 109.1 
H(38A)-C(38)-H(38B) 107.8 
C(40)-C(39)-C(38) 112.2(2) 
C(40)-C(39)-H(39A) 109.2 
C(38)-C(39)-H(39A) 109.2 
C(40)-C(39)-H(39B) 109.2 
C(38)-C(39)-H(39B) 109.2 
H(39A)-C(39)-H(39B) 107.9 
C(45)-C(40)-C(41) 116.6(2) 
C(45)-C(40)-C(39) 120.8(3) 
C(41)-C(40)-C(39) 121.2(3) 
C(42)-C(41)-C(40) 121.0(3) 
C(42)-C(41)-H(41) 119.5 
C(40)-C(41)-H(41) 119.5 
C(41)-C(42)-C(43) 120.7(3) 
C(41)-C(42)-H(42) 119.6 
C(43)-C(42)-H(42) 119.6 
C(44)-C(43)-C(42) 117.0(2) 
C(44)-C(43)-C(46) 121.5(3) 
C(42)-C(43)-C(46) 119.9(3) 
C(45)-C(44)-C(43) 121.0(2) 
C(45)-C(44)-H(44) 119.5 
C(43)-C(44)-H(44) 119.5 
C(44)-C(45)-C(40) 120.7(2) 
C(44)-C(45)-H(45) 119.7 
C(40)-C(45)-H(45) 119.7 
C(43)-C(46)-C(47) 113.3(2) 
C(43)-C(46)-H(46A) 108.9 
C(47)-C(46)-H(46A) 108.9 
C(43)-C(46)-H(46B) 108.9 
C(47)-C(46)-H(46B) 108.9 
H(46A)-C(46)-H(46B) 107.7 
C(34)-C(47)-C(46) 112.9(2) 
C(34)-C(47)-H(47A) 109.0 
C(46)-C(47)-H(47A) 109.0 
C(34)-C(47)-H(47B) 109.0 
C(46)-C(47)-H(47B) 109.0 
H(47A)-C(47)-H(47B) 107.8 
C(49)-N(48)-C(32) 127.08(19) 
C(49)-N(48)-H(48) 114(2) 
C(32)-N(48)-H(48) 117(2) 
N(48)-C(49)-C(50) 122.5(2) 
N(48)-C(49)-C(54) 120.0(2) 
C(50)-C(49)-C(54) 117.5(2) 
C(51)-C(50)-C(49) 121.4(2) 
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C(51)-C(50)-H(50) 119.3 
C(49)-C(50)-H(50) 119.3 
C(50)-C(51)-C(52) 121.0(2) 
C(50)-C(51)-H(51) 119.5 
C(52)-C(51)-H(51) 119.5 
C(53)-C(52)-C(51) 118.9(2) 
C(53)-C(52)-H(52) 120.6 
C(51)-C(52)-H(52) 120.6 
C(52)-C(53)-C(54) 121.3(2) 
C(52)-C(53)-H(53) 119.4 
C(54)-C(53)-H(53) 119.4 
C(53)-C(54)-C(49) 120.0(2) 
C(53)-C(54)-C(55) 118.9(2) 
C(49)-C(54)-C(55) 121.1(2) 
N(59)-C(55)-O(56) 117.6(2) 
N(59)-C(55)-C(54) 126.9(2) 
O(56)-C(55)-C(54) 115.56(19) 
C(55)-O(56)-C(57) 105.78(18) 
O(56)-C(57)-C(58) 104.95(17) 
O(56)-C(57)-H(57A) 110.8 
C(58)-C(57)-H(57A) 110.8 
O(56)-C(57)-H(57B) 110.8 
C(58)-C(57)-H(57B) 110.8 
H(57A)-C(57)-H(57B) 108.8 
N(59)-C(58)-C(60) 111.24(18) 
N(59)-C(58)-C(57) 103.27(18) 
C(60)-C(58)-C(57) 114.7(2) 
N(59)-C(58)-H(58) 109.2 
C(60)-C(58)-H(58) 109.2 
C(57)-C(58)-H(58) 109.2 
C(55)-N(59)-C(58) 108.02(19) 
C(62)-C(60)-C(58) 111.1(2) 
C(62)-C(60)-C(61) 110.5(2) 
C(58)-C(60)-C(61) 110.3(2) 
C(62)-C(60)-H(60) 108.3 
C(58)-C(60)-H(60) 108.3 
C(61)-C(60)-H(60) 108.3 
C(60)-C(61)-H(61A) 109.5 
C(60)-C(61)-H(61B) 109.5 
H(61A)-C(61)-H(61B) 109.5 
C(60)-C(61)-H(61C) 109.5 
H(61A)-C(61)-H(61C) 109.5 
H(61B)-C(61)-H(61C) 109.5 
C(60)-C(62)-H(62A) 109.5 
C(60)-C(62)-H(62B) 109.5 
H(62A)-C(62)-H(62B) 109.5 
C(60)-C(62)-H(62C) 109.5 
H(62A)-C(62)-H(62C) 109.5 
H(62B)-C(62)-H(62C) 109.5
 
 Table 3: Anisotropic displacement parameters  (Å2x 103) for TCD334.  The anisotropic 
displacement factor exponent takes the form:  - 2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
___________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
___________________________________________________________________________  
C(1) 18(1)  17(1) 28(1)  0(1) -1(1)  2(1) 
C(2) 22(1)  21(1) 24(1)  -2(1) 1(1)  4(1) 
C(3) 20(1)  17(1) 35(1)  -2(1) 6(1)  1(1) 
C(4) 17(1)  19(1) 44(1)  -6(1) -1(1)  0(1) 
C(5) 25(1)  23(1) 33(1)  -3(1) -7(1)  5(1) 
C(6) 26(1)  19(1) 28(1)  1(1) -3(1)  4(1) 
C(7) 37(1)  31(1) 24(1)  3(1) -2(1)  1(1) 
Appendices      
252 
   
C(8) 54(2)  44(2) 49(2)  13(1) 23(1)  12(1) 
C(9) 31(1)  33(1) 37(1)  1(1) 11(1)  9(1) 
C(10) 32(1)  34(1) 34(1)  -11(1) 0(1)  10(1) 
C(11) 27(1)  22(1) 44(1)  -6(1) 1(1)  4(1) 
C(12) 30(1)  19(1) 40(1)  2(1) 3(1)  8(1) 
C(13) 27(1)  28(1) 36(1)  -6(1) -5(1)  10(1) 
C(14) 20(1)  26(1) 51(2)  -5(1) 5(1)  4(1) 
C(15) 45(2)  28(1) 47(2)  10(1) 11(1)  11(1) 
C(16) 30(1)  23(1) 42(1)  3(1) 9(1)  -3(1) 
N(17) 22(1)  20(1) 27(1)  3(1) -5(1)  -2(1) 
C(18) 23(1)  20(1) 18(1)  -2(1) 3(1)  -1(1) 
C(19) 23(1)  24(1) 26(1)  -1(1) 1(1)  1(1) 
C(20) 31(1)  23(1) 32(1)  -2(1) 0(1)  7(1) 
C(21) 37(1)  18(1) 37(1)  -1(1) 2(1)  0(1) 
C(22) 32(1)  22(1) 27(1)  -3(1) 3(1)  -5(1) 
C(23) 24(1)  23(1) 18(1)  -1(1) 3(1)  -2(1) 
C(24) 21(1)  26(1) 19(1)  0(1) 2(1)  -5(1) 
O(25) 24(1)  34(1) 54(1)  12(1) -9(1)  -8(1) 
C(26) 21(1)  57(2) 114(3)  44(2) -12(2)  -7(1) 
C(27) 18(1)  37(1) 32(1)  3(1) 2(1)  2(1) 
N(28) 22(1)  27(1) 26(1)  2(1) -1(1)  1(1) 
C(29) 22(1)  36(1) 30(1)  1(1) -2(1)  6(1) 
C(30) 36(2)  42(2) 76(2)  26(2) 1(1)  1(1) 
C(31) 45(2)  105(3) 33(1)  -22(2) -9(1)  31(2) 
C(32) 20(1)  21(1) 25(1)  2(1) 1(1)  2(1) 
C(33) 26(1)  22(1) 23(1)  4(1) 0(1)  2(1) 
C(34) 27(1)  22(1) 32(1)  0(1) -9(1)  3(1) 
C(35) 21(1)  22(1) 48(1)  7(1) -3(1)  0(1) 
C(36) 25(1)  26(1) 37(1)  7(1) 10(1)  5(1) 
C(37) 27(1)  22(1) 26(1)  2(1) 5(1)  6(1) 
C(38) 43(1)  34(1) 21(1)  0(1) 6(1)  1(1) 
C(39) 46(2)  53(2) 28(1)  -4(1) -10(1)  7(1) 
C(40) 33(1)  38(1) 32(1)  4(1) -10(1)  10(1) 
C(41) 39(1)  38(1) 40(1)  15(1) 2(1)  14(1) 
C(42) 33(1)  25(1) 55(2)  7(1) 1(1)  8(1) 
C(43) 37(1)  22(1) 49(2)  -5(1) -3(1)  11(1) 
C(44) 32(1)  29(1) 40(1)  -2(1) 3(1)  10(1) 
C(45) 26(1)  33(1) 40(1)  2(1) -6(1)  8(1) 
Appendices      
253 
   
C(46) 53(2)  34(1) 60(2)  -19(1) -14(1)  11(1) 
C(47) 41(1)  27(1) 39(1)  -6(1) -9(1)  -3(1) 
N(48) 24(1)  22(1) 26(1)  -3(1) 6(1)  -3(1) 
C(49) 26(1)  24(1) 19(1)  0(1) 0(1)  0(1) 
C(50) 27(1)  27(1) 26(1)  1(1) 3(1)  1(1) 
C(51) 31(1)  28(1) 30(1)  -1(1) 3(1)  5(1) 
C(52) 39(1)  21(1) 38(1)  -2(1) 1(1)  2(1) 
C(53) 31(1)  24(1) 33(1)  2(1) 0(1)  -3(1) 
C(54) 26(1)  25(1) 21(1)  2(1) -3(1)  -1(1) 
C(55) 24(1)  25(1) 21(1)  5(1) -2(1)  -4(1) 
O(56) 25(1)  26(1) 48(1)  4(1) 7(1)  -5(1) 
C(57) 22(1)  36(1) 38(1)  6(1) 6(1)  0(1) 
C(58) 21(1)  30(1) 27(1)  6(1) 2(1)  2(1) 
N(59) 24(1)  26(1) 26(1)  -1(1) 4(1)  -2(1) 
C(60) 29(1)  45(1) 24(1)  5(1) 0(1)  11(1) 
C(61) 44(2)  71(2) 31(1)  10(1) 12(1)  20(1) 
C(62) 41(1)  42(2) 37(1)  -11(1) -5(1)  8(1) 
 
 Table 4: Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for TCD334. 
___________________________________________________________________________  
 x  y  z  U(eq) 
___________________________________________________________________________  
H(2) 3240 624 -677 27 
H(4) 6208 1486 1429 32 
H(5) 5422 821 2847 33 
H(7A) 3399 145 3611 37 
H(7B) 2158 -161 2781 37 
H(8A) 625 617 3314 58 
H(8B) 1933 980 4005 58 
H(10) 3007 1983 3276 40 
H(11) 3638 2599 1758 37 
H(13) 576 1647 -129 37 
H(14) -113 1053 1396 39 
H(15A) 3510 2712 -386 48 
H(15B) 2557 2171 -1060 48 
H(16A) 4728 1653 -1244 37 
H(16B) 5533 2068 -270 37 
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H(19) 3949 -890 1519 29 
H(20) 3853 -2019 1730 34 
H(21) 1729 -2610 1158 37 
H(22) -348 -2045 471 32 
H(26A) -3939 -733 390 77 
H(26B) -3806 -866 -907 77 
H(27) -2984 245 194 35 
H(29) -3838 285 -1676 35 
H(30A) -981 882 -1400 77 
H(30B) -2432 1179 -886 77 
H(30C) -2320 1141 -2195 77 
H(31A) -1083 -286 -2169 92 
H(31B) -2219 23 -3078 92 
H(31C) -2675 -613 -2400 92 
H(33) 1863 8732 4180 28 
H(35) -1346 7804 5730 36 
H(36) -756 8411 7316 35 
H(38A) 1207 8863 8465 39 
H(38B) 2101 9455 7944 39 
H(39A) 4202 8861 7873 51 
H(39B) 3479 8430 8808 51 
H(41) 1899 7398 8059 47 
H(42) 1204 6752 6550 45 
H(44) 4343 7595 4814 40 
H(45) 5044 8247 6319 40 
H(46A) 1118 6603 4520 60 
H(46B) 2330 6959 3814 60 
H(47A) 732 7748 3322 43 
H(47B) -518 7357 3939 43 
H(50) 897 10158 6623 32 
H(51) 975 11259 7086 35 
H(52) 3081 11893 6792 39 
H(53) 5111 11404 6008 35 
H(57A) 8705 10296 4900 38 
H(57B) 7748 10444 3775 38 
H(58) 7822 9281 4993 31 
H(60) 6261 9528 2913 39 
H(61A) 9195 9025 3316 72 
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H(61B) 8767 9693 2683 72 
H(61C) 8350 9000 2129 72 
H(62A) 6972 8292 3919 60 
H(62B) 6272 8369 2691 60 
H(62C) 5338 8582 3717 60 
H(48) 3740(40) 9314(16) 5370(30) 40(8) 
H(17) 1080(40) 60(16) 310(30) 40(8) 
 
 Table 5: Torsion angles [°] for TCD334. 
___________________________________________________________________________ 
C(6)-C(1)-C(2)-C(3) -0.2(3) 
N(17)-C(1)-C(2)-C(3) 168.22(19) 
C(1)-C(2)-C(3)-C(4) 13.8(3) 
C(1)-C(2)-C(3)-C(16) -152.9(2) 
C(2)-C(3)-C(4)-C(5) -13.4(3) 
C(16)-C(3)-C(4)-C(5) 153.3(2) 
C(3)-C(4)-C(5)-C(6) -0.7(3) 
C(4)-C(5)-C(6)-C(1) 14.1(3) 
C(4)-C(5)-C(6)-C(7) -151.2(2) 
C(2)-C(1)-C(6)-C(5) -13.7(3) 
N(17)-C(1)-C(6)-C(5) 178.30(19) 
C(2)-C(1)-C(6)-C(7) 151.5(2) 
N(17)-C(1)-C(6)-C(7) -16.6(3) 
C(5)-C(6)-C(7)-C(8) 79.4(3) 
C(1)-C(6)-C(7)-C(8) -85.2(3) 
C(6)-C(7)-C(8)-C(9) 7.7(4) 
C(7)-C(8)-C(9)-C(14) 79.9(3) 
C(7)-C(8)-C(9)-C(10) -86.8(3) 
C(14)-C(9)-C(10)-C(11) -13.5(3) 
C(8)-C(9)-C(10)-C(11) 153.8(2) 
C(9)-C(10)-C(11)-C(12) -1.2(3) 
C(10)-C(11)-C(12)-C(13) 14.8(3) 
C(10)-C(11)-C(12)-C(15) -151.4(2) 
C(11)-C(12)-C(13)-C(14) -13.7(3) 
C(15)-C(12)-C(13)-C(14) 152.7(2) 
C(12)-C(13)-C(14)-C(9) -1.0(3) 
C(10)-C(9)-C(14)-C(13) 14.6(3) 
C(8)-C(9)-C(14)-C(13) -152.5(2) 
C(11)-C(12)-C(15)-C(16) 67.7(3) 
C(13)-C(12)-C(15)-C(16) -98.1(3) 
C(2)-C(3)-C(16)-C(15) 68.3(3) 
C(4)-C(3)-C(16)-C(15) -98.0(3) 
C(12)-C(15)-C(16)-C(3) 16.9(3) 
C(2)-C(1)-N(17)-C(18) 126.5(2) 
C(6)-C(1)-N(17)-C(18) -65.0(3) 
C(1)-N(17)-C(18)-C(19) -0.7(3) 
C(1)-N(17)-C(18)-C(23) -179.86(19) 
N(17)-C(18)-C(19)-C(20) -176.9(2) 
C(23)-C(18)-C(19)-C(20) 2.3(3) 
C(18)-C(19)-C(20)-C(21) 0.3(4) 
C(19)-C(20)-C(21)-C(22) -2.2(4) 
C(20)-C(21)-C(22)-C(23) 1.4(3) 
C(21)-C(22)-C(23)-C(18) 1.2(3) 
C(21)-C(22)-C(23)-C(24) -177.0(2) 
N(17)-C(18)-C(23)-C(22) 176.2(2) 
C(19)-C(18)-C(23)-C(22) -3.0(3) 
N(17)-C(18)-C(23)-C(24) -5.6(3) 
C(19)-C(18)-C(23)-C(24) 175.16(19) 
C(22)-C(23)-C(24)-N(28) -177.7(2) 
C(18)-C(23)-C(24)-N(28) 4.1(3) 
C(22)-C(23)-C(24)-O(25) 4.8(3) 
C(18)-C(23)-C(24)-O(25) -173.43(19) 
N(28)-C(24)-O(25)-C(26) -5.4(3) 
C(23)-C(24)-O(25)-C(26) 172.4(2) 
C(24)-O(25)-C(26)-C(27) 7.1(3) 
O(25)-C(26)-C(27)-N(28) -6.6(3) 
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O(25)-C(26)-C(27)-C(29) 115.3(3) 
O(25)-C(24)-N(28)-C(27) 1.0(3) 
C(23)-C(24)-N(28)-C(27) -176.6(2) 
C(26)-C(27)-N(28)-C(24) 3.7(3) 
C(29)-C(27)-N(28)-C(24) -120.6(2) 
N(28)-C(27)-C(29)-C(31) 59.4(3) 
C(26)-C(27)-C(29)-C(31) -58.0(3) 
N(28)-C(27)-C(29)-C(30) -65.0(3) 
C(26)-C(27)-C(29)-C(30) 177.7(2) 
C(37)-C(32)-C(33)-C(34) 1.1(3) 
N(48)-C(32)-C(33)-C(34) 169.36(19) 
C(32)-C(33)-C(34)-C(35) 13.5(3) 
C(32)-C(33)-C(34)-C(47) -155.2(2) 
C(33)-C(34)-C(35)-C(36) -14.2(3) 
C(47)-C(34)-C(35)-C(36) 154.2(2) 
C(34)-C(35)-C(36)-C(37) 0.5(3) 
C(35)-C(36)-C(37)-C(32) 14.1(3) 
C(35)-C(36)-C(37)-C(38) -150.2(2) 
C(33)-C(32)-C(37)-C(36) -14.7(3) 
N(48)-C(32)-C(37)-C(36) 177.47(19) 
C(33)-C(32)-C(37)-C(38) 149.2(2) 
N(48)-C(32)-C(37)-C(38) -18.6(3) 
C(36)-C(37)-C(38)-C(39) 102.3(3) 
C(32)-C(37)-C(38)-C(39) -61.3(3) 
C(37)-C(38)-C(39)-C(40) -22.1(3) 
C(38)-C(39)-C(40)-C(45) 103.9(3) 
C(38)-C(39)-C(40)-C(41) -61.9(3) 
C(45)-C(40)-C(41)-C(42) -13.7(4) 
C(39)-C(40)-C(41)-C(42) 152.6(2) 
C(40)-C(41)-C(42)-C(43) -0.1(4) 
C(41)-C(42)-C(43)-C(44) 14.1(4) 
C(41)-C(42)-C(43)-C(46) -151.7(2) 
C(42)-C(43)-C(44)-C(45) -14.3(3) 
C(46)-C(43)-C(44)-C(45) 151.3(2) 
C(43)-C(44)-C(45)-C(40) 0.4(4) 
C(41)-C(40)-C(45)-C(44) 13.6(3) 
C(39)-C(40)-C(45)-C(44) -152.8(2) 
C(44)-C(43)-C(46)-C(47) -84.3(3) 
C(42)-C(43)-C(46)-C(47) 80.9(3) 
C(35)-C(34)-C(47)-C(46) -85.2(3) 
C(33)-C(34)-C(47)-C(46) 83.0(3) 
C(43)-C(46)-C(47)-C(34) -4.7(4) 
C(33)-C(32)-N(48)-C(49) 130.4(2) 
C(37)-C(32)-N(48)-C(49) -61.6(3) 
C(32)-N(48)-C(49)-C(50) 4.8(3) 
C(32)-N(48)-C(49)-C(54) -173.5(2) 
N(48)-C(49)-C(50)-C(51) -179.1(2) 
C(54)-C(49)-C(50)-C(51) -0.7(3) 
C(49)-C(50)-C(51)-C(52) 0.5(4) 
C(50)-C(51)-C(52)-C(53) 0.3(4) 
C(51)-C(52)-C(53)-C(54) -0.9(4) 
C(52)-C(53)-C(54)-C(49) 0.7(3) 
C(52)-C(53)-C(54)-C(55) 177.5(2) 
N(48)-C(49)-C(54)-C(53) 178.5(2) 
C(50)-C(49)-C(54)-C(53) 0.1(3) 
N(48)-C(49)-C(54)-C(55) 1.8(3) 
C(50)-C(49)-C(54)-C(55) -176.58(19) 
C(53)-C(54)-C(55)-N(59) -179.8(2) 
C(49)-C(54)-C(55)-N(59) -3.0(3) 
C(53)-C(54)-C(55)-O(56) -0.7(3) 
C(49)-C(54)-C(55)-O(56) 176.08(19) 
N(59)-C(55)-O(56)-C(57) 4.7(3) 
C(54)-C(55)-O(56)-C(57) -174.46(19) 
C(55)-O(56)-C(57)-C(58) -6.3(2) 
O(56)-C(57)-C(58)-N(59) 6.0(2) 
O(56)-C(57)-C(58)-C(60) 127.1(2) 
O(56)-C(55)-N(59)-C(58) -0.6(3) 
C(54)-C(55)-N(59)-C(58) 178.4(2) 
C(60)-C(58)-N(59)-C(55) -126.9(2) 
C(57)-C(58)-N(59)-C(55) -3.5(2) 
N(59)-C(58)-C(60)-C(62) -60.5(3) 
C(57)-C(58)-C(60)-C(62) -177.2(2) 
N(59)-C(58)-C(60)-C(61) 176.6(2) 
C(57)-C(58)-C(60)-C(61) 59.9(3) 
Appendices   
257 
   
Table 6:  Hydrogen bonds for TCD334  [Å and °]. 
___________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
___________________________________________________________________________ 
 N(48)-H(48)...N(59) 0.90(3) 1.94(3) 2.694(3) 140(3) 
 N(17)-H(17)...N(28) 0.90(3) 1.95(3) 2.702(3) 139(3) 
___________________________________________________________________________ 
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